[
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line and bioinformatic analysis",
    "sample_type": "cell-line",
    "sample": "HCT116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-130a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=3.4678, p=0.003971",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC]",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.040 (over all survival), p=0.015(disease free survival)",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues (Surgical specimens of cancer tissues and adjacent nontumor tissue from 36 patients)",
    "expression": "Downregulated",
    "expression_details": "downregulated (hypermethylation)",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "downregulatedregulation-poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26675712"
  },
  {
    "miRNA_name": "miR-132-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=2.9894, p=0.034038",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=1.9819, p=0.0019298",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Tissues cell-line",
    "sample": "tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues) and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictor of poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "SW-48 colon cells",
    "expression": "Downregulated",
    "expression_details": "downregulated (targeted by SD-208)",
    "significance": "P=0.006",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "N/A",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26523217"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "plasma samples from 187 CRC cases and 47 healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.851",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "differentiated stage IV CRC from stage I-III patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "tissues (Cancerous colorectal tissue was collected from 16 patients and normal tissue from 9 patients), SW-480 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p>0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629019"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "fecal samples from 80 CRC patients and 51 normal controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "CRC cell lines and tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inverse correlation with advanced tumor-node-metastasis (TNM) stage (P < 0.01) and lymph node metastasis (P < 0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26820128"
  },
  {
    "miRNA_name": "miR-155-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=9.5344, p=0.003666",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=8.4896, p=0.001783",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "miR-17-5p (p = 0.037) and miR-145-5p (p = 0.023)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "lymphovascular invasion",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "miR-17-5p (p = 0.037) and miR-145-5p (p = 0.023)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "lymphovascular invasion",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "mir-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissue and non-cancer liver tissue were obtained from patients with colorectal cancer. 72 CRC patients and 69 normal (control) patients for survival analysis.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "positive with late liver metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26750720"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood Tissue Stool",
    "sample": "blood, tissue, stool;  39 patients with Colorectal Neuroendocrine tumor , blood and stool from 25 patients with hemorrhoids or other non-neoplastic diseases.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885189"
  },
  {
    "miRNA_name": "miR-193b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=2.0226, p=0.03595",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue Stool",
    "sample": "tissues, faecal; Forty pairs of primary CRC and its adjacent normal tissues and Faecal samples from 595 subjects (198 CRCs, 199 adenomas, and 198 neoplasm-free controls).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues p=0.0065, faecal<0.0001, AUC=0.83",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis: screening",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "plasma,  Plasma samples from healthy individuals and CRC patients (stages I–IV).",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.757",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "separated stage III-IV CRC patients from stage I-II",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=8.5246, p=0.0000345",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-205-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=4.1074, p=0.005377",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "colorectal cancer liver metastasis; formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colorectal cancer, liver metastasis and healthy tissues of 29 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "liver metastasis in colorectal cancer",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26845148"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=1.3418, p=0.017928",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-222-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=3.6624, p=0.025468",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.907",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.907",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-27a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=2.1788, p=0.007623",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=3.1147, p=0.00046",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue and Plasma",
    "sample": "Tissue and Plasma, CRC specimens (tumor and\nadjacent nontumor colon tissues) from 200 patients who had\nundergone resection and 400 Healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "Tissue AUC=0.883, Plasma AUC=0.743",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=1.951, p=0.013832",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-301a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=6.3519, p=0.019431",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-34a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=2.1307, p=0.004859",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=2.1593, p=0.008549",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "fold change=−2.0464, p=0.013107",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "discriminating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "combined miR-4299 and miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Signature",
    "expression_details": "Signature",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "discriminating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HCT8, LOVO, Ls-174, HCT116 and HT29 and tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26840372"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty-three CRC tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885452"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognosis-overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.74",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "distinguished stage I-IV CRC from healthy controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.74",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "distinguished stage I-IV CRC from healthy controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-96-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change=29.9234, p=0.01098",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Serum Tissues",
    "sample": "192 CRC patients,  serum and tumour tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.024",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predict prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "negative correlated with the tumour size, stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "six patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis, CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis in submucosal CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "six patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis, CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis in submucosal CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissue, Fifty-six tissue specimens, including 28 tumor tissues and 28 paired adjacent normal mucosal tissues, were selected from 28 cases of CRC. There were 15 cases of stage II disease and 13 cases of stage III disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II: fold change=-17544, p<0.001; Stage III fold change =-15.152, p<0.001; AUC 0.806, sensitivity 78.57%, specificity 78.57%",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "upregulated-regulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Tissue microarrays containing 56 specimens of normal mucosa, 51 adenoma and 735 colorectal cancer and  5 specimens of normal mucosa, 5 adenoma and 47 colorectal cancer for Real time PCR), CRC cells",
    "expression": "Upregulated",
    "expression_details": "upregulated in stage I and  downregulated from stage II to stage III",
    "significance": "increased gradually from normal mucosa, adenoma to stage I  (P<0.01), and decreased gradually from stage II to stage IIII (P<0.01)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic factor of overall survival (HR=0.550, 95% CI: 0.351-0.863) and disease free survival(HR=0.562, 95% CI: 0.397-0.794)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Overexpression of miR101 corelated with lower incidence of lymph node metastasis, lower metastasis rate, higher differentiation and lower recurrence rate (all P<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940181"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "decreased after surgery. P=0.0004, and P=0.0274, respectively",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-103 was significantly associated with histological differentiation, lymphatic invasion. high expression of miR-720 was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "decreased after surgery. P=0.0004, and P=0.0274, respectively",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-103 was significantly associated with histological differentiation, lymphatic invasion. high expression of miR-720 was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-103a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "",
    "expression_details": "",
    "significance": "P = 0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "",
    "expression_details": "",
    "significance": "P = 0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "",
    "expression_details": "",
    "significance": "P = 0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical specimens of cancer tissue and adjacent normal mucosa from 95 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "shorter overall and disease free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26223867"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "26 pairs of FFPE specimens (primary CRC tissues and lymph node metastasis tissues) and cell line (SW480)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "inversely correlated with distant metastasis and invasion depth",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28383561"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "colorectal cancer samples and non-tumorous adjacent mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0025",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor size, distant metastasis, non-differentiated tumors and vascular invasion.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28345456"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma samples of 543 CRC patients with stage I-IV disease",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Custom TaqMan® Array MicroRNA Cards followed by real time PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis and shorter relapse-free survival and overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27632639"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, CRC patients [male (n = 47), female (n = 21); median age: 57 years; colon cancer (n = 37) and rectal cancer (n = 31)] who underwent surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.016",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly associated with CRC metastasis, tumor T and N stages, and tumor grade (all P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25987767"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "downregulated (hypermethylation)",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "hypermethylated promoter-shorter overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "downregulated (hypermethylation)",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "hypermethylated promoter-shorter overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera, 237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.806",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "100 stage II CRC patients, early- and late-stage CRC tumors",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic value of miR-1269a for disease-free survival was significant (p=0.015)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with relapse and metastasis of disease-free patients (logrank p=0.002).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25872451"
  },
  {
    "miRNA_name": "miR-1280",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "cell line and tissues, human colorectal cancer tissues consisted of surgically resected primary colorectal cancer specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28446464"
  },
  {
    "miRNA_name": "miR-1287",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissues",
    "sample": "40 pairs of CRC tissue samples and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p  > 0.05 (not significant)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "low sensitivity and specificity",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27251300"
  },
  {
    "miRNA_name": "miR-1292",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues cell-line",
    "sample": "cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "overall survival P = 0.040, disease-free survival P = 0.015",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "38 CRC and corresponding non-cancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC = 0.857 (P<0.0001), with 78.9% sensitivity and 81.6% specificity",
    "detection_method": "RT-qPCR, in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098895"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "6 human CRC, 2 adjacent non-tumor and 2 healthy colorectal tissue samples and  HT-29, HCT-116, SW480, SW620, LOVO cell lines",
    "expression": "Downregulated",
    "expression_details": "downregulated (hypermethylation)",
    "significance": "p=0.013",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622593"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum, 60 patients with primary colorectal cancer, 40 patients with colorectal polyps and 50 healthy controls",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.875",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with different degrees of tumour differentiation (  P = 0.029) and different tumour stages (p=0.013)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27126269"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissues",
    "sample": "tissue specimens from 146 primary rectal adenocarcinoma samples, 116 distant normal mucosa samples, 80 adjacent normal mucosa specimens, and 49 lymph node metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "84% tissues",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940441"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues, and in serum samples of 117 patients and 90 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC = 0.9935, sensitivity of 96.6% and specificity of 97.8%",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Serum",
    "sample": "111 stage II/III and 139 stage I-III CRC patients, as well as serum samples and matched primary and metastatic liver tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, miRNAseq and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "serum biomarker for recurrence and metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28262692"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Eighteen colorectal cancer Tissues, 174 stage III or IV CRC patients from the TCGA project",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher miR-140 expression is significantly correlated with better survival in stage III and IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25980495"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty six pairs of CRC tissues and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with advanced CRC stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26402430"
  },
  {
    "miRNA_name": "miR141",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "decreased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HT29, T84 and LS174",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28454307"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Fresh cancer tissues and matched adjacent non-cancerous tissue from 18 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26278151"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "pre-operative plasma from 61 recently diagnosed colorectal cancer patients (including 13 stage I, 41 stage II and 7 stage III patients) and 24 (age and gender-matched) healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.002",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "CAIRO study (ClinTrials.gov NCT00312000) of the Dutch Colorectal Cancer Group",
    "sample_type": "Tissues",
    "sample": "820 patients with advanced CRC, primary tumors and matched normal tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "progression free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26392389"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT-8, HT-29, SW480, SW620, LoVo, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.0098",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973017"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissue, 32 CRC patient",
    "expression": "Differential expression",
    "expression_details": "differed in clinical stage",
    "significance": "P < 0.05; odds ratio = 4.21; 95% CI of odds ratio = 1.17 to 15.13)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe and Asia",
    "population": "Russia",
    "sample_type": "Tissues",
    "sample": "EMT positive tissues, 45 patients with colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145, miR-106a and miR-17-3p panel",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from pre- and post-operative CRC patients and normal subjects, 175 stage II/III CRC patients",
    "expression": "",
    "expression_details": "",
    "significance": "p=< 0.0001, AUC=0.886, AUC=0.85",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "shorter disease-free survival (DFS) (P < 0.0001 for miR-17-3p and P = 0.001 for miR-106a)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26250939"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "Seventy pairs of samples from CRC Tissues for IHC and 20 for real time PCR, HT29, HCT116, RKO, SW480, LoNo, FHC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28186967"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "colorectal adenoma (n = 21) and CRC (stage I-IV, n = 159), formalin-fixed paraffin-embedded tissue samples",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic classifier in patients with stage III CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue Plasma",
    "sample": "Tissue, Plasma, 97 subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "plasma (FC = -1.29, p-value = 0.013) and cancer tissue (FC = -2.55, p-value = 4.104e-08)",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "distinguished groups of patients with polyps from those with advanced cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissue, 169 pairs of CRC specimens and adjacent noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival (P = 0.006)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly associated with large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 POCD patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive biomarkers for POCD",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27872469"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "specimens",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28039449"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "specimens",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28039449"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "specimens",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28039449"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "specimens",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28039449"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "specimens",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28039449"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissues",
    "sample": "182 colorectal adenocarcinoma specimens and 86 non-cancerous colorectal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicts poor disease-free survival (DFS) and overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27930363"
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray, 22 patients with synchronous CRC and 579 solitary CRCs,  CRCs, CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-143-145 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray, 22 patients with synchronous CRC and 579 solitary CRCs,  CRCs, CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "63 stage II CRC Tissues, FFPE tissues, Seven patients with recurrence and 50 patients were recurrence-free",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "miRNA chip followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "recurrence predictor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28036302"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "Twenty-five CRC tissue samples and adjacent normal colon tissue samples , cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398009"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "reduced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "colorectal canecer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic and diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "colorectal canecer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic and diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "63 surgically resected tissues and paired normal",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "upregulated in  40/63 (63.5%)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlate with tumor stage and associated with the absence of lymph node invasion (N0)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27902469"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-1995p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 pairs of primary CRC samples and their corresponding liver metastasis tissues (8 pairs of fresh frozen and 48 pairs of paraffin-embedded specimens)",
    "expression": "Upregulated",
    "expression_details": "high",
    "significance": "higher in primary tumors than in matched liver metastases (P = 0.007), high in stage III patient without metastasis (p=0.028)",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with long overall survival (p=0.01)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "higher in primary tumors of patients with stage III CRC without liver metastases than in CRC patients with liver metastases",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26259252"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "surgical tissue specimens from 11 CRC patients and 275 formalin-fixed, paraffin-embedded CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associiated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26302825"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "colorectal adenomas",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential expression",
    "expression_details": "differential",
    "significance": "miR-19a (p=0·0339) miR-98 (p=0·0266), miR-146b (p=0·0045), miR-186 (p=0·0008) miR-625 (p=0·0049)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "colorectal adenomas",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential expression",
    "expression_details": "differential",
    "significance": "miR-19a (p=0·0339) miR-98 (p=0·0266), miR-146b (p=0·0045), miR-186 (p=0·0008) miR-625 (p=0·0049)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "colorectal adenomas",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential expression",
    "expression_details": "differential",
    "significance": "miR-19a (p=0·0339) miR-98 (p=0·0266), miR-146b (p=0·0045), miR-186 (p=0·0008) miR-625 (p=0·0049)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "colorectal adenomas",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential expression",
    "expression_details": "differential",
    "significance": "miR-19a (p=0·0339) miR-98 (p=0·0266), miR-146b (p=0·0045), miR-186 (p=0·0008) miR-625 (p=0·0049)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "colorectal adenomas",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential expression",
    "expression_details": "differential",
    "significance": "miR-19a (p=0·0339) miR-98 (p=0·0266), miR-146b (p=0·0045), miR-186 (p=0·0008) miR-625 (p=0·0049)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC = 0.830",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC = 0.830",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC = 0.830",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "decreased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "TCGA Data",
    "sample_type": "TCGA dataset",
    "sample": "255 CRC tumor samples from The Cancer Genome Atlas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "survival p < 0.01",
    "detection_method": "TCGA data",
    "marker": "Prognostic",
    "marker_details": "related to overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28567416"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe and Asia",
    "population": "Russia",
    "sample_type": "Tissues",
    "sample": "EMT positive tissues, 45 patients with colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues of 122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with distant metastasis (DM), lymph node metastasis (LNM), and TNM stage (P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues Serum",
    "sample": "short-term survivors compared to long-term survivors, Samples from 100 patients were used in the tumor cohort, and samples from an additional 50 patients were used in the serum cohort.",
    "expression": "Upregulated",
    "expression_details": "overexpressed",
    "significance": "p = 0.010",
    "detection_method": "next-generation sequencing followed by real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictor of short term survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27935861"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissue compared to control tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406866"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "reduced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "decreased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues,  11 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Survival p=0.024",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissues",
    "sample": "326 CRC patients, plasma exosomes, primary tumor tissues, and liver metastasis tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan miRNA assays",
    "marker": "Prognostic",
    "marker_details": "prediction of recurrence and poor prognosis in CRC patients with TNM stage II, III, or IV",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28376502"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe and Asia",
    "population": "Russia",
    "sample_type": "Blood",
    "sample": "34 EDTA stabilized peripheral blood samples and 34 saliva samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "plasma, P = 0.0001; saliva, P = 5e-12, sensitivity and specificity of 65 and 85% in the plasma, and 97 and 91% in the saliva.",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27910062"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.706",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "RKO cells",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "mediate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "(miR-21,miR-143, miR-148a, miR-194, miR-192, miR-200b, miR-200c, miR-10b, miR-26a, miR-145) signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue Cell-line",
    "sample": "48 pairs of samples (CRC and adjunct region normal tissues) and cell line",
    "expression": "Differential expression",
    "expression_details": "dysregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26646696"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Tissue Cell-line",
    "sample": "tumours of patients that had undergone adjuvant 5-FU treatment (n = 11) , Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "hypoxia biomarker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "miR-211 expression level (P = 0.01) was effective on overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "lymphovascular invasion (P = 0.011), perineural invasion (P = 0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26152286"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "decreased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-183-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissue (n=50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.038",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with shorter overall survival p=0.032",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly associated with poor tumor differentiation (P = 0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26016795"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "enhanced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues (20 patients) and cell line (HT-29 (P<0.001), Caco-2 (P<0.001), DLD-1 (P<0.001), SW480 (P<0.001) and SW620 (P<0.001) )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238082"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "118 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "76% had reduced expression by 4 folds",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "correlated with relapse free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28422727"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "193 colorectal cancer patients, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28347238"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, 24 pairs of CRC tissues and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25867276"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma samples,  96 blood samples were obtained from patients that underwent tumor resection for CRC, 48 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001, AUC = 0.842, sensitivity = 84.38%; specificity = 77.08%",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "shorter recurrence-free survival time and poorer overall survival rate",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with clinical stage, tumor depth, distant metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "Panel - (mir-23b, mir-365-1 and mir-365-2)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "TCGA Data",
    "sample_type": "TCGA dataset",
    "sample": "253 samples from TCGA Dataset",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26269151"
  },
  {
    "miRNA_name": "miR-24 3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 paired non-cancerous colorectal mucosae",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-24-3p expression predicts poor disease-free survival (DFS) and overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27939727"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "potential marker for early CRC diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "potential marker for early CRC diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "potential marker for early CRC diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-26a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "plasma, Plasma samples from 61 colorectal cancer patients and 24 normal subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.013",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany, Greece",
    "sample_type": "Tissues Serum",
    "sample": "Ulcerative Colitis-associated Carcinogenesis, 25 fresh-frozen colon biopsies and corresponding serum samples of 6 UC and 15 non-UC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26083618"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "Tissues from 90 CRC cases, HCT116, Caco2, HT29, SW620 and SW480",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28209128"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissues",
    "sample": "40 sample pairs of CRC tissue and adjacent noncancerous tissue",
    "expression": "",
    "expression_details": "",
    "significance": "68% sensitivity and 78% specificity (P=0.001)",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28469363"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera, 237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.741",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues and Plasma",
    "sample": "CRC specimens (tumor and adjacent nontumor colon tissues) from 200 patients and 400 healthy age- and gender-matched controls, Blood samples",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.883, sensitivity of 61.4% and a specificity of 72.5%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-300",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "colorectal cancer (CRC) tissues compared to adjacent colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with lymphatic metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779716"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "Eighty fresh-frozen tumor tissues samples and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inversely associated with advanced stage and lymph node metastatic status",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28528497"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "tissues, 50 submucosally invasive colorectal cancer specimens, along with the corresponding non-tumoral mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173758"
  },
  {
    "miRNA_name": "miR-320e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "tissue, 237 stage II–IV CRC patients treated with 5-FU-based chemotherapy, as well as in normal colonic mucosa from 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Stage III colon cancer, 95% confidence interval (CI)=1.14-1.42; P<0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "poorer DFS (HR)=1.65; 95% CI=1.27-2.13; P=0.0001) and OS (HR=1.78; 95% CI=1.31-2.41; P=0.0003) in stage III CRC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26035698"
  },
  {
    "miRNA_name": "miR-330-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "CRC tissues than and adjacent non-tumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27633518"
  },
  {
    "miRNA_name": "miR-34",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues Plasma",
    "sample": "Tissue (public dataset of 40 CRC samples and paired normal tissues), Plasma (validation cohort of 97 subjects)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissue fold change=1.71, p=8.50e-6; Plasma - FC = 1.90, p-value = 0.001)",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "distinguished groups of patients with polyps from those with advanced cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA and Asia",
    "population": "USA, Hong kong",
    "sample_type": "Tissues",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold change=1.42",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "No significant association with prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA and Asia",
    "population": "USA, Hong kong",
    "sample_type": "Tissues",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold change = 1.27",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "significant poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA and Asia",
    "population": "USA, Hong kong",
    "sample_type": "Tissues",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold change=1.25",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "significant poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues (60 pairs of CRC and non-tumor samples )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "51 of 60 patients,  an average 3.08-fold decrease (P = 0.004)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-371b-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum (20 patients with colon adenoma, 20 patients with colon cancer and 20 healthy subjects )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissues",
    "sample": "serum and tissues in CRC and colorectal precancerous lesions (CPL) patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05, AUC=0.854, 81.9 % and 73.3 %.",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "worse overall survival period (p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor node metastasis (p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "28 tumor tissues and 28 paired adjacent normal mucosal tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II:  fold change=-2.519 p= 0.018; Stage III=-2.924 P=0.049;  AUC 0.724, sensitivity 71.43%, specificity 71.43%, and P=0.004",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Egypt",
    "sample_type": "Serum",
    "sample": "serum of 86 patients with CRC and 36 age- and sex-matched controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "fold change 0.42±0.27",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28374902"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "90 pairs of human colorectal cancer tissues and their corresponding noncancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "predicted tumor metastatic potential",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27276676"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "plasma of ulcerative colitis and colitis associated cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0061",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312900"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissue (surgical specimens of cancer tissue and adjacent normal mucosa from 32 patients with colorectal cancer)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05; odds ratio = 4.6; 95% CI of odds ratio = 1.25 to 16.84",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "expression of miR-378a-3p and miR-378a-5p was significantly associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-378-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "Tissues and Cell line: LoVo, CaCo2, SW1116, SW480, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "44/47 tissues, 93.6%, p<0.001",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25977643"
  },
  {
    "miRNA_name": "miR-384",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "100 cases of fresh primary CRC biopsies and their paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "downregulated in 83.0% (83/100) CRC patients",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with the invasive depth, lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27769041"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "SW480 and SW1116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "correlated with tumor size and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26084278"
  },
  {
    "miRNA_name": "miR-424-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues cell-line",
    "sample": "cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-4316",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0025, 76.8% specificity and 75%",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-4463",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma, 20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissues",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissues",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-4775",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "544 pairs of FFPE normal and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR and in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "high levels predicted poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high-risk factor for CRC metastasis and recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095858"
  },
  {
    "miRNA_name": "miR-487b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "primary, non metastatic and liver metastatic lesions (n=34)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-487b was associated with better prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28000854"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues cell-line",
    "sample": "cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0054, 76.8% specificity and 60.7%",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-5704",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma, 20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-582-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissues compared with corresponding noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26384136"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HT29 and HCT116 CRC cells and tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "negatively correlated with occurance and metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26158514"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Serum",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues, and in serum samples of 117 patients and 90 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "sensitivity of 87.5% and specificity of 63.5%",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "tissues and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "lower in metastatic CRC tissues compared with non metastatic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26333174"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "196 CRCs and 14 normal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival p=0.01",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with tumour depth, venous invasion, lymphatic invasion, lymph node metastasis, and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27919977"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissue (cancer tissues and adjacent normal tissues from 38 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with a poor clinical outcome",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940709"
  },
  {
    "miRNA_name": "miR92a-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "decreased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-92b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-188-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-221-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-425-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-497-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria, Czech Republic",
    "sample_type": "Tissues",
    "sample": "cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "",
    "expression_details": "",
    "significance": "miR-188-3p: HR = 1.538; P = 0.010",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong predictors of survival,",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "corrrelated with prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28498456"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Serum",
    "sample": "tumor tissues, lymph nodes and serum",
    "expression": "Downregulated",
    "expression_details": "decreased",
    "significance": "lymph nodes (P<0.01) and serum (P<0.05)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882171"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "202 colorectal cancer and adjacent colorectal tissues",
    "expression": "Downregulated",
    "expression_details": "decreased",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27784461"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "decreased",
    "significance": "p<0.05",
    "detection_method": "TaqMan® MicroRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "correlated with distant metastasis (DM), lymph node metastasis (LNM), and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "179 primary CRC tissues, serum samples of 211 CRCs, 56 adenomas and 57 control subjects.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Adenoma v/s normal AUC=0.718, CRC patient v/s normal AUC=0.830",
    "detection_method": "miRNA array",
    "marker": "Prognostic",
    "marker_details": "Predictor for prognosis (hazard ratio (HR) = 4.51; P=0.0096) and tumor recurrence",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27502702"
  },
  {
    "miRNA_name": "seven miRNA panel (miR-21, miR-29c, miR-122, miR-192, miR-346, miR-372, and miR-374a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma, Test cohort of 120 patients and validation cohort of 150 patient",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "CRC and colorectal adenomas= 86% to 90% accuracy",
    "detection_method": "microfluidic array technology",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27471839"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "32 patients who underwent primary tumor resection and received palliative chemotherapy for unresectable metastatic CC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "for PFS (p=0.0109) and OS (p=0.0675)",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "associated with reduced progression-free survival (PFS) and overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798874"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "246 pairs of samples, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "rea time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival (P < 0.0001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "advanced stage (P < 0.0001), lymph node metastasis (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27592860"
  },
  {
    "miRNA_name": "four miRNA panel (miR-23a-3p, miR-27a-3p, miR-142-5p and miR-376c-3p)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "427 colon cancer patients and 276 healthy donors, Serum",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "89% and specificity of 81% (AUC = 0.922)",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "early diagnostic and prognostic panel",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27485599"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "CRC tissues and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with  lymph node or distance metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572146"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "prognostic",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "asociated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with poor differentiation and advanced TNM classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27494869"
  },
  {
    "miRNA_name": "miR-544a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "metastatic tumor samples and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27165435"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "38 CRC tissues and the paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "for survival p= 0.007",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly associated with a more aggressive phenotype of CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27602163"
  },
  {
    "miRNA_name": "miR-4282",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27120047"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissues",
    "sample": "108 primary colorectal adenocarcinoma samples and 54 paired non-cancerous colorectal tissue specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicts poor disease-free and overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with advanced stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044381"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "188 CRC samples, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with advanced clinical stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27248318"
  },
  {
    "miRNA_name": "miR-1260b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "120 cases of CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis and venous invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27399918"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "72 pairs of CRC tumor tissues and their corresponding adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with an advanced clinical tumor-node-metastasis stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27376958"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR 10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-28-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR 122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-122*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR 885-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "102 CRC tissues and paired normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with local invasion lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27350737"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "202 colorectal cancer tissues and adjacent colorectaltissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27346400"
  },
  {
    "miRNA_name": "miR-199b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "30 pairs of CRC metastatis tissues and primary CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "longer median survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated to late TNM stage and distant metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27145368"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy, UK, Romania, Austria",
    "sample_type": "Tissues",
    "sample": "85 CRC samples, CRC tissues from patients with and without metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Prognostic",
    "marker_details": "shorter overall survival and shorter metastasis free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25804630"
  },
  {
    "miRNA_name": "three miRNA classifier (miR-342-3p, miR-361-3p, and miR-3621)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "20 T1-stage CRC samples, FFPE tissue sections",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.947, 4% sensitivity, 85% specificity and 89% accuracy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "for predicting LNM in T1 stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27096956"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "predicted",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "97 CRC and normal tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "downregulated in 65 out of 97 samples",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "closely related to TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26935905"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "miR-573",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "miR-573",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "miR-573",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "miR-573",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 139 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173217"
  },
  {
    "miRNA_name": "miR-663b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-4539",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-4506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "1,894 had carcinoma tissue and 1,599 had normal mucosa",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Agilent Human miRNA Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-182-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-200a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-133a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-125b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "three samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-517a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "90 pairs of CRC and matched adjacent non-tumor tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall and disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "high tumor invasion, lymph node metastases, distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073521"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "related",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Serum",
    "sample": "CRC serum and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor size, TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissues",
    "sample": "115 colorectaladenocarcinomas and 66 adjacent non-cancer mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "strong prognosticator, predicts short-term relapse and poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25420464"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "96 CRC tissues, HCT116 and SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poorer five year survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with tumor size, TNM stage, lymphatic metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "Tissue sections, 277 consecutive patients with T3-4a colorectal cancer treated with R0 surgical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.019",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "associated with shorter recurrence-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25609245"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tissues from 126 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 10(-6)",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with regional lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25592646"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "30 CRC specimens, CRC and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.01",
    "detection_method": "MiRNA sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma, Tissues, Cell-line",
    "sample": "Plasma from 118 CRC patients and 61 healthy , CRC tissues and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with lymph node metastasis, distant metastasis, higher pTNM stage (III-IV), and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "downregulatedregulation associated with poorer overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26406866"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "stool samples from 40 patients with early stage (I, II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "stool samples from 40 patients with early stage (I, II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-25-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands, Germany",
    "sample_type": "Tissues",
    "sample": "metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands, Germany",
    "sample_type": "Tissues",
    "sample": "metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in serum of stage I-II CRC patients",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in serum of stage III-IV patients",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "78 cases of CRC tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with lymph node or distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25613903"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with shorter overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with shorter overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe and Asia",
    "population": "Russia",
    "sample_type": "Tissues",
    "sample": "45 CRC tisues",
    "expression": "Upregulated",
    "expression_details": "upregulated in EMT positive Cancer",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Marker for EMT",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe and Asia",
    "population": "Russia",
    "sample_type": "Tissues",
    "sample": "45 CRC tisues",
    "expression": "Downregulated",
    "expression_details": "downregulated in EMT positive Cancer",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with degree of tumor differantiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "Panel of miR-409-3p, miR-7, and miR-93",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 plasma samples for microarray and 161 training and validation plasma samples by real time PCR",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.897",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23456911"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "180 colonic cancer cases",
    "expression": "Downregulated",
    "expression_details": "upregulated in paracancerous tissues compared to colonic cancer tissues",
    "significance": "P < 0.001",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755775"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.026",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "predicts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.027",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "predicts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "5 CRC patients who underwent radical resection, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicators for overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with  local invasion, lymph node metastasis and clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25502080"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "tumor tissue, paired normal tissue, Mesenteric Vein blood and Peripheral Vein blood of 57 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in MV than PV",
    "significance": "P = 0.014",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter disease-free survival (DFS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25569638"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "colorectal adenoma (n = 21) and CRC (stage I-IV, n = 159) FFPE Tissues, HT29 and WiDr",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "independent prognostic classifier in patients with stage III CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-302a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-548ah-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-23a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "let-7c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-124-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Plasma",
    "sample": "71 colorectal cancer patients, Plasma and FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25081869"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC and corresponding adjacent tissues 247 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic factor for progression-free and overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270723"
  },
  {
    "miRNA_name": "miR199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "post-operative serum Vs. pre-operative serum, 30 paired serum samples, 84 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.016",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with deep wall invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25269744"
  },
  {
    "miRNA_name": "Four-miRNA panel (miR-19a-3p, miR-223-3p, miR-92a-3p and miR-422a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum,307 colorectal adenocarcinoma patients, 164 colorectal adenoma patients and 226 healthy controls.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.810",
    "detection_method": "Miseq sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "could differentiate stage I/II CAC from controls and adenoma from carcinoma",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233400"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 62 patients undergoing radical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "corelated with poorer overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with TNM stage and lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270282"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.0001",
    "detection_method": "array followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "non invasive marker for detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.0001",
    "detection_method": "array followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "non invasive marker for detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "63 pairs of colon cancer and adjacent non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.025",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25550849"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "improved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "improved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "colitis-associated cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "Forty UC patients without CAC, four patients with CAC or dysplasia, eight sporadic colorectal cancer (S-CRC) patients, and 12 healthy volunteers (HV)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "methylation-specific polymerase chain reaction (MSP)",
    "marker": "Prognostic",
    "marker_details": "Potential risk marker of colitis-associated cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24825593"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with larger tumor size, higher incidence of lymph node metastasis, and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "206 patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall surviva",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor invasion, lymph node metastasis, distant metastasis, and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24981248"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum of 40 patients with colorectaladenocarcinoma and 40 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with clinical stages of tumors",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25178939"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Plasma",
    "sample": "cancer tissues (n=88) and matched plasma samples (CRC, n=88; control, n=40)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25255814"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "20 normal colorectal mucosa cases, 40 colorectal adenomas cases and 40 CRC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with large tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25285168"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "formalin fixed paraffin embedded tissue from the primary tumours of 560 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "low expression associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25199818"
  },
  {
    "miRNA_name": "miR-193a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "304 formalin-fixed, paraffin-embedded specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.0060",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "downregulated regulation associated with poorer survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlates with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25232258"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "70 patients and CRC cell lines: Caco-2, SW480, HT-29, HCT-116, LOVO and HCEpic cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24393525"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.031",
    "detection_method": "miRNA PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissues",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "20 tubular adenomas, 50 colorectal carcinoma (CRC), and 40 CRC liver metastases, 50 Controls",
    "expression": "Upregulated",
    "expression_details": "upregulated : increased progressively",
    "significance": "in primary CRCs (5.3-fold change; p<0.0001), and CRC liver metastases (7.5-fold change; p=0.005)",
    "detection_method": "in situ hybridization and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 51 CRC patients and controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "3.2-fold change; p=0.008",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor samples and adjacent non-cancerous tissues from 169 patients undergoing radical resection for CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poorer overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with the depth of the local invasion, poor differentiation, lymph node metastasis and advanced disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25170220"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "associated with lower survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "associated with lower survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "116 malignant colorectal adenocarcinoma specimens and 60 paired non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : predicts poor overall survival (p=0.007)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24615484"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "99 CRC patients (44 with and 55 without liver metastases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with an unfavorable prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616020"
  },
  {
    "miRNA_name": "135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "148b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-196a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-223-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-27a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-30e-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-4787-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-485-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-660-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-191-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-5000-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "micro RNA profiling followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "biomarkers of the side population",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-5009-3P",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "micro RNA profiling followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "biomarkers of the side population",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "micro RNA profiling followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "biomarkers of the side population",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 202 patients (117 males and 85 females) undergoing surgical resection for CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.01",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25019299"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "86 patients with primary CRC who underwent surgery without preoperative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent predictor of low survival rates",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24737193"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "17.5 folds higher, AUC=0.939, P<0.01, sensitivity of 76.5% and specificity of 96.4%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "102 folds higher, AUC= 0.971, P<0.01, sensitivity of 88.2% and specificity of 100.0%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-200C",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor and peritumoral tissues of 101 colon cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly correlated with the TNM stage, lymph node metastasis, and invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24682933"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe and USA",
    "population": "Italian and American populations",
    "sample_type": "Tissues",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA microarray and Taqman array followed by real time PCR, TMA and In-situ Hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe and USA",
    "population": "Italian and American populations",
    "sample_type": "Tissues",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA microarray and Taqman array followed by real time PCR, TMA and In-situ Hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe and USA",
    "population": "Italian and American populations",
    "sample_type": "Tissues",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RNA microarray and Taqman array followed by real time PCR, TMA and In-situ Hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-566",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe and USA",
    "population": "Italian and American populations",
    "sample_type": "Tissues",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "RNA microarray and Taqman array followed by real time PCR, TMA and In-situ Hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-324-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "marker",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Eighty-four pairs of colon cancer specimens and their corresponding non-tumor adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated in the recurrence and metastasis groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24888652"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Increased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Increased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "37 healthy volunteers and 227 patients with advanced colorectal adenoma, FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Sensitivity and specificity were 76.1% and 77.2% in prospective cohort",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression is predictor of Recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691499"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool Tissues",
    "sample": "40 pairs of CRC tissues, 16 pairs of advanced adenoma tissues, and 424 stool samples, including 104 CRCs and 109 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive stool marker for CRC and Adenoma patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "increasing trend across the adenoma to cancer sequence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691020"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "induces",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "in-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with T-stage, lymph node metastasis, distant metastasis, and Dukes' stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25031782"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Increased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Decreased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Decreased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "out of 31 patients 13 of stage III tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change  = 17.7 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with stage III",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "out of 31 patients 3 of stage IV tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "fold change = 23.8 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with stage IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "high",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 145 patients were German",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.047",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in stage II German cohhort",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "Six miRNA Panel (miR-21, let-7g, miR-31, miR-92a, miR-181b, and miR-203)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "Serum samples from 83 CRCs and 59 controls in validation set",
    "expression": "Panel",
    "expression_details": "Panel",
    "significance": "AUC = 0.923",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "non invasive biomarker for diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24709885"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Tissues Serum",
    "sample": "3-phase study using FFPE tissue and serum from 446 colorectal specimens,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic marker for CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "higher in stage IV than in stage I-III CRCs: Predictor for lymph node metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Tissues",
    "sample": "721 CRCs, 381 serrated lesions and 251 non-serrated adenomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, 335.0",
    "detection_method": "miRNA Array analysis, real time PCR and Pyro sequencing",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic Marker, associated with BRAF and KRAS mutations, High miR-31 expression was related to cancer-specific mortality",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24242331"
  },
  {
    "miRNA_name": "MiR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "92 pairs of CRC and adjacent nontumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facto for overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with distant metastasis, clinical TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24532280"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Stool Tissues",
    "sample": "Stool samples and Tissue samples from 82 CRC patients, Control samples from 40 healthy individuals",
    "expression": "",
    "expression_details": "",
    "significance": "76.8 % sensitivity and 93.6% specificity of the miR-34a methylation test for detecting CRC using stool samples.",
    "detection_method": "Methylation specific PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "abnormal DNA methylation of miR-34a was correlated with lymph metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573638"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Predictor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Mouse model and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real-time fluorescent quantitative PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "gradually elevated with the formation of colitis-associated colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24989910"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "TCGA",
    "sample": "cohort of 111 patients and 217 patients of the Cancer Genome Atlas data set",
    "expression": "",
    "expression_details": "",
    "significance": "p<0.05",
    "detection_method": "microarray followed by in-situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker - low miR-200a expression was associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24504363"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Correlated with large tumor size, lymph node metastasis, advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "Signature",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissues",
    "sample": "80 patients with wild type KRAS CRC undergoing treatment with the EGFR-targeting monoclonal antibodies cetuximab and panitumumab for metastatic CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Pyrosequencing",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low miR-181a expression was associated with poor progression free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "low miR-181a expression level was associated with poor differentiation of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24098024"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Blood",
    "sample": "peripheral blood from 65 patients",
    "expression": "Downregulated",
    "expression_details": "downregulated in non relapsed",
    "significance": "P-value=<0.0001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic - Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24423916"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "43 colonic cancer tissues",
    "expression": "Downregulated",
    "expression_details": "downregulated in non relapsed",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low expression of miR-146a was associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with poor tumor differentiation, tumor size and clinical stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670457"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 50 colorectal cancer patients and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.012, sensitivity of 62.3%, and a specificity of 68.2%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "significantly decreased after the operation",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670448"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.0001, 77.78% sensitivity and 68.97% specificity",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer:  downregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.0001, 86.11% sensitivity and 76.11% specificity",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "Let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.0120, 73.61% sensitivity and 66.38% specificity",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Surgical tissues from 94 patients with CRC.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stag, lymph node metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24150523"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissues",
    "sample": "Tissues from 122 patients with surgical resection of colorectum (82 adenocarcinomas, 20 adenomas, and 20 non-neoplastic tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "reduced in 76% (n = 62/82) cancer tissues",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "higher expression in distal colorectal adenocarcinomas and in cancers of lower T staging",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24009195"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Upregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Upregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Upregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "mir-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-596",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Washington, DC",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "--",
    "expression_details": "--",
    "significance": "P = 0.0026",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-376a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Tissues from 53 CRC patients and matched matched normals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0294",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "higher expression positively correlated with shorter survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression positively correlated with advanced lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422250"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues cell-line",
    "sample": "15 CRC, 15 Polyps",
    "expression": "Upregulated",
    "expression_details": "upregulated in polyps",
    "significance": "p<0.05",
    "detection_method": "Gene Chip and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422210"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR155",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR29a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissues",
    "sample": "prospectively in 36 pairs of samples of CRC tissue and adjacent noncancerous tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with lymphatic metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24935592"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-194-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-192-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-3651-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< 0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "none",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "none",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissues",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.011, 7 folds higher",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissues",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.032, 4.02 folds higher",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "localization",
    "tumor_size_details": "146a and 147b are biomarkers for colorectal tumor localization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissues",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.002, 8 folds higher",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "40 CRC, adjacent nontumorous tissues and 2 human CRC-derived cell lines (SW-480 and SW-620)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Northern blotting",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-338-3p was associated with unfavorable outcome in disease free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "negatively related to advanced TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24824250"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissues",
    "sample": "125 resected CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-133a had a significantly lower overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Advanced TNM and Dukes staging was associated with higher miR-133a expression even though its expression was mostly lower in tumor tissues. higher expression of miR-133a was associated with the development of distant metastases.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25104873"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Re-elevated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "186 patients who underwent surgery matched adjacent normal tissues and 18 normal tissues from normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor invasion, lymph node metastasis, distant metastasis and the TNM stage of colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24293092"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "5 CRC Tissues for microarray, 141 cases of CRC for real time PCR and 103 cases of CRC for TMA",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR and tissue microarrays",
    "marker": "Prognostic",
    "marker_details": "over-expression of miR-429 was correlated with poor prognosis for CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "downregulated in stage II and stage III clinical progression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24237355"
  },
  {
    "miRNA_name": "miR-200",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissues",
    "sample": "60 FFPE  primary colorectal tumors, normal colon mucosa, and matched liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "in situ hybridization and real time PCR",
    "marker": "Prognostic",
    "marker_details": "Low miR-200 expression in colorectal liver metastases was associated with bad prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "downregulated in metastatic compared to non metastatic CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24376848"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-one fresh, human CRC tissues and nineteen adjacent, non-tumor tissue counterparts",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "in 93.55% tissues (p<0.001), AUC = 0.8081",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24330809"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-1231",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "mouse model",
    "sample": "ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 189 cases and 30 healthy subjects and sera from 30 CRC patients and 30 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "fold-change = 0.27, P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis - significant association between low miR-218 expression and worse survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with TNM stage, lymph node metastasis (LNM) and differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24294377"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "35 colorectalcarcinoma samples, 35 corresponding cancer-adjacent tissue samples, 27 colorectal adenoma samples, and 16 normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "patients with high miR-32 expression had a poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-32 levels were significantly associated with lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24123284"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "high-risk",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor differentiation, lymph node metastasis, L category, V category, TNM stage, and tumor recurrence of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissues",
    "sample": "Tissues from 195 colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "DNA sequencing and real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: patients with APC mutation/high miR-21 had poorer overall survival rates than those with APC mutation/low miR-21, APC wild-type/high miR-21 and APC wild-type/low miR-21",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23773491"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Fecal samples from 117 colorectal cancer patients and 107 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive marker to identify colorectal cancer patients from among those with negative iFOBT results",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23950216"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Blood",
    "sample": "Blood samples were collected from 102 CRC patients undergoing surgery with curative intent.",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent predictor of survival: increase in miR-21 expression was associated with a 50% reduction in the risk of mortality",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "lower expression levels of serum miR-21 were associated with higher local recurrence and mortality.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23970420"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-431",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissues Serum",
    "sample": "Tissues and Serum from 55 early relapsed patients and 55 nonearly relapsed patients, stage II stage and III colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "overexpressed in non-early relapsed samples",
    "significance": "",
    "detection_method": "Microarray followed by validation",
    "marker": "Prognostic",
    "marker_details": "Lower levels associated with significantly shorter disease-free survival rates and poorer overall survival rates.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23933284"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden and Denmark",
    "sample_type": "Tissues Blood",
    "sample": "phase III Nordic ACT (I) multicentre study included 249 patients from Sweden and Denmark, Tissues from 230 patients and blood from 222 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.005",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with longer progression-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23922111"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "96 pairs of primary CRC and their corresponding adjacent nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Decereased expression of miR-625 was positively associated with poor overall survival and an unfavorable prognosis for CRC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Decereased expression of miR-625 was positively associated with advanced lymph node metastasis and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23861214"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "128 pretherapeutic biopsies of rectal cancer patients treated with 5FU",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.028",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of let-7g was associated with better DFS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932154"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "78 samples (23 normal colon mucosa, N; 31 primary colon carcinoma, T; and 24 liver metastases, M), obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "78 samples (23 normal colon mucosa, N; 31 primary colon carcinoma, T; and 24 liver metastases, M), obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p-value: 0.00052",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "patients with high levels of miR-10b expression in their metastatic disease have a shorter time to event",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "78 samples, differential expression in metastases compared to primary tumor",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "SW620 , colon mucosae, 32 cases of colon cancer and 18 cases of nontumorous colon mucosae",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "2.7-folds lower, P < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23714355"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.802, p<0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "non-invasive diagnostic marker for early detection of CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.786 , P<0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "non-invasive diagnostic marker for early detection of CRC, and prognostic indicator: high miR-92a expression in CRC was independently associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-203 was associated with poor survival of whites with stage IV colorectal cancers, but in blacks it was an indicator of poor survival of patients with stages I and II colorectal cancers",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic marker only for Black patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "genome-wide miRNA expression profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "chinese residing in Taiwan",
    "sample_type": "Serum",
    "sample": "serum samples from 61 CRC patients with primary CRC at UICC stages II/III (41 non-early relapsed and 20 early relapsed patients) before they received surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.012",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "circulating miR-29c increased in early relapsed patients than control and non-early relapsed",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23840538"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "serum samples from 186 CRC patients, 60 postoperative patients, 43 advanced adenoma patients, and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < .001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High miR-21 expression significantly associated with tumor size, distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "localization",
    "tumor_size_details": "associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-10b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "localization",
    "tumor_size_details": "associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-615-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Deep sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "localization",
    "tumor_size_details": "associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "Panel (miR-193a-3p, miR-23a and miR-338-5p)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Malaya",
    "sample_type": "Tissues",
    "sample": "paired cancer tissues (n = 30) and blood samples (CRC, n = 70; control, n = 32)",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.887, 80.0% sensitivity, 84.4% specificity and 83.3% accuracy",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23758639"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.028",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0002",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0004",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-127-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-938",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE tissues of 132 primary CRCs and 22 colorectal liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold change = 1470.1004",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23373973"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "loss",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "76 patients who underwent colorectal cancer resection without pre-operative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "high expression of miR-155 significantly correlated with an advanced TNM stage, lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23588589"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-182 expression predicted poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly correlated with large tumor size, positive regional lymph node metastasis, and advanced tumor-node-metastasis stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 paired samples of tumoral and nontumoral colon tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated closely with poor overall survival in patients with colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low miR-93 expression was significantly correlated with advanced tumor stage, positive nodal metastasis, and positive distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23354160"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 92 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facctor for survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "contributed to more advanced lymphatic invasion, lymph node metastasis, liver metastases and late TNM stage in colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292866"
  },
  {
    "miRNA_name": "signature miR-200c and miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma from 78 patients with 86 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "combined AUC of 0.839 with 84.6% sensitivity and 75.6% specificity",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24649179"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "96 colorectal cancers and individual-matched normal mucosa samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker: correlated with worse prognosis, both in terms of overall survival and disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated significantly with the grade of differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22885837"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "combination of miR-375, miR-424 and miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "formalin-fixed paraffin-embedded colorectal tissue samples from 91 surgical resections",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.968,  accuracy of 94.1%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Classifier : To discriminate carcinomas from adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22535378"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predicts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "82 patients with colorectal carcinomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-92a expression had a poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stage, lymph node metastases, and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22772712"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 110 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "94 primary colon cancer samples with and without liver metastases,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "predicts distant metastasis of colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23243217"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "bisulphite sequencing PCR and methylation-specific PCR",
    "marker": "Prognostic",
    "marker_details": "low expression of miR-149 was associated with lower 5-year survival rate, an independent prognostic factor for overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "low expression of miR-149 was associated with a greater depth of invasion,",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22821729"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "colorectal cancer patients with recurrence (40 cases) and without recurrence (40 cases) within 3 years after radical operation",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "independent factor for colorectal cancer recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23355243"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Blood",
    "sample": "Blood samples from 63 colorectal cancer patients and 45 controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.004",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22648208"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "86 patients with primary colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "reduced miR-22 had a poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "low expression of miR-22 correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22492279"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "162 CRC patients who underwent resection of primary CRC",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression group had a significantly poorer prognosis than the low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23023298"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.001, Fold Change = 2.2",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.005, Fold Change = 2.3",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.001, Fold Change = 3.1",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-1224-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "silencing",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "TaqMan MicroRNA Array and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "TaqMan MicroRNA Array and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "TaqMan MicroRNA Array and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "TaqMan MicroRNA Array and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "TaqMan MicroRNA Array and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "involved",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "764 patients diagnosed with stage II colon cancer, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "In situ hybridisation",
    "marker": "Prognostic",
    "marker_details": "patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23011541"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "multicenter cohort of 116 patients, Tumor biopsies",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0000000000283",
    "detection_method": "microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "expression correlated significantly with disease-free and cancer-specific survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22850566"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma from 20 CRC patients and 20 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "90% specificity and sensitivity",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "more upregulated in stages III and IV compared with stages I and II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "48 colon tumor and 48 paired normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "patients expressing high levels of miR-17 showed reduced overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22065543"
  },
  {
    "miRNA_name": "miR-1-133a cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissues",
    "sample": "64 paired tissue samples (CRC tumor and adjacent normal mucosa)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22766685"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "positively correlated with the clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "positively correlated with the clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "positively correlated with the clinical stage, correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 28.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-886-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 26.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 21.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1259",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 20.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 18.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 16.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 12.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1016",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 10.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 10.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 9.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 9.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-190",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 8.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-A1087",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 7.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 6.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-126*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 6.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 6.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-362-3p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7f",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-491-3p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-141*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-452",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1308",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 4.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-9*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 4.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "mir-106a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 4.8, p<0.0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 4.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 4.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1201",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-106b*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-200a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-24-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-30c-1*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1067",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.13, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1973",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.14, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.21, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-147b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.24, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.25, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-378c",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.25, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-7-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.30, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.31, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1027",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-640",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.33, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-186*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.35, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1033",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1238",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1173",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.37, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.37, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1285",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.38, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1026",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1101",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.43, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1155",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.43, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1184",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7d*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1172",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.47, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.47, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.48, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-518e*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519c-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-522*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-523*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320d",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-C1110",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.38, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1192",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.39, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320c",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17-92a cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high miR-92a expression group had greater lymphatic invasion and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high miR-25 expression group had more advanced venous invasion compared with the low expression group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with  histological grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.05",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with clinical stage, lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Israel",
    "sample_type": "Tissues",
    "sample": "110 patients, 51 (46%) with stage I and 59 (54%) with stage II disease, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-29a was associated with a longer disease-free survival (DFS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "miR-29a associated with risk of recurrence in patients with stage II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426940"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 CRC samples from 10 CRC patients with liver metastasis and 15 CRC patients without distant metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "expression of miR-9 in CRC with metastases was significantly higher than its expression in CRC without metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21562850"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Two colorectal cancer cell lines and 85 colorectal cancer and paired normal patient samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.01",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlates with poor prognosis  reduced expression of miR-195 was an independent predictor of overall survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlates with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21390519"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissues",
    "sample": "77 CRC patients who were identified by pyrosequencing to have wild-type KRAS and were subsequently treated with EGFR-targeted therapy with the monoclonal antibodies cetuximab or panitumumab.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "47 out of 77 (61%) tumours",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator- low levels of miRNA-143 expression is an independent prognostic factor with respect to cancer specific survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22549179"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001, sensitivity of 71.6% and specificity of 73.3%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "95 pairs of colorectal cancer tissues and non-tumor adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22377847"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-328",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "marker",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-192,",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "samples of primary CRC, normal adjacent tumor tissue, and liver metastasis tissues were collected from 62 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "downregulation of miR-320 was associated with liver metastasis in colorectal cancer.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22134529"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "114 participants including 58 metastatic patients and 56 non-metastatic CRC patients. Serum from 38 CRC patients with liver metastasis and 36 CRC patients without metastasis. For validation - CRC patients without (n=20) and with liver metastasis (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.803, At a cutoff value of 0.155, the sensitivity was 75% and the specificity was 75% in discriminating metastatic from non-metastatic patients",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - novel noninvasive biomarker for early detection of CRC with liver metastasis.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated in liver metastatic patients compared to non metastatic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018950"
  },
  {
    "miRNA_name": "Panel of miR 21,135a, 335, 206 and let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "North America",
    "population": "Canada",
    "sample_type": "Tissues",
    "sample": "15 primary tumours with adjacent normal tissue from patients that were disease-free at 4 years (cohort A) and 19 paired primary tumours with corresponding liver metastases (cohort B)",
    "expression": "--",
    "expression_details": "--",
    "significance": "specificity of 87% and sensitivity of 76% for the presence of metastases",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for presence of metastasis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "for detecting the presence of metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22120473"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.04",
    "detection_method": "Microarrray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "associated with KRAS mutation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-127-3p,",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.03",
    "detection_method": "Microarrray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "associated with KRAS mutation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "Microarrray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-486-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissues",
    "sample": "primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarrray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "an evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "an evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "an evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No significant difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "an evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "Patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "may",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "144 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor - associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "associated with synchronous liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22456107"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "In",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-601",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma - AUC=0.747,  Sensitivity and specificity of 80.0% and 72.4%, respectively",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-760",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma - AUC = 0.788, Sensitivity and specificity of 69.2% and 72.4%",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-490-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-628-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3151",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3163",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3622a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3656",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-549",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1827",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3144-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3177",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3180-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-4326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissues",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "High throughput sequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "34 paired normal and colon (stage II and III) tumor specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < .0001",
    "detection_method": "real time PCR and immunohistochemistry",
    "marker": "Prognostic",
    "marker_details": "prognostic biomarker in stage II and III colon cancer -  high levels of miR-215 expression closely associated with poor patient's overall survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21752725"
  },
  {
    "miRNA_name": "miR-144*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "75 Fecal specimens were collected from patients who underwent colonoscopy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "sensitivity of 74% and a specificity of 87% (n = 75, p < 0.0001)",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic marker for CRC detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21863218"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "92 cases of colon carcinomas were collected with both the tumor and paired normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "in 87.0% (80/92)",
    "detection_method": "In-situ hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "upregulatedregulation of miR-23a was associated with an advanced clinical stage and depth of invasion,  higher in the tumors with lymph node metastasis than those without",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22455847"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissue samples were obtained from surgical specimens from 66 patients (36 men, 30 women)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20680522"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with mucinous tumors and progressively increased from stage I to IV disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.016",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "38 patients with colorectal, gastric or pancreatic cancer, FFPE Tumours",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with a higher risk of disease progression and risk of death",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21743960"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated at tumor invasion front",
    "significance": "7.7-fold at the tumor invasion front (P = 0.0001)",
    "detection_method": "Microaray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "downregulated at liver invasion front",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated at tumor invasion front",
    "significance": "6.5-fold (P = 0.0001)",
    "detection_method": "Microaray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "downregulated at liver invasion front",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissues",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissues",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.028",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "Patients",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "indicate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-l195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "hypermethylated in 97.5% of  tumours, P=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic",
    "marker_details": "non-invasive faecal-based screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "hypermethylated in 97.5% of  tumours, P=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic",
    "marker_details": "non-invasive faecal-based screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "high miR-125b expression groupregulated showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA and Asia",
    "population": "USA and China",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic marker for metastatic colon cancer and predicts poor prognosis.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "circulating miR-141 was significantly associated with stage IV colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-150*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated-regulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-125b-2*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated-regulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated-regulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated-regulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.06",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "downregulated in colorectal cancer with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "130 stage II colon and 67 stage II rectal cancer specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "correlated significantly with shorter disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21069438"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues of 212 patients with gastric or colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "low expression of miR-203 was correlated with tumor size (p = 0.015) and pT stage (p = 0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21063914"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "80.0% sensitivity and 88.2% specificity for response to therapy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stage and poor cell differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "81 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "methylated in 99% tissues",
    "detection_method": "methylation-specific PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "methylated in 93% tissues",
    "detection_method": "methylation-specific PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "candidate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "candidate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "candidate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-519e*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.0002",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.0002",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers. feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.0003",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P = 0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "103 CRC patients and 37 healthy normal controls, Plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significant prognostic factor for poor overall survival in CRC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "409 colorectal tissues [21 normal colonic mucosa from healthy individuals (N-N), 160 primary CRC tissues and their corresponding normal mucosa (N-C), and 68 adenomas].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR and and in situ hybridization",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic market for early diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20682795"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "46 patients with CRC, Paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "patients with a higher expression of miR-21 had disease-free interval",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "46 patients with CRC, Paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "patients with a higher expression of miR-143 had disease-free interval",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Non invasive marker for diagnosis and prognosis, prognostic factor for poor overall survival in CRC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies, colon adenomas, and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies, colon adenomas, and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.844",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "novel noninvasive biomarkers for early detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC =  0.838, p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "novel noninvasive biomarkers for early detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "combined panel of miR-29a and miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001, AUC of 0.883 with 83.0% sensitivity and 84.7% specificity",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "novel noninvasive biomarkers for early detection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.027",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "low expression correlated with increased tumor size and advanced pT stage.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "low expression correlated with advanced pT stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0289",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "frequently downregulated in the smaller adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "closely associated with the initiation of tumor development and not to progression stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "frequently downregulated in the smaller adenomas",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "closely associated with the initiation of tumor development and not to progression stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.47 by microarray and 8.44 by real time PCR",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 26.32 by microarray and 5.06 by real time PCR",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 21.1",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.48",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.71",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.3",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 7.44",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 3.9",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.55",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.41",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-301b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 5.02",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.34",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.33",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "six specimens, including colonic cancerous and para-cancerous ones,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change = 0.27",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "156 CRC patients, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-21 expression were significantly worse than those of patients with low miR-21 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly associated with venous invasion, liver metastasis and tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "156 CRC patients, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-155 expression were significantly worse than those of patients with low miR-155 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high miR-155 expression was significantly correlated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-9-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Methylation specific PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "methylation of  miR-9-1 was associated with the presence of lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Methylation specific PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Methylation specific PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-3",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "100 primary CRC specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.3, P =0.025",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "related to TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-125",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "100 primary CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "decreased by Fold Change = 3.3, P =0.005",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005",
    "detection_method": "MicroRNA profiling and real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005, sensitivity was 89% and the specificity was 70%",
    "detection_method": "MicroRNA profiling and real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-122a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "20 primary colorectal carcinoma tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "n = 20, p < 0.05",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19607815"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissues",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Northern blot analysis",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissues",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Northern blot analysis",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "colonic tissues derived from stage II-III colon cancer patients with (n = 3) and without (n = 3) lymph node metastasis. Lymph node positive vs. Lymph node negative.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 6.6-folds, P = 0.036",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: to identify ptients with lymph node metastasis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulated in lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19659786"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "1.9-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "3.4-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.3-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.0-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.0-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.4-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.6-fold (p=0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.4-fold (P<0.04)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "3.4-fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.6 fold (P=0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "1.6-fold (P=0.021)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissues",
    "sample": "expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "4.5 fold (P<0.001)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),  18 HPs, 19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "1.82-fold; P = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),  18 HPs, 19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "2.01-fold; P < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "Thirty-four endoscopically resected colorectal polyps and 39 surgically excised colorectal tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Locked nucleic acid in situ hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19509156"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "(p = 0.0278)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "(p = 0.0002)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "(p = 0.0264)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "(p = 0.0017)",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "significantly associated with patient survival (p = 0.0122).  The patients with higher  miR-200c expression had a shorter survival time",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "positively related to advanced TNM stage (p = 0.026) and deeper invasion of tumors (p = 0.024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.023",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.012",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "--",
    "sample": "110 colon cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "downregulation of miR-106a predicted shortened DFS (P = 0.03) and OS (P = 0.04)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18521848"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< or =0.005",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "associated with early onset in young patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< or =0.005",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "associated with early onset in young patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< or =0.005",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "associated with early onset in young patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< or =0.005",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "associated with early onset in young patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P< or =0.005",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "associated with early onset in young patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Prognostic",
    "marker_details": "miR-18a overexpression group had a poorer clinical prognosis than the low expression group (P=0.07)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.9",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.3",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.2",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.0",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.2",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.1",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-432*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.1",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-412-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −2.4",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −2.3",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.9",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.6",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-510",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.5",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.3",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-513",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 1.2",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −2.3",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −2.1",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.5",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-151",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.4",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 0.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 0.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 0.5",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2) = 0.5",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −1.1",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "correlated with the probability of recurrence-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −0.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "correlated with the probability of recurrence-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −0.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2) = −0.7",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "mir-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "colorectal carcinoma and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Northern blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19062714"
  },
  {
    "miRNA_name": "miR-342",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "42 colorectal cancers, 9 colorectal adenomas and 16 samples of grossly normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "methylated in 86% of colorectal adenocarcinomas and in 67% of adenomas,",
    "detection_method": "PCR",
    "marker": "Screening",
    "marker_details": "methylation is an early event in colorectal carcinogenesis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "methylation is an early event in colorectal carcinogenesis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18264139"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "111 CRC tumors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "methylated in 101 of 111 (90%) CRC tumors",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18519671"
  },
  {
    "miRNA_name": "miR-125b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "expression": "",
    "expression_details": "",
    "significance": "P = 0.040",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "negatively associated with overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-378a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "expression": "",
    "expression_details": "",
    "significance": "P = 0.009",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "negatively associated with overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.002",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P=0.025",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P=0.023",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.05",
    "detection_method": "Taqman qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "high plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Plasma",
    "sample": "145 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "Taqman qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "high plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Plasma",
    "sample": "146 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.703, p=0.005",
    "detection_method": "Taqman qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "high plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Plasma",
    "sample": "147 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.717, p=0.001",
    "detection_method": "Taqman qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "high plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "Panel (miR-1, miR9, miR124, and miR137)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "387 colorectal tissue specimens, collected from 238 patients with UC (152 without neoplasia, 17 with dysplasia, and 69 with UC-associated colorectal cancer,validation study of samples from 90 patients without UC and 61 patients with UC-associated dysplasia or cancer",
    "expression": "Downregulated",
    "expression_details": "increased methylation",
    "significance": "AUC=0.78",
    "detection_method": "bisulfite pyrosequencing analysis",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28847750"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "antagonizing",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "71 pair tumor & adjacent normal  tissues,TE12,KYSE510,KYSE450,KYSE410,KYSE150,COLO680N,KYSE180,,KYSe140,YES-2,KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0021(tissues)",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28602785"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue  cell line",
    "sample": "10 paired ESCC & non tumor tisssues,EC109,Het-1A",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28599478"
  },
  {
    "miRNA_name": "miR-1469",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "129 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-1469 expression had significant poorer disease free survival(p=0.004) and OS(p=0.029)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-1469 expression was significantly associated with tumor invasion depth(p=0.026),lymph node metastasis(p<0.001),pathological tumor stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588716"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "high plasma miR-9 level were significantly associated with poor tumor differentiation(p=0.022),large tumor size(p=0.007),deep local invasion(p=0.003),lymph node metastasis(p=0.005),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down( not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MSP,BSP-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down( not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MSP,BSP-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Gastroesophageal Carcinogenesis",
    "continent": "",
    "population": "",
    "sample_type": "tissue plasma",
    "sample": "280gastroesophageal biopsy,30 plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-223 overexpression was significantly associated with the score of intestinal metaplasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28395057"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-218",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "",
    "sample": "85 ESCC & normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prosnostic",
    "marker_details": "Prognosis : low miR-7 expression were associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28314263"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "downregulation",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "downregulation",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-483-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "80 pairs of ESCC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : upregulated miR-483-5p expression was significantly associated with poor survival of ESCC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-483-5p was positively correlated with TNM stage,lymph node metastasis,T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28211800"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "37 paired EC and adjacent normal tissues,HEEC,ECA109,EC9706,TE-1,TE-8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,TE-1),p<0.05(ECA109,EC9706,TE-8)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-30b was strongly correlated with poor overall survival I patients with EC (p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "matastasis,TNM/stage",
    "tumor_size_details": "decreased miR-30b expression was correlated with invasion classification (p<0.01),lymph node metastasis(p<0.01),pathological stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28189678"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "93 ESCC & non neoplastic tissues,5 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28188753"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduced expression of miR-30d occurred more frequently in ESCC patients with positive lymph node metastasis ,moderate-poor differentiation ,advanced tumor node metastasis stage than those with negative features",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28184915"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "66 pairs of ESCC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28108314"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue saliva",
    "sample": "tissues,saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(tissues)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095062"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues,ECA109,HEEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28069583"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "SP1",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "26 pairs of ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.008(serum),p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "serum exosome",
    "sample": "39 ESCC & 39 normal serum,exosomes",
    "expression": "Upregulated",
    "expression_details": "up(serum,exosomes)",
    "significance": "p=0.008(serum),p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "tissues,serum,Kyse170,Eca109",
    "expression": "Downregulated",
    "expression_details": "down(miR-21 in kyse170,Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15,95%CI 1.16-3.97)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was associated with pathogenic sites (P = 0.037): high levels of miR-21 were correlated with upper sites but not with gender (P = 0.229), age (P = 0.722), pathological type (P = 0.191), TNM stage (P = 0.618) and Postoperative metastasis (P = 0.349)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "tissues,serum,Kyse170,Eca109",
    "expression": "Upregulated",
    "expression_details": "up(miR-375 in Kyse170,Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47,95%CI 0.26-0.87)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlations between miR-375 levels and gender (P = 0.506), age (P = 0.704), pathological type (P = 0.708), TNM stage (P = 0.845), Postoperative metastasis (P = 0.190), none of which were correlated with miR-375 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "35 paired  ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882172"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "tissues,serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic, Prognostic- serum level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low serum miR-15a level more frequently occurred in ESCC patients with advanced TNM,Tand N stage(all p=0.01),poor tumor differentiation(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "33 tumor & adjacent normal tissues,TE-1,Eca 107",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27645894"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "25 ESCC & 13 normal esophageal tissues,TE8,TE9",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779648"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 paired ESCC & corresponding normal tissues,HEEC,Eca109,EC1,KYSE150,KYSE158",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27771733"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "90 primary ESCC & 30 non neoplastic tissues,KYSE-520,KYSE70,HACAT",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27658568"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501502"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "tissue serum",
    "sample": "19 EC & 19 normal serum,12 pre neoplastic, 35 neoplastic & matched distant non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.010(tissues),p=0.015(serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- serum level in EC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27748283"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "4 pairs of EAC cell lines & corresponding 5FU resistant variant,14 pairs of EC tumors & surrounding normal",
    "expression": "Upregulated",
    "expression_details": "up(5FU resistant cell lines & in EAC tissues)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501171"
  },
  {
    "miRNA_name": "miR-20b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "38 tumor & adhjacent normal tissues,Het-1A,TE-1,Eca-109,EC9706,KYSE-150,SKGT-5",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues,TE-1),p<0.01(EC9706,KYSE150,SKGT-5)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27701465"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-141-3p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-424-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "32 pairs of ESCC 7 adjacent normal paraffin embeded blocks,EC9706,Eca109,EC-1,SHEE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27628042"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE-1,EC-109",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27621035"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression of miR-214  positively correlated with poor tumor differentiation (p=0.004),tumor invasion(p=0.013) and lymph node metastasis(p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619677"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "35 kazakh's ESCC & paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "matastasis",
    "tumor_size_details": "upregulation of miR-106b was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619676"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27609581"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-127-3p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572270"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "14 with & 5 without postoperative tumor samples,12 ESCC & adjacent normal epithelia",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis & Relapse : OS of patients with high expression of miR-574-3p better than with low expression(p=0.004),higher expression of miR-574-3p was inversely correlated with tumor relapse (p=0.029)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "higher expression of miR-574-3p was inversely correlated with tumor relapse (p=0.029)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27565418"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "44 ESCC & adjacent normal tissues,HEEc,ECA109,TE1,EC9706,KYSE70,KYSE3o",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-630 expression was found to be correlated with tumor range,lymphatic metastasis,pathological stge( all p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "circulating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "elevated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "elevated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "HEEpic,ECA109,TE1,TE6,TE12,TE14,TE8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(TE6,TE12,TE14),p<0.05(TE1,ECA109,TE8)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27480251"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "upregulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 pairs of primary ESCC 7 adjacent normal tissues,HEEC,KYSE30,KYSE70,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,KYSE-30,KYSE-70,ECA109)",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "downregulation of miR-143-3p correlated with advanced clinical stage(p=0.026),lymph node metastasis(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "27 ESCC & paired adjacent non tumor tissues,ESEC,TE1,TE2,ECA109,KYSE30,KYSE140,KYSE150,KYSE410,KYSE510",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues,EC cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27347306"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "elevated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "34 pairs of ESCC & adjacent non tumor tissues,Het-1A,Kyse150,QBC939,AGS,HepG2",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues and KYSE-150 vs Het-1A)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247259"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC and BE",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "22 EC & 14 BE & their corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation of promoter mediated silencing of miR-193b in EC and BE  tissues)",
    "significance": "p=0.001(EC tissues vs normal),p=0.002(BE vs normal)",
    "detection_method": "qRT-PCR,MSP,BSP  analysis",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27176876"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "156  pair of ESCC & healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : serum miR-1297 was an ideal diagnostic marker of ESCC,AUC on serum miR-1297 was 0.840+-0.035 in discovery grp and 0.837+-0.034 in validation grp",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27152453"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "63 ESCC & adjacent non tumor tissues,63 ESCC & 39 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,plasma)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-373 expr. Level in tumor tissues closely associated with differentiation,tumor status and lymph node metastasis(all p<0.05),miR-373 expression in plasma correlated with tumor status and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073718"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 ESCC & matched adjacent non cancerous tissues,HEEC,ECA109,KYSE510",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27045085"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "8 pairs of ESCC & adjacent non tumor tissues,ECA-109,TE1",
    "expression": "Downregulated",
    "expression_details": "down(DNA methylation of miR-34a promoter)",
    "significance": "",
    "detection_method": "qRT-PCR, MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26944831"
  },
  {
    "miRNA_name": "miR-181c-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of miR-181c-3p  associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive cell line)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "OE21,OE33(5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26807179"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-483-3p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues,115 FFPE,154 ESCC & 154 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic : miR-146a expression level is an ideal prognostic and diagnostic biomarker of ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-146a tissues level was significantly reduced with increased T stage(p=0.037) and TNM stage(p=0.004) ,serum miR-146a was negatively associated with T stage (P=0.002",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "111 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level had a significant impact on OS of patients (p=0.006), expression of miR-34a (P = 0.018), tumor\ndifferentiation (P = 0.021), and TNM stage (P = 0.003) were independent prognostic factors for\npatients with ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low miR-34a level was significantly associated with tumor differentiation(p=0.013),lymph node status(p=0.038),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26782413"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "EC109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "significant",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26773497"
  },
  {
    "miRNA_name": "miR-718",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "120 ESCC & 51 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC plasma, up expression in postoperative plasma than in preoperative)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : -plasma miR-718 AUC of 0.715,0.689 and 0.620 for detection of ESCC patients ,early patients with Tis-T1 or early patient with TNM 0-1 respectively",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastsis",
    "tumor_size_details": "plasma miR-718 expression level was inversely correlated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26756617"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "miR-193a-3p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC,EAC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "tissue",
    "sample": "17 paired EAC & adjacent normal tissues & 22 ESCC ,22 EAC samples",
    "expression": "Downregulated",
    "expression_details": "down(in EAC compared to normal & ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : decreased level of miR-205 in tumor tissues correlates with poor OS in EAC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711784"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma cell line",
    "sample": "tissues,plasma,cell lines",
    "expression": "Upregulated",
    "expression_details": "up(tissues,plasma),decreasing order of miR-425 expression in cell lines-YES2<KYSE410<KYSE450<KYSE70<KYSE150<KYSE 510<Colo680N<KYSE410<KYSE30",
    "significance": "p=0.0315(tissues),p=0.047(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "28 paired ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617801"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "EC9706,HEEC",
    "expression": "Upregulated",
    "expression_details": "up(EC9706)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26580839"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203a or hypermethylation of the miRNA\nshowed significantly poorer 5-year survival rates",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "downregulation of miR-203a  associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-203b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203b showed significantly poorer 5-year survival rates",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "downregulation of miR-203b associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "64 surgical fresh tissues, ECA-109,KYSE30,Het-1a",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "inverse correlation between miR-186 expression level and differentiation grade(p=0.013),lymph node metastasis(p<0.001) and TNM(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26568291"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of tissues,Het-1A,KYSE30,KYSE70,KYSE150,KYSE450,KYSE410,KYSE510,TE1,TE9,TE11,EC9706,EC109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(EC cell lines compared to Het-1A)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26556718"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC = 0.72(95% CI:0.62-0.82 :sensitivity=68%,specificity=68%)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC =0.85(95% CI:0.79-0.93;sensitivity=76%,specificity=84%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC= 0.72(95% CI:0.62-0.83,sensitivity=70%,specificity=84%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 tissues,EC109,TE8,TE2,HEEC",
    "expression": "Downregulated",
    "expression_details": "down(ESCC and EC cell line)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression was associated with metastatic property and stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26508028"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "60 pair tissues,75 serum from ESCC and healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- low serum level(AUC-0.767+-0.040,sensitivity-81.3%,specificity-62.7%),prognostic-worse OS(p=0.018) ,PFS(p=0.035) and p=0.006(multivariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "tissue expression reduced with T stage increase(p=0.008),low serum level associates with N stage(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC,EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-21 independent prognostic factor in EAC for DSS but not in ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC,EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic- high miR-375 not correlated with increased survival in both EAC & ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression correlated with lymph node(p=0.002),histological classification(p=0.000),vessel invasion(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26414725"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "chinese",
    "sample_type": "tissue",
    "sample": "45 apired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26396670"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "chinese",
    "sample_type": "tissue cell line",
    "sample": "76 tissues,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "T3/T4 patient had higher exoression than T1/T2(p=0.000),lymph node metastasis had higher expression than without(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26345812"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "chinese",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,SHEE,Kyse150,KYSE510,EC9706,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression correalated with pathological stage and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26339371"
  },
  {
    "miRNA_name": "miR-1291",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "54 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with lymph node metastasis and TNM stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324125"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "60 pairs tissues,HEEc,ECA109,EC9706,TE1,TE13,kyse410",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with tumor grade(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26323919"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "plasma",
    "sample": "28 ESCC and 35 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic-plasma miR-185;AUC was 0.73(95% CI  0.604-0.855)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316588"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "64 tissues,HEEC,EC109,ECA9706,EC1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,EC109,ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316084"
  },
  {
    "miRNA_name": "miR-106a*",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26314198"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-HR=3.72,95% CI:1.36-8.78,p=0.005",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlated with lymph node metastasis(p=0.01),distant metastasis(p=0.007),tumor differentiation(p=0.04),advanced TNM(p=0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309624"
  },
  {
    "miRNA_name": "miR-491",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "99 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlated with tumor depth(p=0.033),stage & metastasis(both p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26279431"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China-Japan union hospital",
    "sample_type": "tissue cell line",
    "sample": "46 paired tissues,NEEC,Eca109,Kyse30,kyse140,Kyse180,Kyse410,Kyse510,kyse520",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26252180"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "103 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with advanced clinical TNM stage and pathological grade( both p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26245343"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "fresh ESCC & FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis),low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression  had negative correlation with T stage(p=0.022),tumor length(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "30 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26191164"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "46 tissues",
    "expression": "Downregulated",
    "expression_details": "down(poor outcome group)",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic:-miR-382 level had reverse correlation with poor outcomes,p<0.001(Kaplan Meier)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26078564"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "35 pairs tissues,Het-1A,EC109,KYSE150",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045986"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "33 pairs tissues,HEEC,EC109,TE1,EC9706,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,TE1,KYSE150),p<0.001(EC109,ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "lower expression in stage III than in stage I &II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25999024"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "20 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25954903"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "tissue",
    "sample": "36 tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "up(after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "67tissues,Het-1A,ECA-109,EC9706,TE1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,ECA109,TE1)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928665"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "up( miR-21  in EAC)",
    "significance": "p=0.0004(miR-21 in EAC vs normal)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "up(EAC compared to ESCC)",
    "significance": "p=0.0446(miR-29c in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-148",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "up(miR-148 in EAC compared to ESCC)",
    "significance": "p=0.0014(miR-148 in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-148 expression have shorter DFS(p=0.0145)  & shorter OS (P=0.0016) in EAC, low miR-148 level have shorter OS(p=0.0014) in ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Downregulated",
    "expression_details": "down(miR-203 in EAC)",
    "significance": "p<0.0001(miR-203 in EAC vs control mucosa)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-203 have shorter DFS in EAC (p=0.026)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "79 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had poorer prognosis(p=0.040)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low expression correlated with tumor size(p=0.018),nos. of lymphatic invasion(p=0.0448),venous invasion(p=0.0211)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "15 pairs tissues,98 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25866219"
  },
  {
    "miRNA_name": "miR-942",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 pairs tissues,TCGA data,NEEC1,NEEC2,EC18,HKESC1,TE1,KYSE520,EC9706,KYSE510,KYSE180,108CA,ECA109,KYSe410,KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(TCGA),p<0.05(cell lines)",
    "detection_method": "qRT-PCR,microarray(TCGA)",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower expression had longer survival time",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level had positive correlation with clinical stage(p<0.001),TNM(T:p=0.005,N:p<0.001,M:p=0.004),histological differentiation(p=0.045)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25844602"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "serum(106 EC &60 healthy)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC:0.833",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower expression in lymph node metastasis,poorer differentiation and later stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25812647"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "24 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRt-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "upregulation correalated with tumor differentiation,TNM(both p=0.021) & N classification(p=0.006)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25805931"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "40 FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(miR-145)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-miR-145 AUC:0.74",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "40 FFPE",
    "expression": "No difference",
    "expression_details": "No significant difference",
    "significance": "p<0.001(miR-145)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRt-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755718"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "49 EC and 12 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25750296"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "49 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with lymph node metastasis and poor tumor differentiation(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25695396"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "64 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with tumor  invasion(p=0.22) & advanced clinical stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25672418"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25637514"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "negative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "85 tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expressioon associated with lymphatic vessel invasion(p=0.0352)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25501018"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "37 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25480402"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induces",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "induces",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "cell line",
    "sample": "Het-1A,TE10,TE11,TE1,ECA109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25436011"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "98 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negatively correlated with TNM(p=0.008),lymphatic metastasis(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400770"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China (Kazakh)",
    "sample_type": "tissue",
    "sample": "50 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400316"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510,KYSE410,KYSE520",
    "expression": "Upregulated",
    "expression_details": "up( except in EC109)",
    "significance": "p=0.0016(tissues),p<0.001(EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510),p<0.05(kyse410,KYSE520)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "upregulation associated  clinical progression(p=0.022),lymph node metastasis(p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25375090"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with higher histological grade(p=0.003),lymph node metastasis(p=0.002),tumor stage(p=0.005),clinical stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25337272"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "89 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with tumor stage(p=0.007),metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25322669"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "combined",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "combined",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "105 tissues,HEEc,KYSe150,KYSE410,OE19,ECA109,EC9706",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "upregualation correlated with lymph node metastasis,advanced tNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "120 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic  for LPFs,DPFS &OS(multivariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression correlated with great depth of invasion(p=0.02),advanced clinical stage & distant metastasis( both p=0.008)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25218280"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "32 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25211657"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue plasma",
    "sample": "tissues,preoperative,postoperative and healthy plasma",
    "expression": "Upregulated",
    "expression_details": "up(ESCC tissues,up in preoperative compared to healthy plasma,down in postoperative compared to preoperative plasma)",
    "significance": "p=0.0157(ESCC tissues),p=0.0093(ESCC cell lines),p<0.0001(preoperative vs healthy plasma),p<0.0005( postoperative vs preoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117812"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "46 EC tissues",
    "expression": "Upregulated",
    "expression_details": "up(good prognostis compared to poor prognosis patients",
    "significance": "p=0.043",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117314"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "34 pairs tiisues,ECa109,KYSE150,TE1,HEPG2,HT-29,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25109390"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "22 ESCC & 15 healthy  serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25069478"
  },
  {
    "miRNA_name": "miR-208",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "10 pair tissues,NEEC,KYSE410,KYSE30,KYSE510,KYSe520,EAC109,TE1,KYSe410,KYSe180,Ec18,HKESC1,108CA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(ESCC cell lines  vs NEEC)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25023649"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "associated with tumor differentiation(p=0.017),lymph node metastasis(p=0.019),tumor depth(p=0.009),TNM stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25017784"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Ec",
    "continent": "Asia",
    "population": "China",
    "sample_type": "saliva plasma",
    "sample": "150 saliva,plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic-plasma miR-21:sensitivity-96%(stageI),64%(stage II),97%(stageI+IIEC) & specificity(44%,84%.56% respectively for stages), saliva miR-25 :sensitivity-90%,88%,89% respectively for stages and specificity 64% for all stages",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24968850"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 pairs of tiisues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24551280"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "158 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression correlated with tumor depth(p=0.002),tunor stage(p=0.003),metastasis(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24508466"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with tumor differentiation(p=0.010),lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24438167"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "up ( in tissues & serum)",
    "significance": "p=0.008(tissue miR-25)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-25 serum associated with lymph node metastasis(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "up( tissue & serum)",
    "significance": "p=0.009(tissue miR-223)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum miR-223",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Downregulated",
    "expression_details": "down(tissue & serum)",
    "significance": "p=0.006(tissue miR-375),p=0.007(serum miR-375)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum  miR-375",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "saliva plasma",
    "sample": "saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24369245"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positive correlation of miR-17a with lymph node metastasis(p=0,035),clinical stage(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positive correlation of miR-18a with tumor stage(p=0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "positive correlation of miR-19b with tumor size(p=0.005),lymph node metastasis(p=0.040),clinical stage(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positive correlation of miR-92a with clinical stage(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "40 tissues,5 ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24356567"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "81 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis,nerve invasio & pathological stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314216"
  },
  {
    "miRNA_name": "miR-655",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis, tumor diffrentiation,TNM stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314023"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "76 invasive ESCC tissues,30 normal biopsy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "stem loop RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expressiond  significantly associated with tumor status,lymph node metastasis & clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24221338"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24204738"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "japan",
    "sample_type": "tissue",
    "sample": "84 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0125",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24196787"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "46 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(poor prognosis )",
    "significance": "p<0.05 ( poor vs good prognosis samples)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24175778"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 ESCC with lymph node metastsis,normal ESCC tissues,NECC,TE1,TE13,ECA109,EC9706,KYSE140,KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025(ESCC tissues with nodal involvement vs normal)",
    "detection_method": "qRt-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24154848"
  },
  {
    "miRNA_name": "Cluster(miR-200b,miR-200a,miR-429)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(miR-200b),p=0.001(miR-200a),p=0.037(miR-429)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with lymph node metastasis(p=0.002),advanced clinical stage(p=0.020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "88 tissues,7 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression of miR-200b correlated with lymph node metastasis and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostric",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-429 significantly correlated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "42 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0007",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24039846"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pairs ESCC tissues,9 pairs dysplasis",
    "expression": "Downregulated",
    "expression_details": "down(ESCC)",
    "significance": "p<0.05(in ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025765"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "23 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025511"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "32 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis(p=0.015),differentiation(p=0.003),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23999873"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "high",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.017",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "Let-7c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "tissue",
    "sample": "FFPE samples of BE-HD,HGD,EAC,NSE",
    "expression": "Upregulated",
    "expression_details": "up(upregulated during BE-dysplasia-EAC sequence)",
    "significance": "p=0.003(BE-ND vs matched NSE tissues),p=0.001(HGD vs NSE),p<0.001(EAC vs NSE)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23757351"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-129-2",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "42 pared surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with advanced clinical TNM stage(p<0.001),distal metastasis(p<0.001),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23677061"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "tissue serum",
    "sample": "tissues,serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004( tissues),p=0.007(serum)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23627613"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue plasma",
    "sample": "10 ESCC &11 normal tissues,106 ESCCplasma,54 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "up(tissues,cell lines plasma),down in postoperative than preoperative(p=0.0076)",
    "significance": "p=0.002(tissues),p=0.0121(cell lines),p<0.0001(plasma),AUC for plasma=0.9449",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23579215"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23504349"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum cell line exosome",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "expression": "Upregulated",
    "expression_details": "up(ESCC serum, exosomes)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "serum low expression in T1/T2 than T3/T4(p=0.0024),low in without lymph node metastasis than with metastasis(p=0.0002),without distant metastasis than with metastasis(p=0.0020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "22  tissues",
    "expression": "No difference",
    "expression_details": "not significant difference in tissues",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "205 archived ESCC,20 paired tissues,NEEC1,NEEC2,KYSE30,KYSE510,ECA109,HKESC1,KYSE180,KYSE410,KYSE140,E18,KYSE520",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had shorter survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "inverse correlation with clinical stage(p<0.001),TNM(p<0.001),histological differentiation(p=0.024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23319823"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues,archived sample",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "MISH,qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had poore oS(p=0.040)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression correlatedwithlymph node metastasis(p=0.04),TNM stage(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23301089"
  },
  {
    "miRNA_name": "miR-99a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "inverse correlation with tumor invasion depth,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "exosome serum",
    "sample": "exosomes of ESCC & benign disease serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression correlated with advanced tumor stage classification,positive lymph node status,metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23224754"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "high",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "clinical samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation related with tumorigenesis and metastasis of EA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23108995"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "108 paired curative surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRt-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-poor prognosis for low expression(univariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with tumor invasion depth(p=0.039),lymph node metastasis(p=0.035),lymphatic invasion(p=0.005),venous invasion(p=0.006),clinical stage(p=0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013135"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low miR-518b expression were prognostic factor for PFS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-518b expression associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "low plasma miR-155 level as Diagnostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression of miR-98 was significantly correlated with pathological grade, tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression  significantly correlated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-214 expression significantly correlated with pathological grade,tumpr stage,lymph node metastasis and miR-101 expression associated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22752059"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "low",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22641236"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Esophageal Cancer",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "174 solid tumors serum,39 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22638884"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "50 preoperative plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic- high miR-21 plasma level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "50 preoperative plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic-  low miR-375 plasma level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "110 preoperative",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-143  expression associated with lymph node  metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "110 preoperative",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-145 expression associated with lymph node  metastasis(p= 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression associated with lymph node metastasis status & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450326"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "serum",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-1322",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum tissue",
    "sample": "serum,tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(serum & tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic-serum miR-1322 (AUC-0.847)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22315007"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "saliva plasma",
    "sample": "32 EC and 16 healthy saliva supernatant",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic- miR-21 saliva supernatant level: AUC-0.762,sensitivity-84.4%,specificity-62.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "no significant correlation with cancer stage,differentiation & nodal metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23464420"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "109 resected  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-high expression poorer prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level associated with gender(p=0.008),tumor size(p=0.042),depth of tumor invasion(p=0.030)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.00001(miR-192 BE vs healthy esophagus),p<0.05(miR-196a)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(miR-196a)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-196a had positive correlation with progression from intestinal metaplasis to adenocarcinoma",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech republic",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.00001( miR-203 BE vs healthy esophagus)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "up(whole spectrum of preneoplastic/neoplastic lesion)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21883657"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-142-3p)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-31 & miR-142-3p expression correlated to histological differentiation(p<0.05),good prognostic group comprised of ESCC patients with small tumor,negative lymph node metastasis or early stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "prognostic- expression correlated with poor OS(p=0.048),DFS(p=0.0006)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with advanced stage(p=0.003),distant metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21813472"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "45 paierd tissues,523 serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(serum),77.8%(tissues)",
    "detection_method": "qRt-pCr",
    "marker": "Prognostic",
    "marker_details": "prognostic & diagnostic-serum miR-31 level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21658006"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired tissues,KYSE150,KYSE410,KYSE450,KYSE510,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21551130"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down(promoter  hypermethylation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21533613"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(mature miR-21 & miR-145)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "mature miR-21  in ESCC positively associated with lymph node(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(mature miR-21 & miR-145)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high mature miR-143 associated with  recurrence of metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-145 associated with recurrence of metasatsis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "miR-205 in ESCC positively associated with lymph node(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "Family(miR-200a,200b,200c,miR-141)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "",
    "sample": "Barrett,gastric,duodenal epithlia &EAC",
    "expression": "Downregulated",
    "expression_details": "down(all miR-200 in EAC compared with BE,miR-141 & miR-200c in BE compared with GC & duodenal epithlium,miR-200a & 200b in BE compared with gastric epithelium)",
    "significance": "p=0.0008(miR-141:duodenal vs BE),p<0.0001(miR-200c: duodenal vs BE),p=0.0004(miR-141:gastric vs BE),miR-200a,200b,200c:p=0.0078,0.0001&<0.0001 respectively in gastric vs BE",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21448356"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "ESCc cell line-OE21,TE5,TE8,TE10,TE11,Het-1a,tissues",
    "expression": "No difference",
    "expression_details": "No difference",
    "significance": "not significant in tissues",
    "detection_method": "qRT-PCr",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21426561"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "confers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "human ESCC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21271217"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "15 matched tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "15 matched tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with tumor invasion (p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.436",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with tumor invasion: (p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "upregulation correlated with lymph node metastasis((p=0.001),TNm(p=0.049)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21148309"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Kazakh,s China",
    "sample_type": "tissue",
    "sample": "18 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21104017"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "82 tissues,HE3,HEEpiC,KYSE150,KYSE170,KYSE180",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21044961"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "88 tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004(tissues)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression in advanced stage 2,3 &4 than in 0 & 1(p=0.039)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22966364"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR,northern blot",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20485139"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20428818"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20075075"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE,EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "up(  EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE,EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "up(  EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE,EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "up(  EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "tissue",
    "sample": "11 paraffin tissues",
    "expression": "Upregulated",
    "expression_details": "up with progression of EA",
    "significance": "",
    "detection_method": "qRt-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19342367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "20 matched normal & ESCC tissues,TE6,TE8,TE10,TE11,TE12,TE14,KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCr,ISH",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression in lymph node metastasis & venous invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19276261"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "38 paired tissues,TE1 to TE15 cell lines",
    "expression": "Upregulated",
    "expression_details": "up(tissues) ,highest in TE1 and lowest in T9 among cell lines",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression in T3 or T4 than in T1 or T2(p=0.0333)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21475818"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "esophageal achalasis",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "biopsy of middle esophageal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28810541"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "--",
    "population": "--",
    "sample_type": "serum",
    "sample": "168 serum,128 ESCC and corresponding normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-serum/ tissue low level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "reduced serum/tissue correlated with T stage,lymph node metastasis,TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759955"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high in metastatic tissues than in non",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656264"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-338-5p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissues,datasets(GEO)",
    "sample": "* apired ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28832500"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "H.Pylori positive & negative gc tissues,tissues",
    "expression": "Downregulated",
    "expression_details": "down(LPS from H.Pylori 26695 downregulates miR-375 & miR-375 expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "H.Pylori positive & negative gc tissues,tissues",
    "expression": "Downregulated",
    "expression_details": "down(LPS from H.Pylori 26695 downregulates miR-375 & miR-106b expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired gc & adjacent non tumor tissues,BGC-823,MKN-28,MKN-45,AGS,MGC-803,SGC-7901,NGEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "miRNA microarray,q-PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival(p=0.003)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with more aggressive tumor phenotypes including local invasion, lymph node metastasis, advanced clinical stage and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "could discriminate non-LNM from LNM with 80.0% sensitivity and 80.0% specificity and discriminate tumor Ι-II stages from tumor III-IV stages with 71.9% sensitivity and 75.0% specificity at the best cut-off value of 0.0125",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "could discriminate non-LNM from LNM with 50.0% sensitivity and 100.0% specificity at the best cut-off value of 0.0901 and discriminate tumor Ι-II stages from tumor III-IV stages with 37.5% sensitivity and 100.0% specificity at the best cut-off value of 0.1122",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-1284",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "gc & adjacent normal tissues ,SGC7901,SGC7901/VCR cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26936591"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "FISH,qRT-PCR,western blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with clinical stages, depth of invasion and lymph node metastasis.",
    "reference": ""
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gastric tissues derived from normal,chronic gastritis,intestinal metaplasia and GAC",
    "expression": "Downregulated",
    "expression_details": "higher in normal gastric mucosa samples, and decreased progressively in non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type GAC samples",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "",
    "expression": "Upregulated",
    "expression_details": "higher expression in the non-atrophic chronic gastritis and the intestinal metaplasia samples and lower values in the normal gastric mucosa and intestinal-type GAC",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 paired gc and matched adjacent normal tissues,BGC-823,HGC-27,SGC-7901,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "<0.001",
    "detection_method": "qRT-PCR,microarray analysis",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "75 H.pylori  positive & 75 H.pylori negative tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0067",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24732377"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 gc & matched adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "up( H.pylori infection increases expression)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22020746"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "2 1 paired normal & gastric tumor tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0239",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "21 paired normal & gastric tumor  tissue",
    "expression": "No difference",
    "expression_details": "No significant difference",
    "significance": "p=0.2514",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "21 paired normal & gastric tumor tissue",
    "expression": "No difference",
    "expression_details": "no significance difference",
    "significance": "p=0.1752",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). Association between presence of metastasis and lower expression of MIR17HG.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 paired gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-198 level was associated with tumor size (p = 0.009), tumor depth (p = 0.005), lymph node metastasis (p = 0.03), and clinical stage (p = 0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "",
    "sample": "18  EBV-asssociated gc & 18 EBV negative gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0107",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "",
    "sample": "18  EBV-asssociated gc & 18 EBV negative gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "SGC7901,MKN45,AGS,BGC823,BGC803,GES-1, 50  H.pylori positive & H.Pylori negative  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25373785"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 pairs of H.Pyloro positive & negative tumor tissue",
    "expression": "Downregulated",
    "expression_details": "down(in H.pylori postive tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24984017"
  },
  {
    "miRNA_name": "miR-99b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-548c-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "korea",
    "sample_type": "tissue",
    "sample": "H.Pylori negative  & H.pylori positive cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "miRNA microarray,TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "56 paired gc & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "56 paired gc & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "gc tissues, normal gastric & H.pyloro infected tissuesSGC7901,MKN-45,MKN28,AGS,GES-1, H.Pylori infected gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(gc tissues vs normal),p<0.05(H.pyloro infected vs normal gastric tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "19 Hp positive & 16negative gastric specimen,20 normal & tumor biopsies",
    "expression": "Downregulated",
    "expression_details": "down(in Hp postive gastric specimec and gc biopsies",
    "significance": "p=0.0066(H.pylori positive vs H.pylori negative specimen)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25187177"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue cell line",
    "sample": "32 pair of Gc and corresponding normal stomach tissues,MKN7,MKN45,MKN74,NUGC3,NUGC4,KATO-III,GC14,TGBC 11TKB",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray analysis,q Real time RT-PCR, end point RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20020497"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "71 paired gc & adjacent normal tissues,SGC-7901,MKN-45,AGS,MKN-28,BGC-823,MGC-803,GES-1",
    "expression": "Downregulated",
    "expression_details": "down(in methylated tumor group and downregulation is due to promoter hypermethylation)",
    "significance": "p=0.03(methylated vs unmethylated tumors),p=0.35(no significant difference between methylated & unmethylated non-tumor group)",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic: methylated tumor had longer OS than unmethylated",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "hypermethylation of miR-212 was significantly associated with tumor depth, lymph node, UICC staging and peritoneal dissemination,",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693054"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 noncardia gastric cancer tissues, in 10 H. pylori-infected and 8 uninfected normal gastric biopsies,",
    "expression": "Downregulated",
    "expression_details": "down( in H.pylori infected tissuse & gc tissues)",
    "significance": "p<0.01( in gc vs paired normal tissues & H.pylori  positive vs normal tissues)",
    "detection_method": "microarray analysis, Taqman qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/19890957"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "AGS,BGC-823,SGC-7901,GES-1,HGC-27,18 H.pylori positive & 12 negative tissues,30 gc & corresponding normal tissues",
    "expression": "Upregulated",
    "expression_details": "up( in gc & H.pylori positive tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22321642"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "38 Hp +ve gc & 27 Hp -ve gc tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "up( H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "high expression of miR-223 associated  with large tumor size (p = 0.006), high metastasis (p = 0.002), and poor TNM staging (p = 0.03)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "50 gc & 50 healthy plasma,tissues,cells,GES-1,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812,sensitivity=70%,specificity=80%)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "70 gc patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired gc & adjacent normal tissues,",
    "expression": "Upregulated",
    "expression_details": "up (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "higher plasma expression in Stage I(p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissues",
    "sample": "70 gc patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired gc & adjacent normal tissues,",
    "expression": "Upregulated",
    "expression_details": "up(distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression( AUC =0.7944)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "elevated plasma level in Stage I(p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissues",
    "sample": "70 gc patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired gc & adjacent normal tissues,",
    "expression": "Downregulated",
    "expression_details": "down (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression(AUC=0.7432)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "decreases plasma expression in Stage- II,III & IV (p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissues",
    "sample": "20 pairs of gc & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24997345"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "138 gc & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :AUC-0.80, Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "associated with T stage, distant metastasis, and differentiation",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "plasma tissues",
    "sample": "plasma & primary gc tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high plasma and primary tissues expression in TNM ( stage III or IV) & lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "gc tissues and cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26781754"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "tissue",
    "sample": "gastric tissues derived from normal,gastritis,metaplasia and gastric cancer",
    "expression": "Downregulated",
    "expression_details": "higher in normal gastric mucosa samples, and decreased progressively in non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type GAC samples",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "differential expression as potential biomarker for GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "tissue",
    "sample": "gastric tissues derived from normal,gastritis,metaplasia and gastric cancer",
    "expression": "Downregulated",
    "expression_details": "higher in normal gastric mucosa samples, and decreased progressively in non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type GAC samples",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "differential expression as potential biomarker for GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "21 pair of gc & adjacent normal gastric tissue, HGC-27, AGS, BGC-823 and SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p< 0.01",
    "detection_method": "qRT-PCR, Northern blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170877"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "150 pairs of gc and adjacent matched normal tissues,MGC-803,HGC-27,SGC-7901,MKN-45",
    "expression": "Downregulated",
    "expression_details": "down-regulation (Hypermethylation)",
    "significance": "p<0.05",
    "detection_method": "q-PCR,MSP,q-MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low level associated with pM stage (p = 0.038, metastasis vs non metastasis) and pTNM stage (p = 0.006, stage I vs IV; p = 0.002, stage II vs IV; p = 0.038, stage III vs IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26729612"
  },
  {
    "miRNA_name": "miR-363-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 gc & adjacent normal tissues,SGC-7901,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26709677"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP(resistant) cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26893657"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gastric cancer tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852749"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissues cell line",
    "sample": "60 pairs of gc & adjacent normal tissues,MCG-803,MKN-28,MKN-45,SGC-7901,BGC-803,BSG-823,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs normal tissues,SGC7901,BGC-803,BSG-823,BGC-823),p<0.05(MCG-803,MKN-28,MKN-45)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "low expression related to advanced clinical features",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26807169"
  },
  {
    "miRNA_name": "miR-488",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues ,gc cell lines,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression negatively correlated with advanced TNM stage in GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26738864"
  },
  {
    "miRNA_name": "miR-508-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "MKN1,MKN7,MKN28,MKN45,AGS,KatoIII,NCI-n87,MGC-803,SGC-7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26801246"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-LNA in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognosis: high miR-92a expression, tumor stage, tumor status, node status, and tumor size were significant negative prognostic predictors for overall survival in patients with GC (P < 0.001, P < 0.001, P = 0.008, P < 0.001, and P = 0.001, respectively)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26790436"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc & paired normal tissues,GSRCC & non- GSRCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA-array",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26742429"
  },
  {
    "miRNA_name": "miR-99b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up( in Hp positive gc)",
    "significance": "P<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up( in Hp positive gc)",
    "significance": "P<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(in HP positive GC)",
    "significance": "P<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up (in HP negative gC)",
    "significance": "P<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(in HP negative GC)",
    "significance": "p<0.01",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(in Hp negative GC)",
    "significance": "<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-548c-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "up(in Hp negative gC)",
    "significance": "<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 pairs of gc & adjacent normal gastric tissues,SGC7901,BGC823,AGS,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues),p<0.05(cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression in tissues with poorly and moderately differentiated type, lymph node metastasis N1-N3 and stage III-IV.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26745603"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "tissue",
    "sample": "115 FFPE biopsy samples",
    "expression": "Downregulated",
    "expression_details": "down( in H.pylori related GC)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26701848"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26478435"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 gc & corresponding normal tissues , AGS,HGC-27,BGC-823,SGC-7901,MKN-7,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26464628"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitizer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-101-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue cell line",
    "sample": "50 gastric  tissue samples,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-125b-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue cell line",
    "sample": "50 gastric  tissue samples,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0459",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue cell line",
    "sample": "50 gastric  tissue samples,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hongkong",
    "sample_type": "plasma tissue",
    "sample": "30plasma initial set & 80 plasma in validation set,34 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(plasma) ,p=0.0015( tissues)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "diagnostic: plasma-miR-940",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26456959"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "36 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.04 in both plasma and tissues",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "correlation between tumor and serum expression of miR-107 with tumor hypoxia was found to be significant(p<=0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406411"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "gc samples and cell lines",
    "expression": "Downregulated",
    "expression_details": "down (C/EBPα  could induce the expression of miR-100 by binding to the putative promoter region of miR-100)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26404754"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "worse survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398444"
  },
  {
    "miRNA_name": "miR-339",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26391641"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "Prognostic",
    "marker_details": "poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression of miR-326 is associated to clinical stage ,tumor depth,lymph node metastasis and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "potential diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "gc tissues,GES-1,SNU16,MKN87,KATOIII,SGC7901,SNU216,MKN28,MGC803,HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "high expression of miR-940 is correlated with advanced N stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "gc & adjacent non-tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26298723"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "ISH,Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261179"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233544"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "130 gc & 22 healthy control serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "Low miR-203 expression levels were significantly associated with male sex (P = 0.018), lymphatic invasion (P = 0.0004), venous invasion (P = 0.0057), high tumor depth (P < 0.0001), lymph node metastasis (P < 0.0001), liver metastasis (P = 0.0058), peritoneal metastasis (P = 0.0001), and distant metastasis (P < 0.0001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "gc & adjacent non tunmor gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26232914"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iranian",
    "sample_type": "tissue",
    "sample": "32 pateints for gc & paired adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "real time RT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=80.3",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iranian",
    "sample_type": "tissue",
    "sample": "32 patients for gc & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "real time RT-PCR",
    "marker": "diagnostic",
    "marker_details": "Diagnostic: AUC=93.3",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 gc & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26186594"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "expression": "Upregulated",
    "expression_details": "up(in gc tissues & plasma,up due to promoter hypomethylation)& down(in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "q-PCR,MSP",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high miR-106a expression was closely related to the degree of lymphatic metastasis and TNM staging of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-197",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue  cell line",
    "sample": "tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression related with low survival rate",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901,MKN-28,MKN-45,BGC-823,AGS,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "SGC7901,HGC27,AGS,MKN45,N87,GES-1,41 gc & adjacent normal tissues,41 gc & 41 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues),p=0.0041(serum),p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-130a expression level were higher in patients with metastasis than in without metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 patients tissues,HGC-27,HGC-803,SGC-7901,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26102366"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 gc & adjacent non-tumor gastric tissues,SGC-7901,HGC-27,MGC-803,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,Northern blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26098560"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Bufalin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "50 gc & healthy serum and PBMCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001 and miR-21 AUC in:serum-0.912,PBMCs-0.898",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  miR-21 AUC in serum=0.912,in PBMC=0.898",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "not associated with clinicopathological features",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26063956"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "radiation associated gastric cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hiroshima(Japan)",
    "sample_type": "tissue",
    "sample": "239 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-24 independent predictor for exposure group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "",
    "sample": "stomach adenocarcinoma samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26041881"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "160 pairs of collected clinical samples included 80 unclassified gastric cancer samples, 40 infiltrative gastric cancer samples and 40 expanding gastric cancer samplesnfiltrative and expanding gc",
    "expression": "Downregulated",
    "expression_details": "down in infiltrative as compared to expanding gc",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26010149"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "102 pairs of tumor & normal gastric tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher expression correlated with distant metastasis (P=0.034), TNM stage (P=0.030) and early recurrence (P=0.044)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "normal gastric mucosa,BGC-823,MKN-45,AGS,SGC-7901,HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "220 self pair of gc & adjacent non-cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Independent Prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression is significantly associated with great depth of invasion,positive lymph node and distant metastasis and advanced TNM stage of human GC(all p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25960238"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "20 pairs of gc & adjacent non-tumor tissues,NCI-N87,AGS,MKN-45,MKN-28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low m-RNA expression of miR-338-3p in advanced stage(III-IV) than in early stage(I-II)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25945841"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25944166"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "CAFs ans NFs of gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25916550"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 gc & adjacent normal tissues,SGC7901,NUGC-3,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "relative more expression in patients with lymph node metastasis or with stage I/II disease than in patients without lymph node metastasis or stage III disease",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25914465"
  },
  {
    "miRNA_name": "miR-16-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "TNM IV stage:AUC=0.832 for miR-16-5p, Poorly diffrentiated: AUC=0.801,0.791 respectively for miR-16-5p and miR-19b-3p",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-19b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "TTNM III stage:AUC=0.822 for miR-19b-3p . Poorly diffrentiated: AUC=0.801,0.791 respectively for miR-16-5p and miR-19b-3p",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of gc & adjacent non cancer  tissues,SGC-7901,AGS,MCG803,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25889078"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "downregulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "AGS,SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25874496"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "12 pairs of gc & adhacent normal gastric  tissues and SGC7901,NEGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25871967"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "83 gc & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression associated with large tumor size(p=0.004),poor differentiation(p=0.008),distant metastasis(p=0.027) and advanced TNM stage(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "gac & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "gac & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "18 gc & matched norma gastric  tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs GES-1 cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25815687"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "gastric adenocarcinoma",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "90 gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.01",
    "detection_method": "miRNA-LNA ISH",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25793394"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "105 gc & adjacent non tumor  tissues,SGC7901,BGc823,MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression associated with degree of differentiation (p=0.01),local invasion(p=0.001),TNM stage(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25780292"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,HGC27,MGC803,AGS,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25753202"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "GAC",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues,GES-1,MKN-1,MKN7,MKN28,MKN45,SNU1,SNU16,AGS,NCI-N87,MGC803,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-16-1",
    "cancer": "GAC",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues,GES-1,MKN-1,MKN7,MKN28,MKN45,SNU1,SNU16,AGS,NCI-N87,MGC803,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "",
    "sample": "141 gc cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-506 expression significantly correlated with poorely differentiated type(p=0.015)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25707493"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "80 paired gc & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower level of miR-181a were associated with the pM and pTNM stage in gc patients",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25706394"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "silencing",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "positive correlation between expression & tumor invasion & metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25694126"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "80 gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis,5 year overall and disease free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "miR-153 levels were prominently downregulated in the tumor tissues with lymph node metastasis than without (p=0.012)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25678802"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "160 pair of gc tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "co-expression of both miRNAs in gc tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "160 pair of gc tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "co-expression of both miRNAs in gc tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down(CpG island methylation)",
    "significance": "",
    "detection_method": "qRT-PCR,bisulfite pyrosequencing",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25663388"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.058",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P=0.007",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-329",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "20 pairs of gc & adjacent non tumor gastric tissues,D197MGC-803,SGC-7901,MKN-45,HGC-27,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25654811"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "20 pairs of primary gc tumors & lymph noide metastasis ,MKN28-M,MKN28-NM,SGC7901-M,SGC7901-NM,GES",
    "expression": "Downregulated",
    "expression_details": "down(in lymph node metastasis)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25653235"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "166 gc & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher miR-29c level were correlated with longer disease free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-29c downregulation was correlated with more extensive venous invasion(p=0.02) and more aggressive tumor phenotype(p=0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "166 gc & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.02",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "166 gc & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 pairs of  gc & adjacent non tumor gastric  tissues,AGS,HGC27,BGC823,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in gc vs adjacent normal gastric tissues)",
    "detection_method": "microarray,qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "primary gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "decreased expression is associated with lymph node metastasis in GC patients(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25620172"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 pairs of gc & adjacent normal gastric tissues,AGS,BGC823,MKN28,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "miRNA-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25596740"
  },
  {
    "miRNA_name": "miR-500",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 gc & adjacent matched normal gastric tissues,NGEC-1,NGEC-2,mKN28,MGC803,BGC823,HGC27,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: shorter overall survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression  correlated with clinical stage (p < 0.001), TNM classification (T: p < 0.001; N: p = 0.018; M: p = 0.001), and histological differentiation (p = 0.028) in gc patients",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25595906"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sera",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "down (order of decreasing level of miR-17 in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.879 with 80.6% sensitivity and 87.5% specificity for discriminating GC patients from controls , AUC of 0.717 with 90.6% sensitivity and 57.5% specificity for discriminating GC patients from BGD patients and  AUC of 0.725 with 62.9% sensitivity and 81.2% specificity for discriminating BGD patients from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-17  was  associated with patients age(p<0.05) but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sera",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "down (order of decreasing level of miR-106b in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.856 with 75.0% sensitivity and 92.5% specificity for discriminating GC patients from controls, AUC of 0.700 with 87.2% sensitivity and 45.0% specificity for discriminating GC from BGD patients and  AUC of 0.739 with 75.0% sensitivity and 68.7% specificity for discriminating BGD patients from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-106b  was associated with patients age(p<0.05)  but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of H.Pylori positive & -ve tissues,7901,GES-1,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(in tumor compared to normal & down in H.pylori positive compared to -ve  tumor & normal tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561270"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "18 pairs of gc & adjacent non cancer tissues,MKN45,HGC27,BGC823,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25554419"
  },
  {
    "miRNA_name": "miR-103a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line tissue",
    "sample": "cell lines,clinical specimen",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25530421"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "81 tumor  & adjacent non-tumor tissues,SGC7901,MKN45,MKN28,BGC823,MGC803,Ges-1",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP,BSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-335 methylation level was significantly associated with lymph node and peritoneal metastasis ,poor pT stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25520857"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "Cell lines",
    "sample": "SGC-7901,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25516656"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "decitabine",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "decitabine",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpressed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "37 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "downregulation of miR-367was significantly correlated with differentiation level,TNM stage and metastasis of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25489984"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "",
    "sample": "54 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25479940"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "66 gc & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25474430"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "52 gc & matched non-tumor  tissues,GES-1,MKN-45,BGC-823,MKN-28,AGS,SGC-7901,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-199a-3p high expression group had inclination towards TNM stage(P=0.037),invasion depth(P=0.08)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25448600"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "100 pairs of gc & adjacent non-neoplastic tissues,GES1,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-133b in GC was associated with venous invasion(p<0.05),more aggressive tumor phenotype(p<0.05,stage I/II vs stage III/IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25433493"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(gc tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25432696"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 gc  & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428912"
  },
  {
    "miRNA_name": "miR-29s(miR-29a,miR-29b,miR-29c)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "GC clinical samples,HGC27,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "downregulation of miR-194 is significantly associated with tumor size,location invasion and TNM",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of gc & matched adjacent non neoplastic tissues,SGC7901,NUGC-3 ,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "relative expression of miR-19a increased in patients with lymph node metastasis or with stage I and II were higher than patients without lymph node metastasis or stage III(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25400827"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "48 pairs of gc & matched ANTTs  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high fold change of down regulated miR-193b had significant shorter survival time compared to low fold change of down regulated miR-193b",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "down expression of miR-193b was significantly correlated with  Lauren type,differentiation ,UICC,stage,invasion and metastasis of GC(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "48 pairs of gc & matched ANTTs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival time for low fold change of upregulated miR-196a was significantly lower than that with high fold change of upregulated miR-196a",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "overexpression of miR-196a was significantly associated with poor differentiation(p=0.022)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of H.pylori positive & negative tumor & normal tissues,SGC7901,AGS,MKN45,BGC-823,BGC-803,GES-1",
    "expression": "Downregulated",
    "expression_details": "down(in H.pylori positive normal & tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25373785"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 patients tissues,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": ".",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression in cancer tissues of patients with lymph node metastasis, vascular invasion and TNM stage III(-IIII( was down-regulated more obviously(P<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25341915"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "52 pairs of paraffin embedded gc & adjacent  normal tissues,MGC-803,SGC-7901,BGC823,MKN45,MKN28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "levels of miR-183 expression were associated with lymph node metastasis and pathological TNM stage (P=0.005 and P=0.007, respectively).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "89 gc & 41 normal stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "ISH (TMA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-22 levels were inversely correlated with the tumor stage (P=0.03) and lymph node metastasis (P=0.001).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25323629"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increase",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "65 gc & matched adjacent normal tissues,GES-1,MGC-803,MKN28,SGC7901,AGS,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc cell lines),p<0.001(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low miR-183 expression levels were significantly associated with increased tumor type(P=0.003),presence of distant metastasis(P=0.018) and increased tumor-node-metastasis stage(P=0.019)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "51 gc & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "association between expression level and distant metastasis was observed (P<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25231560"
  },
  {
    "miRNA_name": "miR-160b  25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue",
    "sample": "40 operative & 20 preoperative plasma,40 gc & adjecent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-160b 25 cluster in gc tissues  & plasma  correlated with tumor size,borrmann type,TNM stage(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "66 gc & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25202363"
  },
  {
    "miRNA_name": "miR-645",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 pair of AGEJ & t gastric cardiac non cancer tissues,SGC7901,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(AGEJ tissues),SGC7901,BGC823(p<0.001)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "tumor size greater than or equal to 5cm group had significant increased miR-645 expression as compared to tumor size less than 5cm group(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25174799"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "21 paired gc & adjacent non tumor tissues,HGC27,AGS,BGC-823,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines),p=0.002( tissues)",
    "detection_method": "qRT-PCR,NB",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170877"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-218",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "32 paired gc & adjacent non-tumor tissues,GES1,SGC7901,MKN28,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues,SGC7901),p<0.05(BGC823,MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25169484"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-133",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "180 pairs of GC tissues,AGS,BGC823,MGC803,SGC7901,MKN-45,MKN-1,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival rate of high expression group was higher than low expression(P=0.003)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-133 expression was lower in T3 and T4 groups(-4.11 to -3.08) than in T1 and T2 group(-1.91 to 0.07)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25152372"
  },
  {
    "miRNA_name": "miR-410",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,HGC-27,MKN-45,SGC7901,MGC803,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower level associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25136862"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity,Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high level was significantly correlated with clinical stage (p<0.001),lymph node metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,AGS,BGC823,MKN28, SGC7901,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25119599"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "56 paired gc & corresponding non cancer normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "56 paired gc & corresponding non cancer normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-513b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "74 gc & corresponding non malignant tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25095979"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "107 paired gc & matched normal gastric FFPE tissues,MGC-803, HGC-27,MKN-45,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25064845"
  },
  {
    "miRNA_name": "miR-520d-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "Lower expression of miR-520d-3p was associated with tumor invasion (P = 0.0357), lymph nodes metastasis (P = 0.0272), a higher clinical stage (P = 0.0041),",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25063221"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "39 pair of gc & matched normal gastric tissues(30 metastatic positive & 9 metastasis free tissues)",
    "expression": "Downregulated",
    "expression_details": "down(in metastasis positive gc tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25055044"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 gc ,pericarcinoma & normal gastric tissues,MGC-803, BGC-823,SGc-7901,HGC-27,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25041019"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 pairs of primary gc & corresponding adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression of miR-126 significantly associated with lymph node metastasis(p<0.001),poor histological grade(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25027343"
  },
  {
    "miRNA_name": "miR-129-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25008064"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "upregulation associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "upregulation associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981249"
  },
  {
    "miRNA_name": "Family(miR-34a,miR-34b,miR-34c)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Downregulated",
    "expression_details": "down(miR-34a,miR-34c)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24970812"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "52 gc & corresponding normal  tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24969405"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "45gc(22 metastatic & 23 without metastatic) & 31 adjacent normal mucosa tissues,SGc7901,HGC27, AGS,MKN45,MGC803,NCI-N87,GES-1",
    "expression": "Downregulated",
    "expression_details": "down(in gc & metastatic gc tissues)",
    "significance": "p<0.01(gc vs normal & metastasis vs non metastasis tissues)",
    "detection_method": "qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944699"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "serum",
    "sample": "68 gc & 56 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: decreased miR-218 expression was independent prognostic marker for overall survival /(p=0.035)in addition to presence of tumor metastasis (p=0.005) and high tumor grade(p=0.000)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "serum miR-218 significantly associated with GC metastasis(P=0.003),tumor stage(P=0.018),tumor grade(P=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944481"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "109 gc tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196a have poorer 5 year survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "109 gc tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196b have poorer 5 year survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901/DDP, SGC7901,MKN45,MGC803,BGC823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24931256"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 pairs of gc & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "down(especially in ERBB2 +ve tissues",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24926380"
  },
  {
    "miRNA_name": "miR-30b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "51gc tissues,AGS,BGC-823",
    "expression": "Downregulated",
    "expression_details": "down(by DNMT1 methylation regulation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP,BGS",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "in tumor expression level of miR-30b-5p was profound correlated with lymph node metastasis(p=0.019)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24913034"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "63 gc & adjacent non tumor  tissues,Ges-1,BGC823,MKN28,KATOIII,SGC7901,NCI-N87,,AGS,MKN45,SNU-1,SNU-16",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low-expression group exhibited significantly lower tumor differentiation (P = 0.021)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24886316"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan(for NGS),korea(validation from qRT-PCR)",
    "sample_type": "tissue",
    "sample": "4 pairs of gc & adjacent normal f&2 additional normal for NGS and 24 pairs for qRT-PCR validation tissues,SNU601,SNU668,AGS,MKN28,HSC45,NM",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003(24 pairs of gc  vs adjacent normal tissues)",
    "detection_method": "NGS,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24870620"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1,MKN28,BGC823,SNU-1,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc tissues and cell lines)",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-497 expression was associated with shorter overall survival(P<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-497 low expression was significantly associated with lymph node metastasis rate(p=0.006),local invasion(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24845562"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "GC fibroblasts,normal fibroblasts",
    "expression": "Upregulated",
    "expression_details": "up(in gc fibroblast compared to norma fibroblast)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-106b stromal expression in in GC is associated with decreased overall survival(p=0.03)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24842611"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "41gc( 25 metastatic & 16 non metastatic) & 41 normal adjacent tissues, MKN,AGS,GEs1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "decreased miR-34a expression is associated with GC metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24837198"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 patients gc & adjacent  normal  tissues,SNU-601,SNU-668,AGS,MKN-28, HeLa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: expression not associated wth patients OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-17-5p was associated with differentiartion degree of GC (P=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24801601"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "25 pair gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-205 expression level was significantly correlated with the progress of tumor invasion (p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763883"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-185",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24748184"
  },
  {
    "miRNA_name": "miR-338",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "41 gc & 24 adjacent normal mucosal  tissues,SGC7901,HGC27,AGS,MKN45,N87,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24736504"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<=0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: independent prognostic factor associated with OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expr. Of miR-19a remote metastasis(p<0.001) ,  TNM stage(p<0.001),lymph node metastasis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<=0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expr. Of miR-19b  associated with remote metastasis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "tissues, GC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24658854"
  },
  {
    "miRNA_name": "miR-199a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "34 matched gc & adjacent normal tissues,MKN45,MKN28,SGC7901,BGC823,HGc27,AGS,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "higher miR-199a-5p expression level was associated with increased likelihood of lymph node metastasis and later TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24655788"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "overexpr. Of miR-1303 and downregulation of clauding was significantly associated with tumor size,location invasion,histologic type and lymph node metastasis stage in GC tissues",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Knockdown",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue plasma cell line",
    "sample": "21 paired gc & adajcent normal FFPE  tissues,104 gc  & 65 healthy  plasma,preoperative and postoperattive plasma,MKN28,MKN45,MKN74,NUGC4,HGC27,KATO III,WI38",
    "expression": "Upregulated",
    "expression_details": "up(in gc tissues,plasma,preoperative plasma",
    "significance": "p=0.0286(gc vs normal tissues),p<0.0001(gc  vs healthy plasma),p=0.0002(preoperative  vs post operative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24626859"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24623314"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "236 gc, matched adjacent normal & 18 cases normal control tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : independent prognostic factor for overall survival(log rank test,p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNm/satge",
    "tumor_size_details": "elevated miR-630 expr.  associated with T3 and T4 stage(p=0.007),positive lymph node(p<0.001),distant metastasis(p=0.002),advanced TNM(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24621930"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "MKN-1,MKN-7,AGS,SGC7901,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "MKN-1,MKN-7,AGS,SGC7901,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 gastric carcinoma tissues, 18 nontumourous gastric tissues ,MKN28,BGC823,MKN45,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-124 exp. was inversely correlated with tumor size(t-test: p=0.0265 and spearmans:p=0.0083) and lymph node metastasis(t-test:p=0.0164)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "26 paired gc & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "26 paired gc & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "26 paired gc & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level correlates with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24612089"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cinobufacin treated BGC823 cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24606447"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum cell line",
    "sample": "75 gc & adjacent normal tissues,57 gc & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-191 level correlates with tumor size(p<0.01 ,stage IV vs stage II and p<0.05 stage IV vs stageIII) also miR-425 correlates with tumor(p<0.01 stage IV vs II),miR-191 level metastasis-nonmetastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum cell line",
    "sample": "75 gc & adjacent normal tissues,57 gc & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-425 in tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "Panel(miR-16,miR-25,miR-92a,miR-451,miR-486-5p)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "(gastric non cardia adenocarcinoma;GNCA), plasma: training set(40 GNCA & 40 control), validation set(48 GNCA & 102 control)",
    "expression": "Upregulated",
    "expression_details": "up(in GNCA plasma)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: miR-16,miR-25,miR-92a,miR-451,miR-486-5p panel in plasma is potential biomarker for early detection of GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24595006"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "23 patients tissues,MGC803,MKN45,SGC7901,NCI-N87,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines,moderetly and poorly differentiated gc tissues",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573489"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "3 normal gastric tissues & 3 gc cell lines SGC7901,MGC803,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24531888"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "",
    "sample": "35 gc & 33 normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- both miRNAs are potential biomarker for GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "",
    "sample": "35 gc & 33 normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Diagnostic- both miRNAs are potential biomarker for GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "100 pateints gc  &  adjacent non neoplastic tisssues,HGC27,MGC803,SGC7901,MKN45,GES1",
    "expression": "Downregulated",
    "expression_details": "down(due to hypermethylation of CpG island upstream of miR-10a",
    "significance": "",
    "detection_method": "qRT-PCR,qMSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24498243"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,MKN28,NUGC-3,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,SGC7901),p<0.05(MKN28,NUGC-1)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495805"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "184 gc ,169 normal gastric & 10 pairs of gc & adjacent normal tissues,NGEC,BGC823,HGC27,MGC803,MKN28,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(gc vs normal gastric tissues),p<0.05(10 paired gc vs adjacent normal tissues, BGC823,HGC27,MGC803,MKN28,SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495516"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "100 pairs of gc & matched adjacent normal tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(due to methylation of miR-10b upstream)",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR,MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481854"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Downregulated",
    "expression_details": "down(in Gc/DM)",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC for plasma miR-122=0.808(95%CI,0.712-0.905,p<0.01),Prognostic:  higher plasma miR-122 in GC is a favourable Prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Upregulated",
    "expression_details": "up(in Gc/DM)",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC for plasma miR-192=0.732(95%CI,0.625-0.841,p<0.01),Prognostic :  plasma miR-192 level not associated with OS  in GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "58 paired gc & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0015",
    "detection_method": "Real time RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: expression inn GC not  correlates with survival time of patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-1266",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "58 paired gc & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": ",p=0.0288",
    "detection_method": "Real time RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: higher miR-1266 exp. In GC tissues correlates with a longer survival time",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue cell line",
    "sample": "59 patients GC & adjacent normal  tissues,AGS,YCC2,MKN28,KATO III,SNU 1,SNU5,SNU16,SNU216,SNU601,SNU638,SNU668,SNU719,HFE145",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.009(more down in IB than IA patient,p<0.002(more down in LN+ve than LN-ve",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low exp. miR-135a have advanced TNM(p=0.045) and higher rate of LN metastasis(p=0.014)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24465504"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "pre-operative and post-operative paired plasmas from 42 patients with primary GCs",
    "expression": "Downregulated",
    "expression_details": "down(post operative plasma of GC)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "plasma miR-21 exp was highly associated with differentiation degree and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460332"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "140 patients for gc & adjacent non tumor tissues,GES1,SGC7901,NCI-N87,BGC823,AGS,KATO III,MKN45,MKN28,SNU1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.01(MKN28),p<0.05(SGC7901,NCI-N87,AGS,KATO III,MKN45,SNU1",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-133b exp was negatively correlated with lymph node metastasis of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24443799"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1, SGC7901,BGC823,MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.000(tissues,SGC7901,BGC823)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-106a positively correlates with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24440352"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "53 pairs of gc & matched adjacent normal tissues,GES-1,BGC823,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24375644"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "65 paired gc & adjacent normal non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-107 exp. Was associated significantly with tumor size (p=0.0032) and differentiation (p=0.028))",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24374340"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES-1,SGC7901,BGC823,MKN28,MGC803,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : low miR-185 level correlates with shorter survival(p<0.0001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-185 suppresses tumor metastasis in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24352663"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hiroshima(Japan)",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 5 non neoplastic tissues & 61 pair  tissues,MKN1,HCS-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test,p<0.0001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "downregulation of miR-148a significantly correlated with advanced clinical stage,lymph node metastasis and poor clinical outcome",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hiroshima (Japan)",
    "sample_type": "tissue",
    "sample": "15 schirrous type gc & 5 non scirrous type GC tissues,30 FFPE schirrous & non schirrous type gc GC,FFPE",
    "expression": "Upregulated",
    "expression_details": "up(in schirrous type gc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression of miR-143 in GC associated with worse cancer specific mortality(p=0.0141)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283360"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24276755"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs of GAC & adjacent matched normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24260067"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24248414"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "South Korea",
    "sample_type": "tissue",
    "sample": "12 pairs of & non cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: poor prognosis(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24222951"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "26 samples of gastric cancer without metastasis, 20 samples of gastric cancers with metastasis, and 15 samples from healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(GC with and without metastasis)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24209632"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "15 gastric adenocarcinoma & 15 matched normal tissues,AGS,GES1,HGC25",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24179536"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "115 pairs of gc & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "115 pairs of gc & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "115 pairs of gc & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNm/satge",
    "tumor_size_details": "miR-29c in GC was significantly associated with a more extensive venous invasion ( P = 0.05) and a more aggressive tumor phenotype ( P < 0.05, stage I/II versus III/IV)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,MKN28,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,SGC7901,MKN45),p<0.05(MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24078004"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-34a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1,AGS,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(AGS),p<0.01(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24065659"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "downregulation of miR-200b level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNMN/stage",
    "tumor_size_details": "downregulation of miR-200c level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "40 pairs of gc & matched adjacent tissues,MKN 28,SGC7901,AGS,MGC803,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24015269"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hangzhou, China",
    "sample_type": "tissue cell line",
    "sample": "51 pairs of gc & adjacent non malignant  tissues,GES1,SGC7901,BGC823,NCI-N87,AGS,HGC27,MGC803,MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential biomarker(AUC=0.824,95% CI is 0.699-0.947)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-215 expr. Level was correlated with progression of tumor invasion(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23981575"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-106a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-20a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-181a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "40 pairs of gc & adjacent non tumor  tissues,GES1,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-181a-5p upregulation  correlated with vascular invasion(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23886199"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "86 pairs of gc & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(epigenetic modification)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "lower miR-433 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "86 pairs of gc & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(epigenetic modification)",
    "significance": "p<0.05  (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "lower miR-127 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 gc & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "lower mIR-148a was associated with lymph node metastasis,N stage and blood vessel invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23873106"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-375",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 gc & adjacent non tumorous tissues,GEs1,BGc823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,BGC823),p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high miR-214 expre is significantly associated with invasion(p=0.01),metastasis(p=0.05),TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc & matched non tumor tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "overexpr. Is associated with tumor size,invasion depth,lymph node metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "30 patients tissues and plasma of GC,gastric ulcer,chronic gastritis each",
    "expression": "Upregulated",
    "expression_details": "up(GC tissues and plasma)",
    "significance": "p=0.000(in GC tissues and plasma compared to gastric ulcer and chronic gastritis)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803080"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,MKN45,MKN28,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(MKN45),p=0.003(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803041"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "75 pairs of gc & non cancerous tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23800944"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "98 pairs of gc & adjacent norma mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: shorter overall survival(p=0.03)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-22 expr. Had grater extent of lymph node metastasis(p=0.02),distant metastasis(p=0.01),worse stage(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23786758"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "24 gc & matched normal tissues,AGS,BGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-204 expr. Was lower in metastasis group than in non-matastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23768087"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "98 gc  & adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "shorter overall survival(p=0.02)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-206 expr. Had greater extent of lymph node metastasis(p=0.01),venous invasion(p=0.008),hematogenous recurrence(p=0.01),worse stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "80 gc post & pre operative plasma & 70 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker(AUC=0.818,sensitivity=76%,specificity=74%,accuracy=75%)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23733518"
  },
  {
    "miRNA_name": "miR-370",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721824"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "57 paired gc & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23644120"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "GES-1,MGC803,BGC823,MKN28,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23621248"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 gc & 18 non tumor tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p=0.0077(SGC7901)",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23611267"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "up(MDR cell lines)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "up(MDR cell lines)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-1228*",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of gc & adjacent non tumor tissues,GES1,BGC823,AGS,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23554909"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc & matched normal tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23529765"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-21",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "12 paired gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23442884"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "86 cases for gc & adjacent non neoplatic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "Real time qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-9 exp. Was significantly lower in GC with deeper invasion(p<0.001),lymph node metastasis(p<0.001),distant metastasis(p=0.022),advanced TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23383271"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "56 gastric tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "reverse transcriptase-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : in stage I,II,III 5 year survival rate with high miR-10b exp. Was significantly lower than with low miR-10b exp.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-10b high expr. Correlates with size of tumor,Lauren clasiification,depth of invasion,lymph node and distant metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23351547"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "30 gc samples,GES1,SGC7901,MKN28,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "lower miR-206 exp. Significantly correlated with patients differentiation grade and TNM stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23348698"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1,AGS,MGC803",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1,AGS,MGC803",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "66  pairs of gc & corresponding non tumor tissues,GES1,BGC823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-135b was related with Lauren classification,tumor differentiation ,invasion,pTNM(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23328512"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23322197"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "juice mucosa",
    "sample": "141 gastric juices samples from gastric cancer, gastric ulcer, atrophic gastritis, and minimal gastritis patients or subjects with normal mucosa",
    "expression": "Downregulated",
    "expression_details": "down(in gc disease compared with benign gastric diseases",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.639(miR-129-1-3p),0.651(miR-129-2-3p)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23307240"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "tissues,MGC803,SGC7901,MKN45,BGC823,MKN74,AGS,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23296701"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "69 preoperative GC plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : prognostic factor(p=0.0133,HR=13.4(95% CI=1.72-104.4)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high plasma miR-21 had vascular invasion(p=0.0311)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267156"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "GES1,MGC803,HGC27,NCI-N87,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23264087"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "89 gc & 89 normal gastric mucosa tissues,GES-1,AGS,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down( in gc & especially in metastatic gc tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower expression in metastatic than in non metastatic gc tissues(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23233482"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-27a",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Rome,Italy",
    "sample_type": "tissue",
    "sample": "84 gastric tumor & matched peritumoral tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower miR-204 had worst survival(p=0.017)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23152059"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "44 gc & matched adjacent tissues,GES1,MKN45,GC9811,AGS,SGC7901,MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "decreased miR-149 exp. Correlates with lymph node metastasis(p=0.046),TNM stage(p=0.0011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23144691"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 samples of gc & corresponding para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23128435"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 patients tumor & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower miR-101 was associated with increased tumor invasion and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013439"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "mIR-29c",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "tissue",
    "sample": "37 gastric adeno carcino & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22992343"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression miR-181a in GCT associated with positive lymph node metastasis(p=0.042)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22971574"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Shanghai,China",
    "sample_type": "tissue cell line",
    "sample": "33 patients for gc & correspondinf normal gastric gastric mucosa tissues,GES1,MKN28,SGC7901,AGS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues),15 fold in MKN28,11.7 fold in SGC7901,10.1 fold AGS",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-10a expression was associated with lymph node metastasis(p=0.047)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969895"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Shanghai,china",
    "sample_type": "plasma",
    "sample": "210 gc & 110 healthy plasma(qRT-PCR)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker,ROC- 0.837 with 80% sensitivity and 74% specificity",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22956063"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "blood",
    "sample": "52 patients & 15 healthy blood",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(blood)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC-ROC was 0.715(p=0.012),sensitivity=65.4%,specificity=100%,accuracy rate=73.1%.Prognostic : Increased miR-200c level had poor OS(9 vs 24 months;p=0.016),PFS(4 vs 11 months;p=0.044)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "increased miR-200c expression levels correlates with no. of lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Ningbo,China",
    "sample_type": "tissue",
    "sample": "tisssues",
    "expression": "Upregulated",
    "expression_details": "up(tissues),down(gastric juice)",
    "significance": "p=0.001(mucosa biopsies)",
    "detection_method": "Real time qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Ningbo,China",
    "sample_type": "gastric juice",
    "sample": "gastric juice",
    "expression": "Downregulated",
    "expression_details": "up(tissues), down(gastric juice)",
    "significance": "p<0.001(gastric cancer  juices vs benign gastric diseases)",
    "detection_method": "Real time qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Ningbo,China",
    "sample_type": "tissue cell line",
    "sample": "12 gc & corresponding adjacent non neoplastic tissues,GES1,AGS,HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22901205"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "60 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "up, (plasma levels of miR-223 were significantly higher in GC patients with helicobacter pylori (Hp) infection than those without (P = 0.014), and significantly higher in healthy control subjects with Hp infection than those without (P = 0.016).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC:0.9089",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "plasma miR-223(p<0.001)  increased in StageI GC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "60 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC= 0.7944",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "plasma miR-21(p=0.003) level was increased in StageI GC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "60 gc & 60 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Diagnostic : AUC:0.7432",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Fuzhou,China",
    "sample_type": "tissue",
    "sample": "stage II tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : shorter survival in low expression grp(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression was  associated with histological differentiation(p<0.05),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22851079"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hubei,China",
    "sample_type": "tissue plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence).tissues,plasma",
    "expression": "Upregulated",
    "expression_details": "up(reccurence GC grp)",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic ,Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.79,Prognostic : overall survival rate with high miR-21 expr. Was lower than low expr.(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high up regulated miR-21 expr. Associated with histological type(p<0.001),T stage(p<0.001),lymph node metastasis(p<.001),pTNM (p<0.05) in univariate amd pTNM(p=.001),lymph node metastasis (p=.001) in multivariate analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Changchun,China",
    "sample_type": "tissue",
    "sample": "20 gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qReal time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduced miR-574-3p expr. Significantly associated with higher level of differentiation and early stage of cancer(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Changchun,China",
    "sample_type": "tissue",
    "sample": "20 gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qReal time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-768-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Changchun,China",
    "sample_type": "tissue",
    "sample": "20 gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qReal time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Changchun,China",
    "sample_type": "tissue",
    "sample": "20 gc & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qReal time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "nanjing,China",
    "sample_type": "tissue",
    "sample": "92 pairs of Gc & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expr. Showed significant correlation with advanced tumour-node-metastasis,local invasion and lymphatic metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22613407"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,MGC803,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22581522"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "gastric adenocarcinoma(GAC)",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10  pairs of GAC & adjacent normal tissues,SGC7901,BGC 823,MGC-803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22539488"
  },
  {
    "miRNA_name": "miR-495",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,DES1,SGC7901,MKN28,HFE-145",
    "expression": "Downregulated",
    "expression_details": "down(gc tissues,SGC7901,MKN28)",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-551a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,DES1,SGC7901,MKN28,HFE-145",
    "expression": "Downregulated",
    "expression_details": "down(gc tissues,SGC7901,MKN28)",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "Baltimore,USA",
    "sample_type": "tissue",
    "sample": "39 gc & 40 normal stromach tissues",
    "expression": "Upregulated",
    "expression_details": "up(gc tissues)",
    "significance": "p=0.02",
    "detection_method": "microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22464652"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Portugal",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down (due to deletions and/or microdeletions at miR-101 genomic loci)",
    "significance": "p<0.0089",
    "detection_method": "qReal Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450781"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22431000"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "AGS,SNU-16,KATO III,MKN28,SGC-7901,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426647"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "72 gc & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22420029"
  },
  {
    "miRNA_name": "Panel( miR-107, miR-21, miR-196a,\nmiR-26b, miR-9, miR-142-3p, miR-30b, miR-150, miR-191 and miR-17 )",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "161 gc & adjacent normal tissues(for miR-107 real time pcr) and 5 pairs of gc & adjacent normal for panels of miRNA expression study",
    "expression": "Upregulated",
    "expression_details": "up( all upregulated but miR-107 had highest upregulation)",
    "significance": "p<0.001",
    "detection_method": "Real time PCR based miRNA array,Real timT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic -for miR-107worse survical rates with OS(P=0.002) and DFS(P=0.017)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-107 showed significant association with depth of tumor invasion,lymph node metastasis and stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22407237"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES-1,MKN45,SGC7901,NCI-N87,AGS,,MKN28,SNU-16,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22388101"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 gc & adjacent normal tissues,MGC803,MKN-28,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qReal Time-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "higher miR-196a expression was associated with tumor size,a higher clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "10 pairs of GAC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22325466"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Saitama,Japan",
    "sample_type": "tissue",
    "sample": "70 paired gc & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low miR-125a-3p expression  associated with tumor size(p=0.0002),tumor invasion(p=0.0149),lymph node metastasis(p=0.018),liver metastasis(p=0.016),peritoneal dissemination(p=0.03),advanced clinical stage(p=0.0037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "11 pairs of gc & adjacent normal  tissues,SGC-7901,SGC7901/VCR,MGC-803,MKN-45,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22310976"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "15 gc patients ,GES-1,AGS,N87,SGC7901,BGC-823,MKN45",
    "expression": "Upregulated",
    "expression_details": "up( in metastasis positive gc)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22293682"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "22 gc & matched normal gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "Real time RT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-223 upregulation correlated with lymph node metastasis(p=0.086),metastasis (p=0.002),advanced pathological stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22270966"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 patients(gc & adjacent normal tissues),GES-1,CRL-5971, CRL-5974, BGC-823,AGS,SGC7901,MKN45,HTB-103,MKN28,CRL",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high miR-21 expression was associated with degree of differentiation of tumor tissues(p=0.004),local invasion and lymph node metastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22267008"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "118 gc & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No difference",
    "expression_details": "down (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-192 was significantly lower in the pT4 stage of gastric cancer than in pT1, pT2 and pT3 stages (p = 0.026) and low miR-192  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 )",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "118 gc & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No difference",
    "expression_details": "down (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low miR-215 expression  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 and p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "3 pairs of gc & corresponding adjacent non tumor tissues,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22189055"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Shanghai,China",
    "sample_type": "tissue cell line",
    "sample": "90 pairs of gc & corresponding non tumor tissues( 52 lymph node positive & 38 lymph node negative),HGC-27,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down( in gc with  lymph node positive)",
    "significance": "p=0.01(gc vs normal),p=0.00",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-409-3p low expression  associated with TNM stage(p=0.01),lymph node metastasis(p=0.00",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22179828"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "20 gc & matched non tumor adjacent tissues,BGC-823,MKN-45,HGC-27,AGS,SGC-7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22020746"
  },
  {
    "miRNA_name": "miR-27",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-27 level in metastatic group were higher than those in the non metastatic group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018270"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Shanghai,China",
    "sample_type": "tissue",
    "sample": "90 gc & corresponding non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "downregulated miR-148a  associated with TNM stage (p=0.0049) and lymph node metastasis(p=o.0003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21994419"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 pairs of GAC  & matched normal gastric tissues, MGC803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(cell line)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21947487"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "119 patients tissues,SGC7901,MGC-803,BGC-823",
    "expression": "No difference",
    "expression_details": "down(cell lines),no difference  in tissues",
    "significance": "p<0.001( cell lines),not significant in tissues",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "lower miR-194 expression tends to have larger tumor size(p=0.002),more advanced pT stage(p=0.028) and miR-194 have significant lower exp. In Borrmann IV than in I,II,III group(p=0.019),lower expr. In male than in female(p<0.034)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "70 gc & paired matched adjacent tissues,SGC7901,BGC823,MGC-803,GES-1,AGS",
    "expression": "No difference",
    "expression_details": "down(cell line),no significant difference between gc & adjacent normal tissues",
    "significance": "p<0.01(SGC7901,MGC-803,BGC-823),tissues(p=0.7)",
    "detection_method": "Real time qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expr. Of miR-335 asssociated with lymph node metastasis(p<0.001),poor pT stage(p<0.05),poor pN stage and invasion of lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21822301"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc  & matched normal tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real Time-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21628394"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "advanced gastric cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 advanced primary gastric tumors & adjacent non tumor  gastric tissues,AGS,BGC-823,SGC7901,SNU-16,GES-1,BGC-803",
    "expression": "Downregulated",
    "expression_details": "down, relatively up in Ags,BGC-823,SGC-7901 compared with GES-1",
    "significance": "p=0.005(tissues)",
    "detection_method": "Northern blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21552422"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "57 pair matched gastric neoplastic & adjacent non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "lower expression of miR-622 associated with differentiation and lymphativ metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21528065"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 patients tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low expression miR-146a was associated with increased tumor size(p=0.06),poor differentiation(p=0.010)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901,NCI-N87,MKN-45,MKN-28,BGC-823,Snu-16,AGS,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low miR-126 expression was associated with large tumor size(p=0.017),local invasion(p=0.006),lymph node metastasis(p=0.013),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "48 paired gc & matched adjacent non tumor  tissues,GES-1,MGC0803,SGC7901,AGS,BGC-823,HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20548334"
  },
  {
    "miRNA_name": "miR-663",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEK-293,HUVEC,GES-1,BGC-823,SNU-5,MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20514450"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "GES-1,AGS,MKN45,KATO-III,BGC-823,NCI-N87,SNU-16,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20510161"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 gc tissues & non tumor mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression was associated with TNM stage(p=0.0010),lymph node metastasis(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20300657"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Oita,Japan",
    "sample_type": "tissue",
    "sample": "22 gc & 5 normal control tissues",
    "expression": "Downregulated",
    "expression_details": "down( DNA methylation & histone deacetylation)",
    "significance": "p<0.001",
    "detection_method": "microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20215506"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-181b",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20067763"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "16 gc & 18 non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19802518"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19598010"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "3 normal gastric & 24 malignant  tissues,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "3 normal gastric & 24 malignant  tissues,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 pair matched gastric neoplastic &  adjacent non neoplastic tissues,NCI-N87,MGC803,BGC823,SGC7901,HGC27",
    "expression": "Downregulated",
    "expression_details": "down,up in NCI-N87",
    "significance": "p<0.01(tissues)",
    "detection_method": "qReal Time-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19363643"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "55 gc & 17 non-tumor FFPE tissues,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues(p=0.026),SGC7901(p<0.01),MGC-803(p<0.05)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-106a level  associated with tumor stage,size(p<0.001),differentiation(p<0.001),lymphatic and distal metastasis(p<0.001)invasion(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "10 gc & normal tissues,GES-1,AGS,SGC7901,MKN28,MKN45",
    "expression": "Upregulated",
    "expression_details": "up (due to H.pylori infection)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "gastric adenocarcinoma",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "8 pairs of gc & adjacent non tumor tissues tissues( 4 pairs for microarray & 4 for semiquantitative RT-PCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,semiquantitative -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18789835"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "37 pairs gc & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18507035"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-15b",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-16",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-136",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "GC peritoneal metastatic parental sublines : GC-9811,GC-9811P,GC-9811P1,GC-9811P2,GC-9811P3",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression associated with worse Prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression is associated with more peritoneal metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656883"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "78  GC tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-31 expression was associated with lymph node metastasis ,poor pT and pN stage and invasion ability into lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656284"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "4 pair of gc & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "4 pair of gc & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues and drug resistance cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28609840"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "8 pairs of gc & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588702"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "80 paired gc samples,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR,MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28586056"
  },
  {
    "miRNA_name": "miR-15b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line plasma",
    "sample": "cell lines,tissues,plasma sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28560431"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,GES1,BGC-823,AGS,HGC27,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28537672"
  },
  {
    "miRNA_name": "miR-1258",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "116 pairs of gc & adjacent normal tissues,SGC7901,MGC803, BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(SGC7901,MGC-803,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "there was association between decreased miR-1258 expression level and increased age(p=0.042),advanced pathological tumor stage (p=0.027),positive lymphatic vessel invasion(p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28521475"
  },
  {
    "miRNA_name": "miR-129-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 paired tissues,AGS,SGC7901,BGC823,MKN45,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28653880"
  },
  {
    "miRNA_name": "miR-2392",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "GC tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28512191"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "90 paired tissues,GES1,MKN28,SGC7901,NCI-N87,BGC-823,AGS,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-worse OS for low expression(p=0.0027)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with higher potential to develop vascular invasion(p=0.033),lymph node involvement(p=0.040),distant metastasis(p==0.020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28493075"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Colombia",
    "sample_type": "",
    "sample": "",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28489839"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Colombia",
    "sample_type": "",
    "sample": "",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28489839"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "gastric acncer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "50 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression level correlated with progression of tumor invasion & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28485164"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "92 primary Gc,20 adjacent non tumorous tissues,SGc7901,MKN45,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "prognostic-high expression had poor OS & DFS for Gc patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression correlated with tumor size,Lauren's classification,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-584-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "75 paired surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level had nrgative correlation with tumor size larger than 3cm",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431583"
  },
  {
    "miRNA_name": "miR-9-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "100 matched tissues,HGC27,MGC803,BGC823,SGC7901,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlated with higher lymph node metastasis incidence(p=0.004)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28418879"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "pre and post operative serum",
    "expression": "Downregulated",
    "expression_details": "down(postoperative serum)",
    "significance": "p<0.01( 55 paired pre-postoperative),p<0.05( 15 paired pre-postoperative serum)",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: miR-20a serum level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "serum level correlated with  differentiation degree,lymph node metastasis,age,tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "pre and post operative serum",
    "expression": "Downregulated",
    "expression_details": "down(postoperative serum)",
    "significance": "p<0.01(55 paired pre-postoperative),p<0.05(in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "pre and post operative serum",
    "expression": "Downregulated",
    "expression_details": "down(postoperative serum)",
    "significance": "p<0.01(in 55 paired pre-postoperative),p<0.05( in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "GC &  normal tissues(42 each),GEs1,SGC7901,HGc27,MGC803,Ags,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "up(in H.pylori infected GC compared to H.pylori negative GC),down(GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-high H.pylori infection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression In lymph node positive than in negative & stage III- IV thgan in I-II (both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "H.pylori positive & negative GC(42)",
    "expression": "Upregulated",
    "expression_details": "up(in H.pylori infected GC compared to H.pylori negative GC),down(GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-high H.pylori infection",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression In lymph node positive than in negative & stage III- IV thgan in I-II (both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "273 tissues,MGC803,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "expression associated with lymph node metastasis,tumor diggerentiation & TNM( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28401000"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "up in high dose exposed group",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "high miR-24 expression is independent predictor for exposure status",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "up in high dose exposed group",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "low expression correlated with low survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "Family(miR-200a,200b,200c,miR-141,miR-429)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "46 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: predictor of aggressiveness of GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression of all 5 family members associated with histological grade & presence of intravascualr embolus(both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26137064"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "SGC7901,MKN28,MKN45,BGC823,AGS,GES1",
    "expression": "Upregulated",
    "expression_details": "up(GC cell lines)",
    "significance": "",
    "detection_method": "qRt-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "ISH",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173586"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired tissues,HGC27,SGC7901,MGC803,AGS,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "QPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression inversely correlated with tumor size (P = 0.017), tumor stage (P = 0.035), lymph node metastasis (P = 0.018), and TNM stage (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "64 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression not significantly asociated with tumor location,size,stage & grading(p>0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26250158"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 Gc & 20 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation with depth of invasion & lymph node metastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26238271"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233544"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "130 GC & 22 control serum",
    "expression": "Downregulated",
    "expression_details": "down(in stage IV than in I &III)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression in T stage,vessel invasion,lymph node,peritoneal & distant metastasis,predicts metastasis & early recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "35 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "38 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRt-PCR",
    "marker": "Prognostic",
    "marker_details": "prognodtic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high expression correlated with advanced N stage(p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "23 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0016(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with lymph node metastasis(p=0.021)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309359"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Upregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.Pylori infected tissues)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "up(H.Pylori infected tissues)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression associated with tumor size,lymph node metastasis,primary tumors( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression level inversely correlated with pathological differentiation & distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26352175"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue plasma",
    "sample": "tissues,plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26471298"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "107 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positive correlation with lymphatic metastasis,clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464633"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0133",
    "detection_method": "qRt-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.029",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-128",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-101-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue",
    "sample": "25 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-125b-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue",
    "sample": "25 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0495",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "tissue",
    "sample": "25paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "76 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator of GC(p=0.0027, according to multivariate)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "expression associated with Lauren classification(p=0.034)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26415802"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "cell lines- GES1,SNU5,HGC27,BGC823,SGC7901,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26573417"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "154 GAC tissues after radical gastrectomy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for GC except for TNM stage",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with tumor cell differentiation,N stage,TNM stage( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26545111"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue plasma",
    "sample": "73 paired tissues,35 GC & 35 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic & Diagnostic-plasma miR-27a level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "40 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26513239"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :high miR-21 related with lower OS rate, diagnostic: AUC-0.75,sensitivity-0.70,specificity-0.78",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :high miR-29 related with higher OS rate, diagnostic: AUC-0.73 ,sensitivity-0.70,specificity-0.68",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "inverse correlation with invasion depth(p=0.031),clinical stage(p=0.002),Lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-577",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "3o paired tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622688"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 tumor & matched normal tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617808"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "61 paired tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "correlated with aggressive phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26610210"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,NCI-N87,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(SGC7901,MGC803)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26576674"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "77 paired tissues,AGS,BGC823,HGC-27,MGC803,MKN45,NCI-N87,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "Real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "higher expression in advance GC( stage III/IV,p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26716895"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711782"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "95 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor : lymph node metastasis(p=0.003),distant metastasis(p=0.001),TNM(p<0.001) & miR-141  expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "associated with tumor diffrentiation(p=0.044),positive lymph node metastasis(p=0.010),distant metastasis(p<0.001),advanced TNM stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26681225"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum levelof miR-200c",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "associated with tumor grade(p=0.01) & TNM stage(p=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26662382"
  },
  {
    "miRNA_name": "miR-193-3p",
    "cancer": "gastric canecr",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26753960"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 gc and matched nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26729198"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722508"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "80 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "level was also correlated with cancer differentiation stage, lymph node metastasis, TNM stage and tumor size (P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "43 tissues below 40 years age",
    "expression": "Upregulated",
    "expression_details": "up(in  recurrence group)",
    "significance": "p=0.03( recurrence vs nonrecurrence)",
    "detection_method": "qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "Recurrence-predictor of recurrence in young GC patients whose tumors contain a high proportion of intratumoral stroma.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26824898"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "no correlation between miR-421 level and age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis,but correlatrd with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "50 gc & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823741"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 gc & corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues & cell lines except AGC),p<0.01(AGS)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823713"
  },
  {
    "miRNA_name": "miR-519",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26819420"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "18 tissues,GES1,HGC27,AGS,GC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26781754"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "associated with tumor size,TNM stage,lymph node metastasis presence(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-524-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "15 tissues,MKN45,SGC7901,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26998102"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "81 tissues,GES1,NCI-N87, MKN87, SNU16, SGC7901, AGS, MKN28, and MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression associated with poor histological diffrentiation & distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "inverse correlation  with tumor size & pathological stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "18 tissues,GES1,SGC7901,BGC823,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,BGC823,HGC27),p<0.05(SGC7901)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26949090"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27071318"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044823"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "44 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "63.60%",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27042104"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "107 paired tissues, AGS, MKN-28, MKN-45, NCI-N87, HGC-27, SNU-16,SGC-7901,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had longer OS (p=0.006) & time to relapse (p=0.007)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27016414"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "50 paired tissues,80 gc & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.882)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "51 paired tissues,80 gc & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :plasma level( AUC=0.839)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "52 paired tissues,80 gc & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.842)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "53 paired tissues,80 gc & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.765)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27007598"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "115 gc 7 40 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down( in GC plasma samples),up(after treatment)",
    "significance": "p<0.01( for gc vs normal & before treatment vs after treatment plasma)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis (P = 0.016), tumor differentiation (P = 0.001), and TNM stage (P = 0.005).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173244"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue serum",
    "sample": "tissues,62 gc & 36 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05( tissues & serum)",
    "detection_method": "QF-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation with the infiltration depth, the extent of differentiation, the clinical staging and lymph node metastasis (all p <0.05), but not correlated with tumor locations (p >0.05).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27097947"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "juice",
    "sample": "204 gastric juices",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=0.907",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27268657"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-30a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "40 tissues ,MGC-803, MKN-45, AGS, SGC- 7901,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression of miR-31 was associated with poor tumor differentiation, lymph node metastasis, advanced T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 tissues,SGC-7901, AGS, MKN-45, MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "high expression  associated with poor histological features (P=0.025), large tumor size (P=0.003), advanced TNM stage (P=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "15 paired tissues, AGS, BGC-823, MKN-28, MKN-45, MGC-803, SGC-7901,HEK293",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00015(tissues),p<0.05( gc cell lines vs HEK293)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27366092"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "gc & healthy Plasma,gc FFPE tissues,normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP,preoperative plasma,gc FFPE )",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27357419"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "20 paired tissues,HGC27,BGc823,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "detection_method": "qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27353653"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "112 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression associated with tumor differentiation (P < 0.001), depth of tumor invasion (P = 0.006), and TNM stage (P < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323107"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "18 paired gc & surgical margin tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27468717"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic indicator for OS (p = 0.011).",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis, metastasis stage, and distant metastasis (all p < 0.05).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27460730"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "82 paired tissues,MKN45,SGC7901,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27451075"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "low expression associated with adverse clinicopathological characteristics including poor differentiation, large tumor size and advanced TNM stage.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572553"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "41 paired tissues,SNU-1, SNU-16, AGS, NCI-N87, KATOIII, SGC-7901, BGC-823, MKN-45 , MKN-28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression more lymph node metastasis(p=0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27518872"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(DDP resistant tissues & SGC7901/DDP",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27513895"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27733214"
  },
  {
    "miRNA_name": "miR-489",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 paired tissues,MGC-803, SGC-7901, AGS, MKN45, MKN28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725907"
  },
  {
    "miRNA_name": "miR-561",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell lien",
    "sample": "50 gc & adjacent tissues,SGC-7901, HGC-27, MKN-45, MGC-803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated   with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725860"
  },
  {
    "miRNA_name": "miR-509-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 gc & 64 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27697095"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue cell line",
    "sample": "20 paired tissues,KATO-III,MKN-1,MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues),p<0.001( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27696637"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down(proximal promoter methylation)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic- stge III and stage IV low expression in GCA patients had poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "low expression in stage III & stage IV GCA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27791400"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "",
    "sample": "gc samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27780852"
  },
  {
    "miRNA_name": "miR-337-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "90 normal gastric & 90 gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27259238"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression associated with TNM stage & lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27220320"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "106 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0318",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression is correlated with advanced tumor stage and lymph node metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27078844"
  },
  {
    "miRNA_name": "miR-151-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27191259"
  },
  {
    "miRNA_name": "miR-151-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27191259"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 paired tissues,SGC-7901, MKN-28, MKN-45, BGC-823, AGS,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "positive association with tumor size(p=0.012),lymoh node metastasis(p0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No difference",
    "expression_details": "no alteration",
    "significance": "",
    "detection_method": "Real time-RT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.548,plasma miR-103 level is not a biomarker for DGC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No difference",
    "expression_details": "no alteration",
    "significance": "",
    "detection_method": "Real time-RT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.563, plasma miR-107 level is not a biomarker for DGC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma",
    "sample": "diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No difference",
    "expression_details": "no alteration",
    "significance": "",
    "detection_method": "Real time-RT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.512,plasma miR-194 level is not a biomarker for DGC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "40 paired tissues,MGC-803, MNK-45, SGC-7901, HGC-27,GES",
    "expression": "Downregulated",
    "expression_details": "down( epigenetic regulation)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904681"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Real time RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with lymphovascular invasion & TNM-III & IV(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904131"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 drug treated gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "low",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 paired tissues,SGC7901,NCI-N87,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27874950"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "associated with depth of invasion (P = 0.005), tumor size (P = 0.024), lymph node metastasis (P = 0.048), and TNM stage (P = 0.035)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "55 paired tissues,TCGA data",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.001(TCGA)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "associated with tumor sizes(p=0.015)and depth of invasion(p=0.010).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27827403"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 paired tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27810403"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "180 gc patient after surgery for microarray preparation,paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "low expression of miR-16 (HR 2.26; 95 % CI 1.51-3.40; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.according to multivariate",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "180gc patient after surgery for microarray preparation,paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "low expression of miR-451 (HR 2.01; 95 % CI 1.36-2.96; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-375 was found to be associated with low T-stage cancers (T1+T2) and differentiated histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue",
    "sample": "34 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "",
    "sample": "16 gastric MALT lymphoma & 12 cgronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "",
    "sample": "16 gastric MALT lymphoma & 12 cgronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "",
    "sample": "16 gastric MALT lymphoma & 12 cgronic gastritis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0299",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "",
    "sample": "16 gastric MALT lymphoma & 12 cgronic gastritis",
    "expression": "No difference",
    "expression_details": "no difference in gastric MALt lymphoma vs chronic gastritis",
    "significance": "not significant",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-520b",
    "cancer": "gastric acncer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Real time RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-520e",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Real time-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "200 gc patientstissues (112 H.pylori infected & 88 H.Pylori negative),88 healthy tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001( gc tissues vs normal)",
    "detection_method": "RT-qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27994199"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "15 patients for gc & adjacent matched normal tissues,GES-1,MGC-803, BGC-823, MKN-45, and SGC-7901,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27983934"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "54 gc & 54 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "ISH",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-204 level was significantly associated with no lymph node metastasis (P = 0.003) and early tumor stages (stages I-II; P = 0.048).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28133610"
  },
  {
    "miRNA_name": "miR-511",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "12 paired gc & normal  tissues,AGS, BGC823, MGC803, HGC-27,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114950"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "promising",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "52 gc and paired normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28113080"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression associated with depth of invasion (P = 0.030), tumor size (P = 0.047), lymph node metastasis (P = 0.047), and TNM stage (P = 0.048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-1296-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 gc and 30 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(in gc and lymph node metastatic tissues)",
    "significance": "p<0.01(gc vs adjacent normal & lymph node metastatic vs non metastatic tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28099468"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low expression associated with tumor size(p=0.012), TNM stage(p=0.007)  lymph node metastasis(p=0.007) and distant metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-423-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum tissue",
    "sample": "67 serum,119 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-tissues expression of miR-423-3p",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28254439"
  },
  {
    "miRNA_name": "miR-383",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "40 paired intestinal type GAC & adjacent tumor free tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28243881"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "231 pared gc &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "Low expression  associated with tumor size (P = 0.030), venous invasion (P = 0.027), peritoneal dissemination (P = 0.027), lymph node metastasis (P = 0.033), poor pT stage (P = 0.040), poor pN stage (P = 0.038), poor TNM stage (P = 0.005), and invasion into lymphatic vessels (P = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "90 paired gc & adjacent non tumor tissues,N‐87, SGC‐7901, AGS, SNU‐16, MKN‐45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "high expression reduced OS(p=0.012) & DFS(p=0.015)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression of miR‐520c had more lymph node metastasis (P = 0.019) and advanced TNM stage (P = 0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "up( gc and metastasis positive tissues) &HIF-1α upregulates miR-224 expression)",
    "significance": "p<0.01( gc vs adjacent non-tumor tissues),p<0.05(metastatis vs non metastatic)",
    "detection_method": "real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28173803"
  },
  {
    "miRNA_name": "miR-491-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue ecll line",
    "sample": "22 pairs of gc & matched adjucent non tumor tissues,SGC-7901, MKN45, BGC823, AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28358374"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28356225"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 paired gc and matched adjacent tissues,MGC-803, HGC-27, BGC-823, AGS , SGC-7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression associated with advanced clinical stage(p=0.002),advanced T stage(p<0.001),advanced N stage(p=0.026), advanced M stage(p=0.004)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28327189"
  },
  {
    "miRNA_name": "miR-519d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "lower miR-519d expression was associated with distant metastasis, lymph node metastasis and clinical stage for patients with GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28861156"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28260021"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "36 paired surgically resected gc tissues & matched adjacent normal",
    "expression": "Downregulated",
    "expression_details": "hypermethylation of promoter region,DNMT3A mediate downregulation)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829505"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "low expression  associated with tumor size (p=0.001), lymphatic metastasis (p=0.008) and TNM stage (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-584-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "GES-1,SGC7901,AGS,MKN45,MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28827574"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800791"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue blood",
    "sample": "tissues and peripheral blood samples from 96 gastric cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "tissue and serum miR-144 levels were both associated with clinical stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "Low expression correlated with lymph node metastasis, invasive depth and TNM staging in gastric cancer patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-4269",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "41 paired gc & adjacent normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.006",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759040"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "GES-1,SGC7901,MGC803,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28718369"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression  correlated with the clinical stage, lymph node metastasis and tumor invasion in gastric cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28714005"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "21 paired gc & adjacent matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28713899"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28701053"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "30 paired gs & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28693382"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,AGS, SGC-7901, NCI-N87, GES-1, MKN-45 ,BGC-823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "correlated with the progression of tumor invasion and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28689850"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 paired gc & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28680805"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "increased",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 gc & 10 normal gastric tissues,GES-1,AGS, HGC27, BGC823 , SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672911"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "miR-148-3p",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 paired GC and distal normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28955960"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 paired GC and matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression of miR-381 was associated with lymphatic metastasis (P=0.031) and advanced TNM stage (III+IV, P=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927144"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell lines",
    "sample": "36 paired gc and adjacent normal gastric tissues,GES1,SGC7901,MKN1,AGS,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927076"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression  correlated with age (p = 0.036), tumor size (p = 0.001), histological type (p = 0.003), depth of invasion (p = 0.007), venous invasion (p = 0.002), hematogenous metastasis (p = 0.022), and pathological stage (p = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "urine",
    "sample": "50 GC patients urine",
    "expression": "Upregulated",
    "expression_details": "expression level reduced following surgical removal of GC tissues",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28915598"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "109 GC patients,MGC 80-3, MKN45, SNU-5, AGS and KATOIII",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "a strong correlation between miR-647 expression and TNM stage (p=0.0020), lymph-node metastasis (p=0.0046) and local invasion (p=0.0062)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-4317",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "17 gc & adjacent non tumor stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28880489"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue Stool",
    "sample": "tissues, faecal; Forty pairs of primary CRC and its adjacent normal tissues and Faecal samples from 595 subjects (198 CRCs, 199 adenomas, and 198 neoplasm-free controls).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues p=0.0065, faecal<0.0001, AUC=0.83",
    "detection_method": "real time PCR",
    "marker": "Screening",
    "marker_details": "Diagnosis: screening",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "colorectal canecer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "prognostic and diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "colorectal canecer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "prognostic and diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "32 patients who underwent primary tumor resection and received palliative chemotherapy for unresectable metastatic CC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "for PFS (p=0.0109) and OS (p=0.0675)",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with reduced progression-free survival (PFS) and overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798874"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "high-risk",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "",
    "expression_details": "",
    "significance": "AUC = 0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.786 , P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "non-invasive diagnostic marker for early detection of CRC, and prognostic indicator: high miR-92a expression in CRC was independently associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "Screening",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001, sensitivity of 71.6% and specificity of 73.3%",
    "detection_method": "real time PCR",
    "marker": "Screening",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "hypermethylated in 97.5% of  tumours, P=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Screening",
    "marker_details": "non-invasive faecal-based screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "hypermethylated in 97.5% of  tumours, P=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Screening",
    "marker_details": "non-invasive faecal-based screening marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA and Asia",
    "population": "USA and China",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "diagnostic marker for metastatic colon cancer and predicts poor prognosis.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "circulating miR-141 was significantly associated with stage IV colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for diagnosis and prognosis, prognostic factor for poor overall survival in CRC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "tissues,serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic, Prognostic- serum level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low serum miR-15a level more frequently occurred in ESCC patients with advanced TNM,Tand N stage(all p=0.01),poor tumor differentiation(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues,115 FFPE,154 ESCC & 154 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic : miR-146a expression level is an ideal prognostic and diagnostic biomarker of ESCC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-146a tissues level was significantly reduced with increased T stage(p=0.037) and TNM stage(p=0.004) ,serum miR-146a was negatively associated with T stage (P=0.002",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "60 pair tissues,75 serum from ESCC and healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic- low serum level(AUC-0.767+-0.040,sensitivity-81.3%,specificity-62.7%),prognostic-worse OS(p=0.018) ,PFS(p=0.035) and p=0.006(multivariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "tissue expression reduced with T stage increase(p=0.008),low serum level associates with N stage(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum cell line exosome",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "expression": "Upregulated",
    "expression_details": "up(ESCC serum, exosomes)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "serum low expression in T1/T2 than T3/T4(p=0.0024),low in without lymph node metastasis than with metastasis(p=0.0002),without distant metastasis than with metastasis(p=0.0020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "138 gc & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic :AUC-0.80, Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "associated with T stage, distant metastasis, and differentiation",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "expression": "Upregulated",
    "expression_details": "up(in gc tissues & plasma,up due to promoter hypomethylation)& down(in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "q-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high miR-106a expression was closely related to the degree of lymphatic metastasis and TNM staging of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "SGC7901,HGC27,AGS,MKN45,N87,GES-1,41 gc & adjacent normal tissues,41 gc & 41 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues),p=0.0041(serum),p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-130a expression level were higher in patients with metastasis than in without metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Prognostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity,Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high level was significantly correlated with clinical stage (p<0.001),lymph node metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Downregulated",
    "expression_details": "down(in Gc/DM)",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-122=0.808(95%CI,0.712-0.905,p<0.01),Prognostic:  higher plasma miR-122 in GC is a favourable Prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Upregulated",
    "expression_details": "up(in Gc/DM)",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-192=0.732(95%CI,0.625-0.841,p<0.01),Prognostic :  plasma miR-192 level not associated with OS  in GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "blood",
    "sample": "52 patients & 15 healthy blood",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(blood)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic: AUC-ROC was 0.715(p=0.012),sensitivity=65.4%,specificity=100%,accuracy rate=73.1%.Prognostic : Increased miR-200c level had poor OS(9 vs 24 months;p=0.016),PFS(4 vs 11 months;p=0.044)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "increased miR-200c expression levels correlates with no. of lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hubei,China",
    "sample_type": "tissue plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence).tissues,plasma",
    "expression": "Upregulated",
    "expression_details": "up(reccurence GC grp)",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic ,Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic : AUC=0.79,Prognostic : overall survival rate with high miR-21 expr. Was lower than low expr.(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "high up regulated miR-21 expr. Associated with histological type(p<0.001),T stage(p<0.001),lymph node metastasis(p<.001),pTNM (p<0.05) in univariate amd pTNM(p=.001),lymph node metastasis (p=.001) in multivariate analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue plasma",
    "sample": "73 paired tissues,35 GC & 35 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic & Diagnostic-plasma miR-27a level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic :high miR-21 related with lower OS rate, diagnostic: AUC-0.75,sensitivity-0.70,specificity-0.78",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic :high miR-29 related with higher OS rate, diagnostic: AUC-0.73 ,sensitivity-0.70,specificity-0.68",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "discriminating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "colon cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "biomarkers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "wt-RAS",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "mCRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "biomarkers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "wt-RAS",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "mCRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "",
    "expression_details": "associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "colon cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "combined miR-4299 and miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Signature",
    "expression_details": "Signature",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "combined miR-4299 and miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Signature",
    "expression_details": "Signature",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "colon cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "CCL-244",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "X-ray",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "irradiation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "IR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "vitro",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "vivo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "SW620",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "cell line HT29, SW480, SW620 and LOVO",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR141",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR141",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "curative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR141",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "surgery",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "during",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "found",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "be",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "significantly",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "postoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "lymph",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "node",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "negativity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p< 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "curative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "surgery",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predicting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "during",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "found",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "be",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "significantly",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "postoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "lymph",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "node",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "--",
    "sample": "--",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "negativity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990503"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "curative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "surgery",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "antagonist",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "tumor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "grade",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "(P = 0.013)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "pathological",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "77.6%, Sensitivity, specificity, negative predictive values, and positive predictive value were 86.6, 60, 42.8, and 92%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "(P = 0.013)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "RKO cells",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drug",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "RKO cells",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "RKO cells",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "RKO cells",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "curative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "surgery",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "5-FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "cytotoxicity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "targeting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "enzyme",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "thymidylate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "CT",
    "therapy_details": "synthase",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "antagonist",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "biomarkers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vaccine",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "biomarkers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vaccine",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival (P=0.003, hazard ratio, 3.67)",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR92a-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR92a-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "curative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR92a-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "surgery",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "indicator",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "chemo-response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "5-FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "CT",
    "therapy_details": "therapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "pathological",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "(FFPE) biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC = 0.71, p=0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predicted worse overall survival",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "preoperative",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "biopsies from 147 rectal cancer patients",
    "expression": "--",
    "expression_details": "--",
    "significance": "p < 0.05",
    "detection_method": "microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b correlated with distant-metastasis-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "P=0.002",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "bevacizumab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "causes",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "selective",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "L-OHP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "EMT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "causes",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "selective",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "L-OHP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "EMT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.026",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.026",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.027",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p = 0.027",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "marker",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "complete",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "tumor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "regression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "south America",
    "population": "Brazil",
    "sample_type": "Tissues",
    "sample": "training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "outcome",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CAPEOXBEV",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cohorts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "showed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "significant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "interaction",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "bevacizumab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "effectiveness",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "outcome",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CAPEOXBEV",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cohorts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "showed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "significant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "interaction",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "bevacizumab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "effectiveness",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "miR-345",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "lack",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Danish",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "CT",
    "therapy_details": "irinotecan.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "Response",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "EGFR",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissues",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "",
    "expression_details": "",
    "significance": "For Training set 1: p = 0.01, for training set 2: p = 0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "associated with prognosis",
    "therapy": "CT",
    "therapy_details": "therapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "bevacizumab-induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cardiotoxicity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "bevacizumab-induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "",
    "expression_details": "",
    "significance": "P < 0.0001",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cardiotoxicity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "treated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "fluoropyrimidines and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "levels",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "miR-200a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "longer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "overall",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "survival",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "treated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "fluoropyrimidines and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "levels",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "miR-200a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "longer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "overall",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "CT",
    "therapy_details": "survival",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "treated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "fluoropyrimidines and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "levels",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "miR-149",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "longer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "overall",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissues",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "CT",
    "therapy_details": "survival",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "drug",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "resistance,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "miR-17-5p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "negatively",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "related",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "chemosensitive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "status",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "CRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "Microarray and real time PCR",
    "marker": "Prognostic",
    "marker_details": "in late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "miR-21",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "was",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "associated",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "with",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "poor",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "therapeutic",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0008",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "outcome",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "surgical",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by real time PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "resection",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel of five miRNAs (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Serum",
    "sample": "serum of 253 patients who had chemotherapy treatment",
    "expression": "",
    "expression_details": "",
    "significance": "AUC =  0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "metastatic colorectal",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "cancer patients",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "treated",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "anti-EGFR",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Let-7c miR-99a miR-125b signature",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "CT",
    "therapy_details": "therapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "non-responders",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "non-responders",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "upregulated in non reponders",
    "significance": "p = 0.008",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "non-responders",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "not",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "group",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "were",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "found",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "have",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "favourable",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "miR-296",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "may",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "be",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "one",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "mechanisms",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "primary",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "colorectal",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "chemotherapy,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "Sunitinib",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Progostic",
    "marker_details": "patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "CT",
    "therapy_details": "Capecitabine",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "expressions",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "miR-215",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "could",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "benefit",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "from",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "5-fluorouracil-containing",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictive marker for relapse",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "Recurrence",
    "tumor_size_details": "low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "first-line",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "based",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "metastatic colorectal",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predict",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "complete",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "vs.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "incomplete",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Three miRNA transcript (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "predict",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "good",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "vs.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Two miRNA Transcript (miR-519c-3p and miR-561)",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "FOLFOX",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "advanced colorectal",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity = 66.7%, specificity = 63.9% and AUC = 0.679.",
    "detection_method": "Microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cancercases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "miR-21",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "when",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "combined",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "chemotherapeutics",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "(5-FU,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "L-OHP,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "SN38),",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "contributed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "decrease",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated to shorter overall survival of CRC patients",
    "therapy": "CT",
    "therapy_details": "viability.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in non-responders",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "rectal cancer to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "upregulated in responsers",
    "significance": "p < 0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "whose",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "tumours",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "low",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "miR-150",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "worse",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "miR-10b",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "confers",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "chemoresistance",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "colorectal",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "cancer",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high expression of miR-10b associated with poor prognosis",
    "therapy": "CT",
    "therapy_details": "5-FU",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "reversed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drug",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "first",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "line",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "XELOX",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "upregulated in responders",
    "significance": "p < 0.0001, positive predictive value was 90%, and the negative predictive value was 71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "CT",
    "therapy_details": "mCRC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "miR-17-5p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "showed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "better",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "paraffin-embedded specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "rescue",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "anti-EGFR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "therapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "effects",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "chemotherapy-refractory",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "metastatic",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "CT",
    "therapy_details": "disease",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "stage",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "III",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "IV",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "CRC,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "low",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "miR-148a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "worse",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "therapeutic",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "low",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "intratumoral",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "post-therapeutic",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "miR-145",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "worse",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "therapy",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "compared",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "a",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "high",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "successful",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissues",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan.",
    "sample_type": "Tissues",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor survival",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "80.0% sensitivity and 88.2% specificity for response to therapy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stage and poor cell differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "80.0% sensitivity and 88.2% specificity for response to therapy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapeutic",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stage and poor cell differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "80.0% sensitivity and 88.2% specificity for response to therapy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "correlated with advanced clinical stage and poor cell differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "molecular",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "markers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "molecular",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "markers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "molecular",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "markers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cetuximab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissues",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5-Fluorouracil",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and/or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "oxaliplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "levels",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "miR-137",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "worse",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "6.5 folds (0.0004)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "therapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "levels",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "miR-125b",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "associated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "worse",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissues",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "upregulated (after therapy)",
    "significance": "2.5 folds (p=0.05)",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "therapy.",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "miR-455-3p",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "inhibits",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "chemoresistance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "aggressiveness",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "specimen",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "esophageal",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "via",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "targeting",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "survivin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "down(Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "miR-377",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "was",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "correlated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "poor",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "chemoresponse(5FU",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "cisplatin),",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "high",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "serum",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "level",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "inversely",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "associated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "miR-377",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "was",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "correlated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "poor",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "chemoresponse(5FU",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "and",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "cisplatin),",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "high",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "serum",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "inversely",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "associated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "chemoradiotherapy",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "CRT",
    "therapy_details": "resistance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "mediated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "transcriptional",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "activation",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "miR-205",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "promotes",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "radioresistance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "through",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "up(KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "",
    "therapy_details": "PTEN",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "contributed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "an",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "acquired",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "through",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "PTEN",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "modulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vitro",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "up(5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vivo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "EC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "phenanthroline-dione",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "derivative",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-21",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "is",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "an",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "independent",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "biomarker",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "plasma tissue",
    "sample": "plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-21",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "reduced",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "the",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "sensitivity",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "RT",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-21",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "reduced",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "the",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "sensitivity",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "RT",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-98",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radiosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radiosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "descending",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "order:",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell lines)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "EC9706,KYSE30,KYSE450,TE1,ECA109,KYSE150",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "confers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radiosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "EC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive cell line)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitive),KYSE450,OE19(comparatively",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive cell line)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive cell line)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive cell line)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5FU)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "inhibit",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "cell lines",
    "expression": "Upregulated",
    "expression_details": "up(ESCC cell lines )",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drugs",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "after",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "regulate",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "chemoradiation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "EC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "via",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "PSEN1",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "gene,",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "miR-193a-3p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "radioresistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "chemoresistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "KYSE150,KYSE410",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "tissue",
    "sample": "36 tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "up(after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Upregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "tissue",
    "sample": "36 tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "up(after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "after",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "tissue",
    "sample": "36 tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "up(after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "correlation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "between",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-381",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radioresistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "",
    "expression_details": "radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "capacity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppresses",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "tumor",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "growth",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "chemo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "radio",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "downregulating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "RECK",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "EC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radio",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "downregulating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "RECK",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "EC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "downregulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "predicts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "paclitaxel",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "based",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "downregulation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "predicts",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "paclitaxel",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "based",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "CT",
    "therapy_details": "patients",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "miR-200c",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "associated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "poor",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "response",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "to",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- serum miR-200c level",
    "therapy": "",
    "therapy_details": "chemotherapy(p=0.0211)",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-200c level high in T3-4 tumor compared to T1-2(p=0.0310),high serum level in stageIII/IV than in stage II(p=0.0048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "miR-483",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "&",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "miR-214",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "predict",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "less",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "effect",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "miR-483",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "&",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "miR-214",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "predict",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "less",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "CT",
    "therapy_details": "effect",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "miR-22",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "sensitizes",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "ESCC",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "to",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "irradiation",
    "tumor_size": "TNM",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "had",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "no",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "significance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "poor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "neoadjuvant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "",
    "sample": "",
    "expression": "Downregulated",
    "expression_details": "down(radioresistant cell)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "Surgery",
    "therapy_details": "CRT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "miR-21",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "act",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "as",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "marker",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "serum",
    "expression": "Upregulated",
    "expression_details": "up(in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "lines,order",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "decreasing",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "cell line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "up(cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin:KYSE890>KYSE960>KYSE70>KYSE140>KYSE590>KYSE170>KYSE190>KYSE520>KYSE450",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "correlated",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "chemotherapy(p=0.009",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "clinical",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "&p=0.007",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "pathological",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "CT",
    "therapy_details": "response)",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "decreases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drug",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "tissue",
    "sample": "ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "65.50%",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "is",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radioresiatant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "ESCC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell line",
    "population": "cell line",
    "sample_type": "cell line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "down(in TE-4R cell compared to TE-4)",
    "significance": "",
    "detection_method": "microarray,Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy(cisplatin)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "for",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/5-FU,SGc7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC-7901/5-FU)",
    "significance": "p<0.05",
    "detection_method": "MTT,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "inhibited",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "proliferation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "promoted",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "apoptosis",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-298",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "miR-23b-3p",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "dramatically",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "enhanced",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "SGC7902/VCR",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "cell line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR & chemoresistant gc patients)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "CT",
    "therapy_details": "5-FU,VCR,CDDP",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-223",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "significantly",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "7901/DDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "DDp(cisplatin)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-100",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitizes",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "gc",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-141",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-141",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-143",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/DDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin(DDP)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-103/107",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/ADR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "dexorubicin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-103/107",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/ADR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "dexorubicin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "decrease",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-135a-5p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "inhibited",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "impaired",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "adriamycin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "apoptosis",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "BGC-823",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells(p<0.05),compared",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "group",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "without",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "gene",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 pairs gc & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "intervention",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Gc",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vitro",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "inhibited",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "gastric",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "tumor",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "growth",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "vivo",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "(p<0.05)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-223",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "reduced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivityto",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "trastuzumab",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drug",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "docetaxel",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppressesgc",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "movement",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "via",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulating",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-29c-mediated",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "catenin-δ",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "axis",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "enhances",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy(cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "or",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "25 patients gc & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "doxorubicin)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-141",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "7901/DDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "7901",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "could",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "significantly",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "improve",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "H.pylori infected gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(H.pylori infection downregulate expression)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-106a",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "confers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "DDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "improve",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "against",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "based",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CT",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppressed",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Gc",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "anticancer",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "drug(ADR,CDDP,5-FU)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "promoted",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemoresistance(cisplatin,docetaxel)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "28 gc & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "desensitizes",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "ionizing",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "radiation",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "etoposide",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "confers",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Gc",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulating",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "Cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "up(SGC7901/DDP)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "PTEN",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-34c-5p",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "the",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Paclitaxel",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sample cell line",
    "sample": "paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "down(in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "inhibitors",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "alone",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "or",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "combination",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "Perifosine",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppresses",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "growth",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 gc & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells(AGS,MGC803)",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "was",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "significantly",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "activated",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "by",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "celecoxib",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "53 gc &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early G C vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "reduced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "BCL2",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "protein",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "level",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitized",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "CDDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "apoptosis",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitize",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "apoptosis",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitize",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "VCR",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "induced",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down(SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "apoptosis",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "enhances",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "SGC7901/5FU",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "down( in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "gastric cancre",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue cell line",
    "sample": "plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "line",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "overexpression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "had",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "higher",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "DDP",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "sensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "than",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "up(chemosensitive)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "knockdown",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 drug treated gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 drug treated gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "decreases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "20 drug treated gc tissues",
    "expression": "Downregulated",
    "expression_details": "down(chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "decreases",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistance",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "in",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "resistant",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cells",
    "expression": "Downregulated",
    "expression_details": "down (in cisplatin resistant tissues & cells)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "predictive",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "value",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "of",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-939",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regarding",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "(AUC",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "celll line tissue",
    "sample": "cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "=0.777, P < 0.001)",
    "tumor_size": "",
    "tumor_size_details": "",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "miR-125b",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "level",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "associated",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "with",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "trastuzumab",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "resistance",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "in",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "HER2-positive gastric",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "cancer (P<0.05).",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "sensitizes",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "CDDP",
    "tumor_size": "tumor",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "group",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "were",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "found",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "have",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "a",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "favourable",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "response",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "adjuvant",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "six miRNA panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "to classify patients at high risk of disease progression from those at low risk",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "Recurrence",
    "tumor_size_details": "predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "tumor",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Tissues cell-line",
    "sample": "tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues) and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictor of poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "--",
    "population": "--",
    "sample_type": "Tissues cell-line",
    "sample": "tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues) and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predictor of poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "CRC cell lines and tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "inverse correlation with advanced tumor-node-metastasis (TNM) stage (P < 0.01) and lymph node metastasis (P < 0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26820128"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Serum Tissues",
    "sample": "192 CRC patients,  serum and tumour tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.024",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "predict prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "negative correlated with the tumour size, stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Tissue microarrays containing 56 specimens of normal mucosa, 51 adenoma and 735 colorectal cancer and  5 specimens of normal mucosa, 5 adenoma and 47 colorectal cancer for Real time PCR), CRC cells",
    "expression": "Upregulated",
    "expression_details": "upregulated in stage I and  downregulated from stage II to stage III",
    "significance": "increased gradually from normal mucosa, adenoma to stage I  (P<0.01), and decreased gradually from stage II to stage IIII (P<0.01)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic factor of overall survival (HR=0.550, 95% CI: 0.351-0.863) and disease free survival(HR=0.562, 95% CI: 0.397-0.794)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Overexpression of miR101 corelated with lower incidence of lymph node metastasis, lower metastasis rate, higher differentiation and lower recurrence rate (all P<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940181"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "decreased after surgery. P=0.0004, and P=0.0274, respectively",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-103 was significantly associated with histological differentiation, lymphatic invasion. high expression of miR-720 was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "decreased after surgery. P=0.0004, and P=0.0274, respectively",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-103 was significantly associated with histological differentiation, lymphatic invasion. high expression of miR-720 was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "colorectal cancer samples and non-tumorous adjacent mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0025",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor size, distant metastasis, non-differentiated tumors and vascular invasion.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28345456"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "colorectal cancer samples and non-tumorous adjacent mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.0025",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with tumor size, distant metastasis, non-differentiated tumors and vascular invasion.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28345456"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, CRC patients [male (n = 47), female (n = 21); median age: 57 years; colon cancer (n = 37) and rectal cancer (n = 31)] who underwent surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P = 0.016",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "significantly associated with CRC metastasis, tumor T and N stages, and tumor grade (all P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25987767"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissues",
    "sample": "100 stage II CRC patients, early- and late-stage CRC tumors",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic value of miR-1269a for disease-free survival was significant (p=0.015)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "associated with relapse and metastasis of disease-free patients (logrank p=0.002).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25872451"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues Serum",
    "sample": "111 stage II/III and 139 stage I-III CRC patients, as well as serum samples and matched primary and metastatic liver tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, miRNAseq and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "serum biomarker for recurrence and metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28262692"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissue, 169 pairs of CRC specimens and adjacent noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival (P = 0.006)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "significantly associated with large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "tissue, 169 pairs of CRC specimens and adjacent noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival (P = 0.006)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "significantly associated with large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues of 122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with distant metastasis (DM), lymph node metastasis (LNM), and TNM stage (P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "miR-211 expression level (P = 0.01) was effective on overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "lymphovascular invasion (P = 0.011), perineural invasion (P = 0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26152286"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma samples,  96 blood samples were obtained from patients that underwent tumor resection for CRC, 48 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001, AUC = 0.842, sensitivity = 84.38%; specificity = 77.08%",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "shorter recurrence-free survival time and poorer overall survival rate",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with clinical stage, tumor depth, distant metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "plasma samples,  96 blood samples were obtained from patients that underwent tumor resection for CRC, 48 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001, AUC = 0.842, sensitivity = 84.38%; specificity = 77.08%",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "shorter recurrence-free survival time and poorer overall survival rate",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "associated with clinical stage, tumor depth, distant metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "miR-300",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "colorectal cancer (CRC) tissues compared to adjacent colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with lymphatic metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779716"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "Eighty fresh-frozen tumor tissues samples and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "inversely associated with advanced stage and lymph node metastatic status",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28528497"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissues",
    "sample": "serum and tissues in CRC and colorectal precancerous lesions (CPL) patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05, AUC=0.854, 81.9 % and 73.3 %.",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "worse overall survival period (p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor node metastasis (p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "cell line",
    "population": "cell line",
    "sample_type": "cell-line",
    "sample": "SW480 and SW1116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with tumor size and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26084278"
  },
  {
    "miRNA_name": "miR-4775",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "544 pairs of FFPE normal and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR and in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "high levels predicted poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "high-risk factor for CRC metastasis and recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095858"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "196 CRCs and 14 normal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "overall survival p=0.01",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with tumour depth, venous invasion, lymphatic invasion, lymph node metastasis, and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27919977"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "202 colorectal cancer and adjacent colorectal tissues",
    "expression": "Downregulated",
    "expression_details": "decreased",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27784461"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "246 pairs of samples, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.0001",
    "detection_method": "rea time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival (P < 0.0001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "advanced stage (P < 0.0001), lymph node metastasis (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27592860"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "188 CRC samples, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with advanced clinical stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27248318"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "72 pairs of CRC tumor tissues and their corresponding adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with an advanced clinical tumor-node-metastasis stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27376958"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "202 colorectal cancer tissues and adjacent colorectaltissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27346400"
  },
  {
    "miRNA_name": "miR-199b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "30 pairs of CRC metastatis tissues and primary CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "longer median survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated to late TNM stage and distant metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27145368"
  },
  {
    "miRNA_name": "three miRNA classifier (miR-342-3p, miR-361-3p, and miR-3621)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissues",
    "sample": "20 T1-stage CRC samples, FFPE tissue sections",
    "expression": "",
    "expression_details": "",
    "significance": "AUC=0.947, 4% sensitivity, 85% specificity and 89% accuracy",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "for predicting LNM in T1 stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27096956"
  },
  {
    "miRNA_name": "miR-517a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "90 pairs of CRC and matched adjacent non-tumor tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall and disease-free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high tumor invasion, lymph node metastases, distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073521"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Serum",
    "sample": "CRC serum and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor size, TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues Serum",
    "sample": "CRC serum and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with tumor size, TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "96 CRC tissues, HCT116 and SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poorer five year survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with tumor size, TNM stage, lymphatic metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "96 CRC tissues, HCT116 and SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poorer five year survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "correlated with tumor size, TNM stage, lymphatic metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissues",
    "sample": "Tissues from 126 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 10(-6)",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with regional lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25592646"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma, Tissues, Cell-line",
    "sample": "Plasma from 118 CRC patients and 61 healthy , CRC tissues and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with lymph node metastasis, distant metastasis, higher pTNM stage (III-IV), and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma, Tissues, Cell-line",
    "sample": "Plasma from 118 CRC patients and 61 healthy , CRC tissues and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "associated with lymph node metastasis, distant metastasis, higher pTNM stage (III-IV), and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "78 cases of CRC tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Diagnostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with lymph node or distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25613903"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "5 CRC patients who underwent radical resection, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicators for overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with  local invasion, lymph node metastasis and clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25502080"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 62 patients undergoing radical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "corelated with poorer overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with TNM stage and lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270282"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with larger tumor size, higher incidence of lymph node metastasis, and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "correlated with larger tumor size, higher incidence of lymph node metastasis, and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "206 patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with poor overall surviva",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor invasion, lymph node metastasis, distant metastasis, and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24981248"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "20 normal colorectal mucosa cases, 40 colorectal adenomas cases and 40 CRC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated with shorter survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with large tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25285168"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor samples and adjacent non-cancerous tissues from 169 patients undergoing radical resection for CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poorer overall survival (OS)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with the depth of the local invasion, poor differentiation, lymph node metastasis and advanced disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25170220"
  },
  {
    "miRNA_name": "miR-200C",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tumor and peritumoral tissues of 101 colon cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "significantly correlated with the TNM stage, lymph node metastasis, and invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24682933"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Eighty-four pairs of colon cancer specimens and their corresponding non-tumor adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "upregulated in the recurrence and metastasis groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24888652"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < 0.001",
    "detection_method": "in-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with T-stage, lymph node metastasis, distant metastasis, and Dukes' stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25031782"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Tissues Serum",
    "sample": "3-phase study using FFPE tissue and serum from 446 colorectal specimens,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic marker for CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "higher in stage IV than in stage I-III CRCs: Predictor for lymph node metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japanese",
    "sample_type": "Tissues Serum",
    "sample": "3-phase study using FFPE tissue and serum from 446 colorectal specimens,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic marker for CRC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "higher in stage IV than in stage I-III CRCs: Predictor for lymph node metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "MiR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "92 pairs of CRC and adjacent nontumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facto for overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with distant metastasis, clinical TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24532280"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with large tumor size, lymph node metastasis, advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "correlated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Correlated with large tumor size, lymph node metastasis, advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "43 colonic cancer tissues",
    "expression": "Downregulated",
    "expression_details": "downregulated in non relapsed",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low expression of miR-146a was associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with poor tumor differentiation, tumor size and clinical stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670457"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "Surgical tissues from 94 patients with CRC.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with advanced clinical stag, lymph node metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24150523"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR155",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR29a",
    "cancer": "Rectal cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "Taqman miRNA assay",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Chinese",
    "sample_type": "Tissues",
    "sample": "40 CRC, adjacent nontumorous tissues and 2 human CRC-derived cell lines (SW-480 and SW-620)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "real time PCR and Northern blotting",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-338-3p was associated with unfavorable outcome in disease free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "negatively related to advanced TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24824250"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissues",
    "sample": "125 resected CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P < 0.0001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-133a had a significantly lower overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Advanced TNM and Dukes staging was associated with higher miR-133a expression even though its expression was mostly lower in tumor tissues. higher expression of miR-133a was associated with the development of distant metastases.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25104873"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "and",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "and",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "and",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Re-elevated",
    "expression_details": "Re-elevated or high",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "re-elevation associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "186 patients who underwent surgery matched adjacent normal tissues and 18 normal tissues from normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor invasion, lymph node metastasis, distant metastasis and the TNM stage of colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24293092"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues from 189 cases and 30 healthy subjects and sera from 30 CRC patients and 30 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "fold-change = 0.27, P < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis - significant association between low miR-218 expression and worse survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with TNM stage, lymph node metastasis (LNM) and differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24294377"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor differentiation, lymph node metastasis, L category, V category, TNM stage, and tumor recurrence of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Recurrence",
    "tumor_size_details": "associated with tumor differentiation, lymph node metastasis, L category, V category, TNM stage, and tumor recurrence of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "serum samples from 186 CRC patients, 60 postoperative patients, 43 advanced adenoma patients, and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < .001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-21 expression significantly associated with tumor size, distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "serum samples from 186 CRC patients, 60 postoperative patients, 43 advanced adenoma patients, and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P < .001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "High miR-21 expression significantly associated with tumor size, distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "76 patients who underwent colorectal cancer resection without pre-operative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.01",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high expression of miR-155 significantly correlated with an advanced TNM stage, lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23588589"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-182 expression predicted poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "significantly correlated with large tumor size, positive regional lymph node metastasis, and advanced tumor-node-metastasis stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-182 expression predicted poor survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "significantly correlated with large tumor size, positive regional lymph node metastasis, and advanced tumor-node-metastasis stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "138 paired samples of tumoral and nontumoral colon tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "associated closely with poor overall survival in patients with colon cancer",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low miR-93 expression was significantly correlated with advanced tumor stage, positive nodal metastasis, and positive distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23354160"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 92 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facctor for survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "contributed to more advanced lymphatic invasion, lymph node metastasis, liver metastases and late TNM stage in colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292866"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "82 patients with colorectal carcinomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-92a expression had a poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with advanced clinical stage, lymph node metastases, and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22772712"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 110 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "Tissues, 110 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "associated with poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "associated with tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "positively correlated with the clinical stage, correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.05",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "Microarray and real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "correlated with clinical stage, lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "92 cases of colon carcinomas were collected with both the tumor and paired normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "in 87.0% (80/92)",
    "detection_method": "In-situ hybridization",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "upregulatedregulation of miR-23a was associated with an advanced clinical stage and depth of invasion,  higher in the tumors with lymph node metastasis than those without",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22455847"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p < 0.001",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.004",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with mucinous tumors and progressively increased from stage I to IV disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissues",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p = 0.016",
    "detection_method": "miRNA profiling followed by real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "high miR-125b expression groupregulated showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "P<0.05",
    "detection_method": "real time PCR",
    "marker": "Prognostic",
    "marker_details": "high miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "high miR-125b expression groupregulated showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues of 212 patients with gastric or colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "low expression of miR-203 was correlated with tumor size (p = 0.015) and pT stage (p = 0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21063914"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p < 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "low expression correlated with increased tumor size and advanced pT stage.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissues",
    "sample": "156 CRC patients, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "real time PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-21 expression were significantly worse than those of patients with low miR-21 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "significantly associated with venous invasion, liver metastasis and tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "100 primary CRC specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change = 2.3, P =0.025",
    "detection_method": "real time PCR PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "related to TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissues",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p = 0.001",
    "detection_method": "real time PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "Metastasis",
    "tumor_size_details": "positively related to advanced TNM stage (p = 0.026) and deeper invasion of tumors (p = 0.024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-1469",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "129 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-1469 expression had significant poorer disease free survival(p=0.004) and OS(p=0.029)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "stage",
    "tumor_size_details": "low miR-1469 expression was significantly associated with tumor invasion depth(p=0.026),lymph node metastasis(p<0.001),pathological tumor stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588716"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "high plasma miR-9 level were significantly associated with poor tumor differentiation(p=0.022),large tumor size(p=0.007),deep local invasion(p=0.003),lymph node metastasis(p=0.005),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high plasma miR-9 level were significantly associated with poor tumor differentiation(p=0.022),large tumor size(p=0.007),deep local invasion(p=0.003),lymph node metastasis(p=0.005),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high plasma miR-9 level were significantly associated with poor tumor differentiation(p=0.022),large tumor size(p=0.007),deep local invasion(p=0.003),lymph node metastasis(p=0.005),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-483-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "80 pairs of ESCC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : upregulated miR-483-5p expression was significantly associated with poor survival of ESCC patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-483-5p was positively correlated with TNM stage,lymph node metastasis,T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28211800"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "tissues,serum,Kyse170,Eca109",
    "expression": "Downregulated",
    "expression_details": "down(miR-21 in kyse170,Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15,95%CI 1.16-3.97)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was associated with pathogenic sites (P = 0.037): high levels of miR-21 were correlated with upper sites but not with gender (P = 0.229), age (P = 0.722), pathological type (P = 0.191), TNM stage (P = 0.618) and Postoperative metastasis (P = 0.349)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum cell line",
    "sample": "tissues,serum,Kyse170,Eca109",
    "expression": "Upregulated",
    "expression_details": "up(miR-375 in Kyse170,Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47,95%CI 0.26-0.87)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlations between miR-375 levels and gender (P = 0.506), age (P = 0.704), pathological type (P = 0.708), TNM stage (P = 0.845), Postoperative metastasis (P = 0.190), none of which were correlated with miR-375 expression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-214  positively correlated with poor tumor differentiation (p=0.004),tumor invasion(p=0.013) and lymph node metastasis(p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619677"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "44 ESCC & adjacent normal tissues,HEEc,ECA109,TE1,EC9706,KYSE70,KYSE3o",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-630 expression was found to be correlated with tumor range,lymphatic metastasis,pathological stge( all p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "elevated",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "elevated",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 pairs of primary ESCC 7 adjacent normal tissues,HEEC,KYSE30,KYSE70,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,KYSE-30,KYSE-70,ECA109)",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-143-3p correlated with advanced clinical stage(p=0.026),lymph node metastasis(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "63 ESCC & adjacent non tumor tissues,63 ESCC & 39 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,plasma)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-373 expr. Level in tumor tissues closely associated with differentiation,tumor status and lymph node metastasis(all p<0.05),miR-373 expression in plasma correlated with tumor status and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073718"
  },
  {
    "miRNA_name": "miR-181c-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of miR-181c-3p  associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "/stage",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "TNM/stsge",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-718",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "120 ESCC & 51 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC plasma, up expression in postoperative plasma than in preoperative)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : -plasma miR-718 AUC of 0.715,0.689 and 0.620 for detection of ESCC patients ,early patients with Tis-T1 or early patient with TNM 0-1 respectively",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "plasma miR-718 expression level was inversely correlated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26756617"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203a or hypermethylation of the miRNA\nshowed significantly poorer 5-year survival rates",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-203a  associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-203b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203b showed significantly poorer 5-year survival rates",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-203b associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 tissues,EC109,TE8,TE2,HEEC",
    "expression": "Downregulated",
    "expression_details": "down(ESCC and EC cell line)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression was associated with metastatic property and stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26508028"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "55 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with lymph node(p=0.002),histological classification(p=0.000),vessel invasion(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26414725"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "chinese",
    "sample_type": "tissue cell line",
    "sample": "76 tissues,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "T3/T4 patient had higher exoression than T1/T2(p=0.000),lymph node metastasis had higher expression than without(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26345812"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "chinese",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,SHEE,Kyse150,KYSE510,EC9706,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correalated with pathological stage and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26339371"
  },
  {
    "miRNA_name": "miR-1291",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "54 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with lymph node metastasis and TNM stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324125"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-HR=3.72,95% CI:1.36-8.78,p=0.005",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression correlated with lymph node metastasis(p=0.01),distant metastasis(p=0.007),tumor differentiation(p=0.04),advanced TNM(p=0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309624"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "fresh ESCC & FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis),low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression  had negative correlation with T stage(p=0.022),tumor length(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "fresh ESCC & FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis),low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression  had negative correlation with T stage(p=0.022),tumor length(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "79 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had poorer prognosis(p=0.040)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low expression correlated with tumor size(p=0.018),nos. of lymphatic invasion(p=0.0448),venous invasion(p=0.0211)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "79 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had poorer prognosis(p=0.040)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlated with tumor size(p=0.018),nos. of lymphatic invasion(p=0.0448),venous invasion(p=0.0211)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "serum(106 EC &60 healthy)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC:0.833",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "lower expression in lymph node metastasis,poorer differentiation and later stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25812647"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "49 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with lymph node metastasis and poor tumor differentiation(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25695396"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "64 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with tumor  invasion(p=0.22) & advanced clinical stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25672418"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "increases",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "98 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "negatively correlated with TNM(p=0.008),lymphatic metastasis(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400770"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "cell line",
    "population": "cell lines",
    "sample_type": "cell line",
    "sample": "EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510,KYSE410,KYSE520",
    "expression": "Upregulated",
    "expression_details": "up( except in EC109)",
    "significance": "p=0.0016(tissues),p<0.001(EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510),p<0.05(kyse410,KYSE520)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "upregulation associated  clinical progression(p=0.022),lymph node metastasis(p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25375090"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "67 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with higher histological grade(p=0.003),lymph node metastasis(p=0.002),tumor stage(p=0.005),clinical stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25337272"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "89 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with tumor stage(p=0.007),metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25322669"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "105 tissues,HEEc,KYSe150,KYSE410,OE19,ECA109,EC9706",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "upregualation correlated with lymph node metastasis,advanced tNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "120 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic  for LPFs,DPFS &OS(multivariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlated with great depth of invasion(p=0.02),advanced clinical stage & distant metastasis( both p=0.008)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25218280"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with tumor differentiation(p=0.017),lymph node metastasis(p=0.019),tumor depth(p=0.009),TNM stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25017784"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "158 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with tumor depth(p=0.002),tunor stage(p=0.003),metastasis(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24508466"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with tumor differentiation(p=0.010),lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24438167"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "positive correlation of miR-17a with lymph node metastasis(p=0,035),clinical stage(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "positive correlation of miR-19b with tumor size(p=0.005),lymph node metastasis(p=0.040),clinical stage(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positive correlation of miR-19b with tumor size(p=0.005),lymph node metastasis(p=0.040),clinical stage(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "positive correlation of miR-19b with tumor size(p=0.005),lymph node metastasis(p=0.040),clinical stage(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "81 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis,nerve invasio & pathological stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314216"
  },
  {
    "miRNA_name": "miR-655",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with lymph node metastasis, tumor diffrentiation,TNM stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314023"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "76 invasive ESCC tissues,30 normal biopsy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "stem loop RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expressiond  significantly associated with tumor status,lymph node metastasis & clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24221338"
  },
  {
    "miRNA_name": "Cluster(miR-200b,miR-200a,miR-429)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(miR-200b),p=0.001(miR-200a),p=0.037(miR-429)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with lymph node metastasis(p=0.002),advanced clinical stage(p=0.020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "88 tissues,7 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-200b correlated with lymph node metastasis and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-429 significantly correlated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "32 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis(p=0.015),differentiation(p=0.003),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23999873"
  },
  {
    "miRNA_name": "miR-129-2",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "42 pared surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with advanced clinical TNM stage(p<0.001),distal metastasis(p<0.001),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23677061"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum cell line exosome",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "expression": "Upregulated",
    "expression_details": "up(ESCC serum, exosomes)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum low expression in T1/T2 than T3/T4(p=0.0024),low in without lymph node metastasis than with metastasis(p=0.0002),without distant metastasis than with metastasis(p=0.0020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues,archived sample",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "MISH,qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had poore oS(p=0.040)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression correlatedwithlymph node metastasis(p=0.04),TNM stage(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23301089"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "exosome serum",
    "sample": "exosomes of ESCC & benign disease serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with advanced tumor stage classification,positive lymph node status,metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23224754"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "high",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "108 paired curative surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRt-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-poor prognosis for low expression(univariate analysis)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with tumor invasion depth(p=0.039),lymph node metastasis(p=0.035),lymphatic invasion(p=0.005),venous invasion(p=0.006),clinical stage(p=0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013135"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-98 was significantly correlated with pathological grade, tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression  significantly correlated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-214 expression significantly correlated with pathological grade,tumpr stage,lymph node metastasis and miR-101 expression associated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with lymph node metastasis status & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450326"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "saliva plasma",
    "sample": "32 EC and 16 healthy saliva supernatant",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "diagnostic- miR-21 saliva supernatant level: AUC-0.762,sensitivity-84.4%,specificity-62.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "no significant correlation with cancer stage,differentiation & nodal metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23464420"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "109 resected  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-high expression poorer prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression level associated with gender(p=0.008),tumor size(p=0.042),depth of tumor invasion(p=0.030)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "109 resected  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-high expression poorer prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression level associated with gender(p=0.008),tumor size(p=0.042),depth of tumor invasion(p=0.030)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-142-3p)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-31 & miR-142-3p expression correlated to histological differentiation(p<0.05),good prognostic group comprised of ESCC patients with small tumor,negative lymph node metastasis or early stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-142-3p)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-31 & miR-142-3p expression correlated to histological differentiation(p<0.05),good prognostic group comprised of ESCC patients with small tumor,negative lymph node metastasis or early stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "up(miR-142-3p)",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-31 & miR-142-3p expression correlated to histological differentiation(p<0.05),good prognostic group comprised of ESCC patients with small tumor,negative lymph node metastasis or early stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "prognostic- expression correlated with poor OS(p=0.048),DFS(p=0.0006)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with advanced stage(p=0.003),distant metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21813472"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(mature miR-21 & miR-145)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "reccurence",
    "tumor_size_details": "high mature miR-143 associated with  recurrence of metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "reccurence",
    "tumor_size_details": "miR-145 associated with recurrence of metasatsis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "upregulation correlated with lymph node metastasis((p=0.001),TNm(p=0.049)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21148309"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "--",
    "population": "--",
    "sample_type": "serum",
    "sample": "168 serum,128 ESCC and corresponding normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-serum/ tissue low level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduced serum/tissue correlated with T stage,lymph node metastasis,TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759955"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired gc & adjacent non tumor tissues,BGC-823,MKN-28,MKN-45,AGS,MGC-803,SGC-7901,NGEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "miRNA microarray,q-PCR",
    "marker": "Prognostic",
    "marker_details": "poorer overall survival(p=0.003)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with more aggressive tumor phenotypes including local invasion, lymph node metastasis, advanced clinical stage and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "could discriminate non-LNM from LNM with 80.0% sensitivity and 80.0% specificity and discriminate tumor Ι-II stages from tumor III-IV stages with 71.9% sensitivity and 75.0% specificity at the best cut-off value of 0.0125",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "could discriminate non-LNM from LNM with 50.0% sensitivity and 100.0% specificity at the best cut-off value of 0.0901 and discriminate tumor Ι-II stages from tumor III-IV stages with 37.5% sensitivity and 100.0% specificity at the best cut-off value of 0.1122",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "FISH,qRT-PCR,western blot",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with clinical stages, depth of invasion and lymph node metastasis.",
    "reference": ""
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). Association between presence of metastasis and lower expression of MIR17HG.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). Association between presence of metastasis and lower expression of MIR17HG.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-17-92",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). Association between presence of metastasis and lower expression of MIR17HG.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 paired gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-198 level was associated with tumor size (p = 0.009), tumor depth (p = 0.005), lymph node metastasis (p = 0.03), and clinical stage (p = 0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 paired gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-198 level was associated with tumor size (p = 0.009), tumor depth (p = 0.005), lymph node metastasis (p = 0.03), and clinical stage (p = 0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "106 paired gc & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-198 level was associated with tumor size (p = 0.009), tumor depth (p = 0.005), lymph node metastasis (p = 0.03), and clinical stage (p = 0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "38 Hp +ve gc & 27 Hp -ve gc tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "up( H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "high expression of miR-223 associated  with large tumor size (p = 0.006), high metastasis (p = 0.002), and poor TNM staging (p = 0.03)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "38 Hp +ve gc & 27 Hp -ve gc tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "up( H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression of miR-223 associated  with large tumor size (p = 0.006), high metastasis (p = 0.002), and poor TNM staging (p = 0.03)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue cell line",
    "sample": "38 Hp +ve gc & 27 Hp -ve gc tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "up( H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression of miR-223 associated  with large tumor size (p = 0.006), high metastasis (p = 0.002), and poor TNM staging (p = 0.03)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "138 gc & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :AUC-0.80, Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with T stage, distant metastasis, and differentiation",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "plasma tissues",
    "sample": "plasma & primary gc tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high plasma and primary tissues expression in TNM ( stage III or IV) & lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "150 pairs of gc and adjacent matched normal tissues,MGC-803,HGC-27,SGC-7901,MKN-45",
    "expression": "Downregulated",
    "expression_details": "down-regulation (Hypermethylation)",
    "significance": "p<0.05",
    "detection_method": "q-PCR,MSP,q-MSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low level associated with pM stage (p = 0.038, metastasis vs non metastasis) and pTNM stage (p = 0.006, stage I vs IV; p = 0.002, stage II vs IV; p = 0.038, stage III vs IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26729612"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 pairs of gc & adjacent normal gastric tissues,SGC7901,BGC823,AGS,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues),p<0.05(cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression in tissues with poorly and moderately differentiated type, lymph node metastasis N1-N3 and stage III-IV.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26745603"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time -PCR",
    "marker": "Prognostic",
    "marker_details": "poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-326 is associated to clinical stage ,tumor depth,lymph node metastasis and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "gc tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "poor overall survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "expression": "Upregulated",
    "expression_details": "up(in gc tissues & plasma,up due to promoter hypomethylation)& down(in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "q-PCR,MSP",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-106a expression was closely related to the degree of lymphatic metastasis and TNM staging of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "102 pairs of tumor & normal gastric tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metstasis",
    "tumor_size_details": "higher expression correlated with distant metastasis (P=0.034), TNM stage (P=0.030) and early recurrence (P=0.044)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "102 pairs of tumor & normal gastric tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "higher expression correlated with distant metastasis (P=0.034), TNM stage (P=0.030) and early recurrence (P=0.044)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "220 self pair of gc & adjacent non-cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "P<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Independent Prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression is significantly associated with great depth of invasion,positive lymph node and distant metastasis and advanced TNM stage of human GC(all p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25960238"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 gc & adjacent normal tissues,SGC7901,NUGC-3,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "relative more expression in patients with lymph node metastasis or with stage I/II disease than in patients without lymph node metastasis or stage III disease",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25914465"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "83 gc & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression associated with large tumor size(p=0.004),poor differentiation(p=0.008),distant metastasis(p=0.027) and advanced TNM stage(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "83 gc & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with large tumor size(p=0.004),poor differentiation(p=0.008),distant metastasis(p=0.027) and advanced TNM stage(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "83 gc & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with large tumor size(p=0.004),poor differentiation(p=0.008),distant metastasis(p=0.027) and advanced TNM stage(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "105 gc & adjacent non tumor  tissues,SGC7901,BGc823,MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with degree of differentiation (p=0.01),local invasion(p=0.001),TNM stage(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25780292"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "160 pair of gc tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "co-expression of both miRNAs in gc tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "160 pair of gc tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "co-expression of both miRNAs in gc tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sera",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "down (order of decreasing level of miR-17 in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.879 with 80.6% sensitivity and 87.5% specificity for discriminating GC patients from controls , AUC of 0.717 with 90.6% sensitivity and 57.5% specificity for discriminating GC patients from BGD patients and  AUC of 0.725 with 62.9% sensitivity and 81.2% specificity for discriminating BGD patients from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-17  was  associated with patients age(p<0.05) but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "sera",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "down (order of decreasing level of miR-106b in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.856 with 75.0% sensitivity and 92.5% specificity for discriminating GC patients from controls, AUC of 0.700 with 87.2% sensitivity and 45.0% specificity for discriminating GC from BGD patients and  AUC of 0.739 with 75.0% sensitivity and 68.7% specificity for discriminating BGD patients from controls",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-106b  was associated with patients age(p<0.05)  but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "81 tumor  & adjacent non-tumor tissues,SGC7901,MKN45,MKN28,BGC823,MGC803,Ges-1",
    "expression": "Downregulated",
    "expression_details": "down(promoter methylation)",
    "significance": "",
    "detection_method": "qRT-PCR,MSP,BSP",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-335 methylation level was significantly associated with lymph node and peritoneal metastasis ,poor pT stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25520857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "decitabine",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "decitabine",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "37 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-367was significantly correlated with differentiation level,TNM stage and metastasis of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25489984"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "52 gc & matched non-tumor  tissues,GES-1,MKN-45,BGC-823,MKN-28,AGS,SGC-7901,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-199a-3p high expression group had inclination towards TNM stage(P=0.037),invasion depth(P=0.08)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25448600"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "100 pairs of gc & adjacent non-neoplastic tissues,GES1,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "Real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-133b in GC was associated with venous invasion(p<0.05),more aggressive tumor phenotype(p<0.05,stage I/II vs stage III/IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25433493"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "downregulation of miR-194 is significantly associated with tumor size,location invasion and TNM",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "downregulation of miR-194 is significantly associated with tumor size,location invasion and TNM",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-194 is significantly associated with tumor size,location invasion and TNM",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 pairs of gc & matched adjacent non neoplastic tissues,SGC7901,NUGC-3 ,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "relative expression of miR-19a increased in patients with lymph node metastasis or with stage I and II were higher than patients without lymph node metastasis or stage III(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25400827"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "48 pairs of gc & matched ANTTs  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high fold change of down regulated miR-193b had significant shorter survival time compared to low fold change of down regulated miR-193b",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "down expression of miR-193b was significantly correlated with  Lauren type,differentiation ,UICC,stage,invasion and metastasis of GC(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 patients tissues,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": ".",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression in cancer tissues of patients with lymph node metastasis, vascular invasion and TNM stage III(-IIII( was down-regulated more obviously(P<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25341915"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "52 pairs of paraffin embedded gc & adjacent  normal tissues,MGC-803,SGC-7901,BGC823,MKN45,MKN28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "levels of miR-183 expression were associated with lymph node metastasis and pathological TNM stage (P=0.005 and P=0.007, respectively).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "89 gc & 41 normal stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "ISH (TMA)",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-22 levels were inversely correlated with the tumor stage (P=0.03) and lymph node metastasis (P=0.001).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25323629"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "65 gc & matched adjacent normal tissues,GES-1,MGC-803,MKN28,SGC7901,AGS,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc cell lines),p<0.001(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-183 expression levels were significantly associated with increased tumor type(P=0.003),presence of distant metastasis(P=0.018) and increased tumor-node-metastasis stage(P=0.019)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-160b  25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue",
    "sample": "40 operative & 20 preoperative plasma,40 gc & adjecent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression of miR-160b 25 cluster in gc tissues  & plasma  correlated with tumor size,borrmann type,TNM stage(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-160b  25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma tissue",
    "sample": "40 operative & 20 preoperative plasma,40 gc & adjecent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression of miR-160b 25 cluster in gc tissues  & plasma  correlated with tumor size,borrmann type,TNM stage(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-645",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 pair of AGEJ & t gastric cardiac non cancer tissues,SGC7901,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(AGEJ tissues),SGC7901,BGC823(p<0.001)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "tumor size greater than or equal to 5cm group had significant increased miR-645 expression as compared to tumor size less than 5cm group(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25174799"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity,Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high level was significantly correlated with clinical stage (p<0.001),lymph node metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 pairs of primary gc & corresponding adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "real time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-126 significantly associated with lymph node metastasis(p<0.001),poor histological grade(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25027343"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "serum",
    "sample": "68 gc & 56 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: decreased miR-218 expression was independent prognostic marker for overall survival /(p=0.035)in addition to presence of tumor metastasis (p=0.005) and high tumor grade(p=0.000)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum miR-218 significantly associated with GC metastasis(P=0.003),tumor stage(P=0.018),tumor grade(P=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944481"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<=0.01",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: independent prognostic factor associated with OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expr. Of miR-19a remote metastasis(p<0.001) ,  TNM stage(p<0.001),lymph node metastasis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-199a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "34 matched gc & adjacent normal tissues,MKN45,MKN28,SGC7901,BGC823,HGc27,AGS,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "q-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "higher miR-199a-5p expression level was associated with increased likelihood of lymph node metastasis and later TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24655788"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "overexpr. Of miR-1303 and downregulation of clauding was significantly associated with tumor size,location invasion,histologic type and lymph node metastasis stage in GC tissues",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "overexpr. Of miR-1303 and downregulation of clauding was significantly associated with tumor size,location invasion,histologic type and lymph node metastasis stage in GC tissues",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "overexpr. Of miR-1303 and downregulation of clauding was significantly associated with tumor size,location invasion,histologic type and lymph node metastasis stage in GC tissues",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "236 gc, matched adjacent normal & 18 cases normal control tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : independent prognostic factor for overall survival(log rank test,p<0.001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "elevated miR-630 expr.  associated with T3 and T4 stage(p=0.007),positive lymph node(p<0.001),distant metastasis(p=0.002),advanced TNM(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24621930"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 gastric carcinoma tissues, 18 nontumourous gastric tissues ,MKN28,BGC823,MKN45,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-124 exp. was inversely correlated with tumor size(t-test: p=0.0265 and spearmans:p=0.0083) and lymph node metastasis(t-test:p=0.0164)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 gastric carcinoma tissues, 18 nontumourous gastric tissues ,MKN28,BGC823,MKN45,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-124 exp. was inversely correlated with tumor size(t-test: p=0.0265 and spearmans:p=0.0083) and lymph node metastasis(t-test:p=0.0164)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum cell line",
    "sample": "75 gc & adjacent normal tissues,57 gc & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-191 level correlates with tumor size(p<0.01 ,stage IV vs stage II and p<0.05 stage IV vs stageIII) also miR-425 correlates with tumor(p<0.01 stage IV vs II),miR-191 level metastasis-nonmetastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum cell line",
    "sample": "75 gc & adjacent normal tissues,57 gc & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-191 level correlates with tumor size(p<0.01 ,stage IV vs stage II and p<0.05 stage IV vs stageIII) also miR-425 correlates with tumor(p<0.01 stage IV vs II),miR-191 level metastasis-nonmetastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum cell line",
    "sample": "75 gc & adjacent normal tissues,57 gc & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-191 level correlates with tumor size(p<0.01 ,stage IV vs stage II and p<0.05 stage IV vs stageIII) also miR-425 correlates with tumor(p<0.01 stage IV vs II),miR-191 level metastasis-nonmetastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "tissue cell line",
    "sample": "59 patients GC & adjacent normal  tissues,AGS,YCC2,MKN28,KATO III,SNU 1,SNU5,SNU16,SNU216,SNU601,SNU638,SNU668,SNU719,HFE145",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.009(more down in IB than IA patient,p<0.002(more down in LN+ve than LN-ve",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low exp. miR-135a have advanced TNM(p=0.045) and higher rate of LN metastasis(p=0.014)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24465504"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "pre-operative and post-operative paired plasmas from 42 patients with primary GCs",
    "expression": "Downregulated",
    "expression_details": "down(post operative plasma of GC)",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "plasma miR-21 exp was highly associated with differentiation degree and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460332"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "65 paired gc & adjacent normal non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-107 exp. Was associated significantly with tumor size (p=0.0032) and differentiation (p=0.028))",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24374340"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "65 paired gc & adjacent normal non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNm/satge",
    "tumor_size_details": "miR-107 exp. Was associated significantly with tumor size (p=0.0032) and differentiation (p=0.028))",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24374340"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hiroshima(Japan)",
    "sample_type": "tissue cell line",
    "sample": "20 gc & 5 non neoplastic tissues & 61 pair  tissues,MKN1,HCS-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test,p<0.0001)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-148a significantly correlated with advanced clinical stage,lymph node metastasis and poor clinical outcome",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "115 pairs of gc & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-29c in GC was significantly associated with a more extensive venous invasion ( P = 0.05) and a more aggressive tumor phenotype ( P < 0.05, stage I/II versus III/IV)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-200b level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "downregulation of miR-200c level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "86 pairs of gc & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(epigenetic modification)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower miR-433 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "86 pairs of gc & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "down(epigenetic modification)",
    "significance": "p<0.05  (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower miR-127 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 gc & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower mIR-148a was associated with lymph node metastasis,N stage and blood vessel invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23873106"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "120 gc & adjacent non tumorous tissues,GEs1,BGc823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,BGC823),p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-214 expre is significantly associated with invasion(p=0.01),metastasis(p=0.05),TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc & matched non tumor tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "overexpr. Is associated with tumor size,invasion depth,lymph node metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc & matched non tumor tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "overexpr. Is associated with tumor size,invasion depth,lymph node metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 pairs of gc & matched non tumor tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "overexpr. Is associated with tumor size,invasion depth,lymph node metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "98 pairs of gc & adjacent norma mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: shorter overall survival(p=0.03)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-22 expr. Had grater extent of lymph node metastasis(p=0.02),distant metastasis(p=0.01),worse stage(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23786758"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "98 gc  & adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "shorter overall survival(p=0.02)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-206 expr. Had greater extent of lymph node metastasis(p=0.01),venous invasion(p=0.008),hematogenous recurrence(p=0.01),worse stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "98 gc  & adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "shorter overall survival(p=0.02)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "low miR-206 expr. Had greater extent of lymph node metastasis(p=0.01),venous invasion(p=0.008),hematogenous recurrence(p=0.01),worse stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "86 cases for gc & adjacent non neoplatic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "Real time qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-9 exp. Was significantly lower in GC with deeper invasion(p<0.001),lymph node metastasis(p<0.001),distant metastasis(p=0.022),advanced TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23383271"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "56 gastric tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "reverse transcriptase-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : in stage I,II,III 5 year survival rate with high miR-10b exp. Was significantly lower than with low miR-10b exp.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-10b high expr. Correlates with size of tumor,Lauren clasiification,depth of invasion,lymph node and distant metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23351547"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "66  pairs of gc & corresponding non tumor tissues,GES1,BGC823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-135b was related with Lauren classification,tumor differentiation ,invasion,pTNM(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23328512"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "44 gc & matched adjacent tissues,GES1,MKN45,GC9811,AGS,SGC7901,MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "decreased miR-149 exp. Correlates with lymph node metastasis(p=0.046),TNM stage(p=0.0011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23144691"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Fuzhou,China",
    "sample_type": "tissue",
    "sample": "stage II tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : shorter survival in low expression grp(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression was  associated with histological differentiation(p<0.05),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22851079"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.79,Prognostic : overall survival rate with high miR-21 expr. Was lower than low expr.(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high up regulated miR-21 expr. Associated with histological type(p<0.001),T stage(p<0.001),lymph node metastasis(p<.001),pTNM (p<0.05) in univariate amd pTNM(p=.001),lymph node metastasis (p=.001) in multivariate analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "Panel( miR-107, miR-21, miR-196a,\nmiR-26b, miR-9, miR-142-3p, miR-30b, miR-150, miR-191 and miR-17 )",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo,Japan",
    "sample_type": "tissue",
    "sample": "161 gc & adjacent normal tissues(for miR-107 real time pcr) and 5 pairs of gc & adjacent normal for panels of miRNA expression study",
    "expression": "Upregulated",
    "expression_details": "up( all upregulated but miR-107 had highest upregulation)",
    "significance": "p<0.001",
    "detection_method": "Real time PCR based miRNA array,Real timT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic -for miR-107worse survical rates with OS(P=0.002) and DFS(P=0.017)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-107 showed significant association with depth of tumor invasion,lymph node metastasis and stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22407237"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 gc & adjacent normal tissues,MGC803,MKN-28,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qReal Time-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "higher miR-196a expression was associated with tumor size,a higher clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 gc & adjacent normal tissues,MGC803,MKN-28,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qReal Time-pCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "higher miR-196a expression was associated with tumor size,a higher clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Saitama,Japan",
    "sample_type": "tissue",
    "sample": "70 paired gc & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low miR-125a-3p expression  associated with tumor size(p=0.0002),tumor invasion(p=0.0149),lymph node metastasis(p=0.018),liver metastasis(p=0.016),peritoneal dissemination(p=0.03),advanced clinical stage(p=0.0037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Saitama,Japan",
    "sample_type": "tissue",
    "sample": "70 paired gc & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-125a-3p expression  associated with tumor size(p=0.0002),tumor invasion(p=0.0149),lymph node metastasis(p=0.018),liver metastasis(p=0.016),peritoneal dissemination(p=0.03),advanced clinical stage(p=0.0037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Saitama,Japan",
    "sample_type": "tissue",
    "sample": "70 paired gc & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-125a-3p expression  associated with tumor size(p=0.0002),tumor invasion(p=0.0149),lymph node metastasis(p=0.018),liver metastasis(p=0.016),peritoneal dissemination(p=0.03),advanced clinical stage(p=0.0037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "22 gc & matched normal gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "Real time RT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-223 upregulation correlated with lymph node metastasis(p=0.086),metastasis (p=0.002),advanced pathological stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22270966"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "30 patients(gc & adjacent normal tissues),GES-1,CRL-5971, CRL-5974, BGC-823,AGS,SGC7901,MKN45,HTB-103,MKN28,CRL",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-21 expression was associated with degree of differentiation of tumor tissues(p=0.004),local invasion and lymph node metastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22267008"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "118 gc & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No difference",
    "expression_details": "down (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "tumor",
    "tumor_size_details": "expression of miR-192 was significantly lower in the pT4 stage of gastric cancer than in pT1, pT2 and pT3 stages (p = 0.026) and low miR-192  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 )",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "118 gc & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No difference",
    "expression_details": "down (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression of miR-192 was significantly lower in the pT4 stage of gastric cancer than in pT1, pT2 and pT3 stages (p = 0.026) and low miR-192  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 )",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "118 gc & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No difference",
    "expression_details": "down (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "Real Time-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low miR-215 expression  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 and p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Shanghai,China",
    "sample_type": "tissue cell line",
    "sample": "90 pairs of gc & corresponding non tumor tissues( 52 lymph node positive & 38 lymph node negative),HGC-27,SGC7901",
    "expression": "Downregulated",
    "expression_details": "down( in gc with  lymph node positive)",
    "significance": "p=0.01(gc vs normal),p=0.00",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-409-3p low expression  associated with TNM stage(p=0.01),lymph node metastasis(p=0.00",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22179828"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "119 patients tissues,SGC7901,MGC-803,BGC-823",
    "expression": "No difference",
    "expression_details": "down(cell lines),no difference  in tissues",
    "significance": "p<0.001( cell lines),not significant in tissues",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "lower miR-194 expression tends to have larger tumor size(p=0.002),more advanced pT stage(p=0.028) and miR-194 have significant lower exp. In Borrmann IV than in I,II,III group(p=0.019),lower expr. In male than in female(p<0.034)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "119 patients tissues,SGC7901,MGC-803,BGC-823",
    "expression": "No difference",
    "expression_details": "down(cell lines),no difference  in tissues",
    "significance": "p<0.001( cell lines),not significant in tissues",
    "detection_method": "Real time -PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "lower miR-194 expression tends to have larger tumor size(p=0.002),more advanced pT stage(p=0.028) and miR-194 have significant lower exp. In Borrmann IV than in I,II,III group(p=0.019),lower expr. In male than in female(p<0.034)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "70 gc & paired matched adjacent tissues,SGC7901,BGC823,MGC-803,GES-1,AGS",
    "expression": "No difference",
    "expression_details": "down(cell line),no significant difference between gc & adjacent normal tissues",
    "significance": "p<0.01(SGC7901,MGC-803,BGC-823),tissues(p=0.7)",
    "detection_method": "Real time qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expr. Of miR-335 asssociated with lymph node metastasis(p<0.001),poor pT stage(p<0.05),poor pN stage and invasion of lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21822301"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "57 pair matched gastric neoplastic & adjacent non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower expression of miR-622 associated with differentiation and lymphativ metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21528065"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 patients tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low expression miR-146a was associated with increased tumor size(p=0.06),poor differentiation(p=0.010)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "43 patients tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low expression miR-146a was associated with increased tumor size(p=0.06),poor differentiation(p=0.010)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901,NCI-N87,MKN-45,MKN-28,BGC-823,Snu-16,AGS,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low miR-126 expression was associated with large tumor size(p=0.017),local invasion(p=0.006),lymph node metastasis(p=0.013),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901,NCI-N87,MKN-45,MKN-28,BGC-823,Snu-16,AGS,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "low miR-126 expression was associated with large tumor size(p=0.017),local invasion(p=0.006),lymph node metastasis(p=0.013),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,SGC-7901,NCI-N87,MKN-45,MKN-28,BGC-823,Snu-16,AGS,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-126 expression was associated with large tumor size(p=0.017),local invasion(p=0.006),lymph node metastasis(p=0.013),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 gc tissues & non tumor mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression was associated with TNM stage(p=0.0010),lymph node metastasis(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20300657"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "55 gc & 17 non-tumor FFPE tissues,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues(p=0.026),SGC7901(p<0.01),MGC-803(p<0.05)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-106a level  associated with tumor stage,size(p<0.001),differentiation(p<0.001),lymphatic and distal metastasis(p<0.001)invasion(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "55 gc & 17 non-tumor FFPE tissues,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues(p=0.026),SGC7901(p<0.01),MGC-803(p<0.05)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/satge",
    "tumor_size_details": "miR-106a level  associated with tumor stage,size(p<0.001),differentiation(p<0.001),lymphatic and distal metastasis(p<0.001)invasion(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "55 gc & 17 non-tumor FFPE tissues,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "tissues(p=0.026),SGC7901(p<0.01),MGC-803(p<0.05)",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-106a level  associated with tumor stage,size(p<0.001),differentiation(p<0.001),lymphatic and distal metastasis(p<0.001)invasion(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "78  GC tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low miR-31 expression was associated with lymph node metastasis ,poor pT and pN stage and invasion ability into lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656284"
  },
  {
    "miRNA_name": "miR-1258",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "116 pairs of gc & adjacent normal tissues,SGC7901,MGC803, BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(SGC7901,MGC-803,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "there was association between decreased miR-1258 expression level and increased age(p=0.042),advanced pathological tumor stage (p=0.027),positive lymphatic vessel invasion(p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28521475"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "gastric acncer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "50 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression level correlated with progression of tumor invasion & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28485164"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "92 primary Gc,20 adjacent non tumorous tissues,SGc7901,MKN45,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "prognostic-high expression had poor OS & DFS for Gc patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression correlated with tumor size,Lauren's classification,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "92 primary Gc,20 adjacent non tumorous tissues,SGc7901,MKN45,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "prognostic-high expression had poor OS & DFS for Gc patients",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression correlated with tumor size,Lauren's classification,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-584-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "75 paired surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression level had nrgative correlation with tumor size larger than 3cm",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431583"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "pre and post operative serum",
    "expression": "Downregulated",
    "expression_details": "down(postoperative serum)",
    "significance": "p<0.01( 55 paired pre-postoperative),p<0.05( 15 paired pre-postoperative serum)",
    "detection_method": "qRT-pCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: miR-20a serum level",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum level correlated with  differentiation degree,lymph node metastasis,age,tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired tissues,HGC27,SGC7901,MGC803,AGS,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "QPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression inversely correlated with tumor size (P = 0.017), tumor stage (P = 0.035), lymph node metastasis (P = 0.018), and TNM stage (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired tissues,HGC27,SGC7901,MGC803,AGS,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "QPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression inversely correlated with tumor size (P = 0.017), tumor stage (P = 0.035), lymph node metastasis (P = 0.018), and TNM stage (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 paired tissues,HGC27,SGC7901,MGC803,AGS,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "",
    "detection_method": "QPCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression inversely correlated with tumor size (P = 0.017), tumor stage (P = 0.035), lymph node metastasis (P = 0.018), and TNM stage (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "64 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression not significantly asociated with tumor location,size,stage & grading(p>0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26250158"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "64 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression not significantly asociated with tumor location,size,stage & grading(p>0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26250158"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "130 GC & 22 control serum",
    "expression": "Downregulated",
    "expression_details": "down(in stage IV than in I &III)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression in T stage,vessel invasion,lymph node,peritoneal & distant metastasis,predicts metastasis & early recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum",
    "sample": "130 GC & 22 control serum",
    "expression": "Downregulated",
    "expression_details": "down(in stage IV than in I &III)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "low expression in T stage,vessel invasion,lymph node,peritoneal & distant metastasis,predicts metastasis & early recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression associated with tumor size,lymph node metastasis,primary tumors( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with tumor size,lymph node metastasis,primary tumors( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "107 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "positive correlation with lymphatic metastasis,clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "36 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "inverse correlation with invasion depth(p=0.031),clinical stage(p=0.002),Lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "95 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor : lymph node metastasis(p=0.003),distant metastasis(p=0.001),TNM(p<0.001) & miR-141  expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with tumor diffrentiation(p=0.044),positive lymph node metastasis(p=0.010),distant metastasis(p<0.001),advanced TNM stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26681225"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "80 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "level was also correlated with cancer differentiation stage, lymph node metastasis, TNM stage and tumor size (P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "80 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "level was also correlated with cancer differentiation stage, lymph node metastasis, TNM stage and tumor size (P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "80 gc & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "level was also correlated with cancer differentiation stage, lymph node metastasis, TNM stage and tumor size (P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "no correlation between miR-421 level and age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis,but correlatrd with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "no correlation between miR-421 level and age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis,but correlatrd with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "no correlation between miR-421 level and age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis,but correlatrd with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "associated with tumor size,TNM stage,lymph node metastasis presence(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with tumor size,TNM stage,lymph node metastasis presence(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with tumor size,TNM stage,lymph node metastasis presence(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "81 tissues,GES1,NCI-N87, MKN87, SNU16, SGC7901, AGS, MKN28, and MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression associated with poor histological diffrentiation & distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "inverse correlation  with tumor size & pathological stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "60 tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "inverse correlation  with tumor size & pathological stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "115 gc 7 40 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down( in GC plasma samples),up(after treatment)",
    "significance": "p<0.01( for gc vs normal & before treatment vs after treatment plasma)",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with lymph node metastasis (P = 0.016), tumor differentiation (P = 0.001), and TNM stage (P = 0.005).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173244"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue serum",
    "sample": "tissues,62 gc & 36 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05( tissues & serum)",
    "detection_method": "QF-RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation with the infiltration depth, the extent of differentiation, the clinical staging and lymph node metastasis (all p <0.05), but not correlated with tumor locations (p >0.05).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27097947"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue cell line",
    "sample": "40 tissues ,MGC-803, MKN-45, AGS, SGC- 7901,GES1",
    "expression": "",
    "expression_details": "",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-31 was associated with poor tumor differentiation, lymph node metastasis, advanced T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 tissues,SGC-7901, AGS, MKN-45, MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "high expression  associated with poor histological features (P=0.025), large tumor size (P=0.003), advanced TNM stage (P=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "80 tissues,SGC-7901, AGS, MKN-45, MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "high expression  associated with poor histological features (P=0.025), large tumor size (P=0.003), advanced TNM stage (P=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "112 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with tumor differentiation (P < 0.001), depth of tumor invasion (P = 0.006), and TNM stage (P < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323107"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression associated with TNM stage & lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27220320"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "tissue",
    "sample": "106 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0318",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression is correlated with advanced tumor stage and lymph node metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27078844"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 paired tissues,SGC-7901, MKN-28, MKN-45, BGC-823, AGS,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "positive association with tumor size(p=0.012),lymoh node metastasis(p0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 paired tissues,SGC-7901, MKN-28, MKN-45, BGC-823, AGS,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "positive association with tumor size(p=0.012),lymoh node metastasis(p0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Real time RT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with lymphovascular invasion & TNM-III & IV(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904131"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "associated with depth of invasion (P = 0.005), tumor size (P = 0.024), lymph node metastasis (P = 0.048), and TNM stage (P = 0.035)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "associated with depth of invasion (P = 0.005), tumor size (P = 0.024), lymph node metastasis (P = 0.048), and TNM stage (P = 0.035)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with depth of invasion (P = 0.005), tumor size (P = 0.024), lymph node metastasis (P = 0.048), and TNM stage (P = 0.035)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "55 paired tissues,TCGA data",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.001(TCGA)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "associated with tumor sizes(p=0.015)and depth of invasion(p=0.010).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27827403"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "55 paired tissues,TCGA data",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.001(TCGA)",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with tumor sizes(p=0.015)and depth of invasion(p=0.010).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27827403"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "54 gc & 54 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "ISH",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-204 level was significantly associated with no lymph node metastasis (P = 0.003) and early tumor stages (stages I-II; P = 0.048).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28133610"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression associated with depth of invasion (P = 0.030), tumor size (P = 0.047), lymph node metastasis (P = 0.047), and TNM stage (P = 0.048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression associated with depth of invasion (P = 0.030), tumor size (P = 0.047), lymph node metastasis (P = 0.047), and TNM stage (P = 0.048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with depth of invasion (P = 0.030), tumor size (P = 0.047), lymph node metastasis (P = 0.047), and TNM stage (P = 0.048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low expression associated with tumor size(p=0.012), TNM stage(p=0.007)  lymph node metastasis(p=0.007) and distant metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression associated with tumor size(p=0.012), TNM stage(p=0.007)  lymph node metastasis(p=0.007) and distant metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "70 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with tumor size(p=0.012), TNM stage(p=0.007)  lymph node metastasis(p=0.007) and distant metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "231 pared gc &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "Low expression  associated with tumor size (P = 0.030), venous invasion (P = 0.027), peritoneal dissemination (P = 0.027), lymph node metastasis (P = 0.033), poor pT stage (P = 0.040), poor pN stage (P = 0.038), poor TNM stage (P = 0.005), and invasion into lymphatic vessels (P = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "231 pared gc &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "Low expression  associated with tumor size (P = 0.030), venous invasion (P = 0.027), peritoneal dissemination (P = 0.027), lymph node metastasis (P = 0.033), poor pT stage (P = 0.040), poor pN stage (P = 0.038), poor TNM stage (P = 0.005), and invasion into lymphatic vessels (P = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "231 pared gc &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "expression": "Downregulated",
    "expression_details": "down(hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic- high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "Low expression  associated with tumor size (P = 0.030), venous invasion (P = 0.027), peritoneal dissemination (P = 0.027), lymph node metastasis (P = 0.033), poor pT stage (P = 0.040), poor pN stage (P = 0.038), poor TNM stage (P = 0.005), and invasion into lymphatic vessels (P = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "90 paired gc & adjacent non tumor tissues,N‐87, SGC‐7901, AGS, SNU‐16, MKN‐45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "high expression reduced OS(p=0.012) & DFS(p=0.015)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high expression of miR‐520c had more lymph node metastasis (P = 0.019) and advanced TNM stage (P = 0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-519d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "lower miR-519d expression was associated with distant metastasis, lymph node metastasis and clinical stage for patients with GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28861156"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "low expression  associated with tumor size (p=0.001), lymphatic metastasis (p=0.008) and TNM stage (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "low expression  associated with tumor size (p=0.001), lymphatic metastasis (p=0.008) and TNM stage (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "88 gc and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression  associated with tumor size (p=0.001), lymphatic metastasis (p=0.008) and TNM stage (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue blood",
    "sample": "tissues and peripheral blood samples from 96 gastric cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "Real time-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "tissue and serum miR-144 levels were both associated with clinical stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "Low expression correlated with lymph node metastasis, invasive depth and TNM staging in gastric cancer patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression  correlated with the clinical stage, lymph node metastasis and tumor invasion in gastric cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28714005"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "tissues,AGS, SGC-7901, NCI-N87, GES-1, MKN-45 ,BGC-823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "correlated with the progression of tumor invasion and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28689850"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "increased",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "miR-148-3p",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "miR-148-3p",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "60 paired GC and matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression of miR-381 was associated with lymphatic metastasis (P=0.031) and advanced TNM stage (III+IV, P=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927144"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression  correlated with age (p = 0.036), tumor size (p = 0.001), histological type (p = 0.003), depth of invasion (p = 0.007), venous invasion (p = 0.002), hematogenous metastasis (p = 0.022), and pathological stage (p = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression  correlated with age (p = 0.036), tumor size (p = 0.001), histological type (p = 0.003), depth of invasion (p = 0.007), venous invasion (p = 0.002), hematogenous metastasis (p = 0.022), and pathological stage (p = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression  correlated with age (p = 0.036), tumor size (p = 0.001), histological type (p = 0.003), depth of invasion (p = 0.007), venous invasion (p = 0.002), hematogenous metastasis (p = 0.022), and pathological stage (p = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "109 GC patients,MGC 80-3, MKN45, SNU-5, AGS and KATOIII",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "a strong correlation between miR-647 expression and TNM stage (p=0.0020), lymph-node metastasis (p=0.0046) and local invasion (p=0.0062)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "ESCC",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "serum cell line exosome",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "expression": "Upregulated",
    "expression_details": "up(ESCC serum, exosomes)",
    "significance": "",
    "detection_method": "",
    "marker": "",
    "marker_details": "serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "serum low expression in T1/T2 than T3/T4(p=0.0024),low in without lymph node metastasis than with metastasis(p=0.0002),without distant metastasis than with metastasis(p=0.0020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "138 gc & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic :AUC-0.80, Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "associated with T stage, distant metastasis, and differentiation",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "expression": "Upregulated",
    "expression_details": "up(in gc tissues & plasma,up due to promoter hypomethylation)& down(in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "q-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high miR-106a expression was closely related to the degree of lymphatic metastasis and TNM staging of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Prognostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity,Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high level was significantly correlated with clinical stage (p<0.001),lymph node metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic : AUC=0.79,Prognostic : overall survival rate with high miR-21 expr. Was lower than low expr.(p<0.05)",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "high up regulated miR-21 expr. Associated with histological type(p<0.001),T stage(p<0.001),lymph node metastasis(p<.001),pTNM (p<0.05) in univariate amd pTNM(p=.001),lymph node metastasis (p=.001) in multivariate analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "g miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "size",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "plasma",
    "sample": "98 gc & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "up( gc & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "metastasis",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "150 gc & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "",
    "therapy_details": "",
    "tumor_size": "recurrence",
    "tumor_size_details": "low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-21",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "reduced",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "the",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "sensitivity",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "RT",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "miR-21",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "reduced",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "the",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "sensitivity",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "of",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "china",
    "sample_type": "tissue serum",
    "sample": "serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "",
    "marker_details": "",
    "therapy": "RT",
    "therapy_details": "RT",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05),miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "Downregulated",
    "tumor_size": "TNM/stsge",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "after",
    "tumor_size": "TNM/stsge",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "up(sera,tissues of ESCC),down( after chemotherapy)",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "CT",
    "therapy_details": "chemotherapy",
    "tumor_size": "TNM/stsge",
    "tumor_size_details": "serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "ESCC",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "chemosensitivity",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cisplatin",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppresses",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "tumor",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "growth",
    "tumor_size": "metastasis",
    "tumor_size_details": "negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "miR-22",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "expression",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "sensitizes",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "ESCC",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "cells",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "to",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "RT",
    "therapy_details": "irradiation",
    "tumor_size": "/stage",
    "tumor_size_details": "associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "had",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "no",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "significance",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-pCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-141",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "increased",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-200c",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "and",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "miR-141",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "gc specimens,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "down( due to highly methylated CpG island located upstream or upregulated TGF-beta signalling",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "CT",
    "therapy_details": "expression",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "docetaxel",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "treatment",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "suppressesgc",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "cell",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "movement",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "via",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "regulating",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "miR-29c-mediated",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "catenin-δ",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue cell line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "",
    "marker_details": "",
    "therapy": "CT",
    "therapy_details": "axis",
    "tumor_size": "metastasis",
    "tumor_size_details": "reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "miR-125b",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "level",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "associated",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "with",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "trastuzumab",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "resistance",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "in",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "HER2-positive gastric",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "tissue",
    "sample": "132 gc & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "",
    "therapy_details": "cancer (P<0.05).",
    "tumor_size": "metastasis",
    "tumor_size_details": "expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "sensitizes",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "sensitizes",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "GC",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "cells",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "to",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "CDDP",
    "tumor_size": "size",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "",
    "population": "",
    "sample_type": "TCGA,GEO,tissues,cell lines",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "down in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "prognostic marker for CDDP resistance in GC",
    "therapy": "CT",
    "therapy_details": "CDDP",
    "tumor_size": "TNM/stage",
    "tumor_size_details": "expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "patients",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "with",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "higher",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "miR-7",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "level",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "were",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "much",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "more",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "sensitive",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "to",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "size",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "down(ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "",
    "marker": "Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841,miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "CRT",
    "therapy_details": "CRT",
    "tumor_size": "metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  }
]